Haemonetics Corporation
Buy, Hold or Sell?

Let's analyse Haemonetics together

Penke I guess you are interested in Haemonetics Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Haemonetics Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Haemonetics Corporation

I send you an email if I find something interesting about Haemonetics Corporation.

Quick analysis of Haemonetics (30 sec.)

What can you expect buying and holding a share of Haemonetics? (30 sec.)

How much money do you get?

$0.11

When do you have the money?

1 year

How often do you get paid?

7.5%

What is your share worth?

Current worth

$18.34

Expected worth in 1 year

$21.52

How sure are you?

62.5%

+ What do you gain per year?

Total Gains per Share

$3.30

Return On Investment

3.9%

For what price can you sell your share?

Current Price per Share

$85.07

Expected price per share

$72.86 - $90.53

How sure are you?

50%

1. Valuation of Haemonetics (5 min.)

Live pricePrice per Share (EOD)

$85.07

Book Value per Share

$18.34

Intrinsic Value Per Share

$-60.73 - $-0.81

Total Value Per Share

$-42.39 - $17.52

My calculation of the intrinsic value of Haemonetics is based how much money is coming from the company's main activities (Free Cash Flow).

The following numbers are based on moving averages and per share and per quarter.
I use a 6% discount rate for the low estimation and 3% for the high estimation.
The current Free Cash Flow Per Share is 10Y: ($0.38) 3Y: ($0.47) TTM: ($0.63)
The change per quarter (trend) of the Free Cash Flow Per Share is 10Y: ($-0.03) 3Y: ($-0.13) TTM: ($-0.34)

Years	Total Low est.	Total High est.	Added Free Cash Flow
1	$0.24	$1.60	$-0.53 - $1.47
2	$-1.41	$2.76	$-2.60 - $1.07
3	$-4.75	$3.52	$-4.67 - $0.67
4	$-9.57	$3.89	$-6.74 - $0.26
5	$-15.70	$3.90	$-8.81 - $-0.14
6	$-22.98	$3.57	$-10.88 - $-0.55
7	$-31.25	$2.91	$-12.95 - $-0.95
8	$-40.38	$1.95	$-15.02 - $-1.36
9	$-50.24	$0.70	$-17.09 - $-1.76
10	$-60.73	$-0.81	$-19.16 - $-2.16

2. Growth of Haemonetics (5 min.)

Is Haemonetics growing?

	Current year	Previous year	Grow	Grow %
How rich?	$943.3m	$756.2m	$123.6m	14.1%

How much money is Haemonetics making?

	Current year	Previous year	Grow	Grow %
Making money	$31.6m	$23.9m	$7.7m	24.3%
Net Profit Margin	10.0%	8.3%	-	-

How much money comes from the company's main activities?

Quarterly Yearly

3. Financial Health of Haemonetics (5 min.)

4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)

Industry Rankings (Medical Instruments & Supplies)

Richest
#48 / 169

Most Revenue
#51 / 169

Most Profit
#44 / 169

Most Efficient
#64 / 169

What can you expect buying and holding a share of Haemonetics? (5 min.)

Welcome investor! Haemonetics's management wants to use your money to grow the business. In return you get a share of Haemonetics.

What can you expect buying and holding a share of Haemonetics?

First you should know what it really means to hold a share of Haemonetics. And how you can make/lose money.

Speculation

The Price per Share of Haemonetics is $85.07. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

The fundamentals: the financial health trends of Haemonetics.
The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Haemonetics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $18.34. Based on the TTM, the Book Value Change Per Share is $0.80 per quarter. Based on the YOY, the Book Value Change Per Share is $0.23 per quarter.
You may receive quarterly/yearly dividend in the form of additional shares.
You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.03 per quarter.

Based on historical numbers we can estimate the returns while holding a share of Haemonetics.

How much money are you going to get?

	MRQ		TTM		YOY		5Y		10Y
	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share
Usd Eps	0.61	0.7%	0.62	0.7%	0.47	0.5%	0.42	0.5%	0.22	0.3%
Usd Book Value Change Per Share	0.95	1.1%	0.80	0.9%	0.23	0.3%	0.31	0.4%	0.07	0.1%
Usd Dividend Per Share	0.00	0.0%	0.03	0.0%	0.35	0.4%	0.08	0.1%	0.04	0.0%
Usd Total Gains Per Share	0.95	1.1%	0.82	1.0%	0.58	0.7%	0.38	0.5%	0.10	0.1%
Usd Price Per Share	85.51	-	85.75	-	70.27	-	88.47	-	69.03	-
Price to Earnings Ratio	35.20	-	36.03	-	46.25	-	16.04	-	-52.79	-
Price-to-Total Gains Ratio	90.13	-	107.38	-	144.00	-	34.55	-	-65.83	-
Price to Book Ratio	4.66	-	5.01	-	4.78	-	6.55	-	5.02	-
Price-to-Total Gains Ratio	90.13	-	107.38	-	144.00	-	34.55	-	-65.83	-

When do you get the money?

Usd Investment	$.00
Usd Price Per Share	85.07
Number of shares	11

Gains per Quarter	Trailing 12 Months	5 Year
Usd Dividend Per Share	0.03	0.08
Usd Book Value Change Per Share	0.80	0.31
Usd Total Gains Per Share	0.82	0.38
Gains per Quarter (11 shares)	9.07	4.23
Gains per Year (11 shares)	36.27	16.90

Years	Return on Investment (TTM)			Return on Investment (5Y)
	Dividend	Book Value gain	Total gains	Dividend	Book Value gain	Total gains
Broker costs	-	-	-10	-	-	-10
1	1	35	26	3	14	7
2	2	70	62	7	27	24
3	4	105	98	10	41	41
4	5	140	134	13	54	58
5	6	175	170	17	68	75
6	7	210	206	20	81	92
7	9	245	242	23	95	109
8	10	280	278	27	108	126
9	11	315	314	30	122	143
10	12	350	350	34	136	160

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %

	Trailing 12 Months				3Y				5 Year				10 Year				ALLTIME
				%				%				%				%				%
Earnings Per Share	4.0	0.0	0.0	100.0%	10.0	2.0	0.0	83.3%	17.0	3.0	0.0	85.0%	28.0	12.0	0.0	70.0%	115.0	16.0	0.0	87.8%
Book Value Change Per Share	4.0	0.0	0.0	100.0%	10.0	2.0	0.0	83.3%	15.0	5.0	0.0	75.0%	24.0	16.0	0.0	60.0%	98.0	33.0	0.0	74.8%
Dividend per Share	2.0	0.0	2.0	50.0%	3.0	0.0	9.0	25.0%	3.0	0.0	17.0	15.0%	3.0	0.0	37.0	7.5%	4.0	0.0	127.0	3.1%
Total Gains per Share	4.0	0.0	0.0	100.0%	11.0	1.0	0.0	91.7%	16.0	4.0	0.0	80.0%	25.0	15.0	0.0	62.5%	99.0	32.0	0.0	75.6%

Fundamentals of Haemonetics

About Haemonetics Corporation

https://www.haemonetics.com
Medical Instruments & Supplies
3034
125 Summer Street, Boston, MA, United States, 02110
Google Maps Bing Maps

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system, and Donor360. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot including collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-04 15:12:03.

Financial Health

Profitability Details

	Compared to previous year	Compared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.

Operating Efficiency Details

	Compared to previous year	Compared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.

Liquidity Details

	Compared to previous year	Compared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.

Solvency Details

	Compared to previous year	Compared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details

	Compared to previous year	Compared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Haemonetics Corporation.

1.1. Profitability

1.1.1. Net Profit Margin

Measures how much net profit Haemonetics earns for each $1 of revenue.

Above 10% is considered healthy but always compare Haemonetics to the Medical Instruments & Supplies industry mean.
A Net Profit Margin of 9.3% means that $0.09 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Haemonetics Corporation:

The MRQ is 9.3%. The company is making a profit. +1
The TTM is 10.0%. The company is making a profit. +1

Trends

Current period		Compared to		+/-
MRQ	9.3%	TTM	10.0%	-0.7%
TTM	10.0%	YOY	8.3%	+1.7%
TTM	10.0%	5Y	8.1%	+1.9%
5Y	8.1%	10Y	4.3%	+3.8%

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	9.3%	6.2%	+3.1%
TTM	10.0%	6.4%	+3.6%
YOY	8.3%	8.0%	+0.3%
5Y	8.1%	7.3%	+0.8%
10Y	4.3%	6.8%	-2.5%

Measures how much net profit Haemonetics earns for each $1 of revenue.

Revenue is the amount of profit Haemonetics generates before taxes and all other costs. For example, when you buy a cup of coffee it will cost you $3. The company does not earn $3 in profit but also has to pay various costs and taxes to create that cup of coffee. Let's assume the cost of creating a cup of coffee is $1.5.

The $3 you pay for a cup of coffee is called revenue.
The $1.5 that’s left over when all costs to create that cup of coffee (including taxes) are deduced from the revenue is called net profit.

The net profit margin looks at how much net profit Haemonetics earns for each $1 in revenue.

How to use net profit margin

Higher profit margin is better (more profit).
Above 10% is considered healthy but always compare Haemonetics to the Medical Instruments & Supplies industry mean.
Can be used to compare companies within the Medical Instruments & Supplies industry.

You typically want a high profit margin. This means that for each $1 in sales, Haemonetics makes more profit. This shows the investor how efficiently Haemonetics is operating in general and compared to other companies in the same industry. Haemonetics operates in the Medical Instruments & Supplies industry.

Why do investors use net profit margin in their analysis

It helps investors to determine the efficiency of Haemonetics. If profit margins remain low (compared to the Medical Instruments & Supplies industry mean) and there are no improvements to make in production costs or other areas that might be a warning sign. If profit margins are high that means the company has low overhead costs and is efficiently using its resources to generate profit.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Net Profit Margin of Haemonetics is 0.09. This means that Haemonetics earned $0.09 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Net Profit Margin of the Medical Instruments & Supplies industry is 6.2%.
What is the trend?
The trend is important because it shows you how Haemonetics is performing over time. The most recent quarter might be important if Haemonetics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Haemonetics up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare Haemonetics with other companies in the same industry (Medical Instruments & Supplies).
Net profit margin should rise over the years.
Can be influenced when Haemonetics sells assets (profit will increase while costs remain the same).
It won’t show what part of Haemonetics is doing great or needs improvement (it only looks at total revenue and total net income).

How to calculate net profit margin

Net profit margin = net income / total revenue * 100%

Real example of Haemonetics

You need the following data to determine net profit margin:

Income statement from the period you want to calculate (for example, MRQ or TTM).

Net income MRQ Haemonetics = 31,241
Total revenue MRQ Haemonetics = 336,250
$31,241 / $336,250 = 0.09 or 9.3%

Higher is better

The higher the net profit margin, the more efficient the company is generating income. This helps investors to determine how the company is managing money. The net profit margin is an important indicator when diving into the financial health of a company. Overall, you want to see the net profit margin rising over the years. That means the company improved their production and made it more efficient (if possible).

You can use the net profit margin to compare companies within the same industry. If there are two companies where one is much bigger but the smaller one has a higher net profit margin, that means the smaller company is more efficiently using operational costs.

Important: Profit margins can be very different between industries. Companies with assembly lines or transports are much more prone to see shifting in prices for fuel, ingredients and maintenance compared to companies that only provide services. You should never compare net profit margin between different industries.

1.1.2. Return on Assets

Shows how efficient Haemonetics is using its assets to generate profit.

Above 5% is considered healthy but always compare Haemonetics to the Medical Instruments & Supplies industry mean.
1.4% Return on Assets means that Haemonetics generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Haemonetics Corporation:

The MRQ is 1.4%. Using its assets, the company is less efficient in making profit.
The TTM is 1.6%. Using its assets, the company is less efficient in making profit.

Trends

Current period		Compared to		+/-
MRQ	1.4%	TTM	1.6%	-0.1%
TTM	1.6%	YOY	1.3%	+0.3%
TTM	1.6%	5Y	1.4%	+0.2%
5Y	1.4%	10Y	0.7%	+0.6%

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	1.4%	1.3%	+0.1%
TTM	1.6%	1.4%	+0.2%
YOY	1.3%	1.9%	-0.6%
5Y	1.4%	2.1%	-0.7%
10Y	0.7%	2.0%	-1.3%

Shows how efficient Haemonetics is using its assets to generate profit.

For a farm, a tractor is considered an asset. The tractor helps ploughing the land making it possible to plant and harvest crops. But the tractor might be old and needing maintenance all the time reducing its efficiency. Return on assets indicates how effectively the farm is using the tractor (and other assets that help the core business) to plough the land.

How to use return on assets

Higher is better.
Above 5% is considered healthy but always compare Haemonetics to the Medical Instruments & Supplies industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on assets in their analysis

Shows the investor how effectively Haemonetics is using its resources to generate profit. If the return on assets (1.4%) from Haemonetics are higher than the Medical Instruments & Supplies mean (1.3%) that means Haemonetics is using its resources better than their competitors. If not, that means their competitors are more efficient in using their resources to generate profit.

An investor should always look at:

What is the current return on assets?
The current most recent quarter (MRQ) Return on Assets of Haemonetics is 1.4%. This means the company generated $0.01 for each $1 in assets.
How does it compare to the industry?
The mean MRQ Return on Assets of the Medical Instruments & Supplies industry is 1.3%.
What is the trend?
The trend is important because it shows you how Haemonetics is performing over time. The most recent quarter might be important if Haemonetics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Haemonetics up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
If a company has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

How to calculate return on assets

Return on assets = net income / total assets * 100%

Real example Haemonetics

You need the following data to determine return on assets (ROA):

Income statement
Balance sheet

Net income MRQ (income statement) from Haemonetics = 31,241
Total assets MRQ (balance sheet) from Haemonetics = 2,200,428
31,241 / 2,200,428 = 0.01 or 1.4%

ROA is an important ratio as it will tell you how effectively Haemonetics is using its resources to generate profits. Example:

Bob and Kristin both sell ice cream in the summer. They both have an ice cream truck. The truck Bob owes cost him $20.000 and the truck Kristin owes cost her $1500. Over the summer, Bob earned $2000 and Kristin earned $200. To calculate the return on assets:

Bob: $2000 / $20.000 * 100% = 10%
Kristin: $200 / $1500 * 100% = 13.3%

This tells you Bob’s company is more valuable but Kristin's company is more efficient. Be aware that total assets can change over time. A transportation business will buy and sell trucks or planes all the time. Before using return on assets as a guideline, you have to know what the exact assets are. For a company that has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

1.1.3. Return on Equity

Shows how efficient Haemonetics is using its investors money to generate profit.

Above 15%-20% is considered healthy but always compare Haemonetics to the Medical Instruments & Supplies industry mean.
3.3% Return on Equity means Haemonetics generated $0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Haemonetics Corporation:

The MRQ is 3.3%. Using its investors money, the company is inefficient in making profit. -1
The TTM is 3.6%. Using its investors money, the company is inefficient in making profit. -1

Trends

Current period		Compared to		+/-
MRQ	3.3%	TTM	3.6%	-0.3%
TTM	3.6%	YOY	3.2%	+0.4%
TTM	3.6%	5Y	3.0%	+0.6%
5Y	3.0%	10Y	1.6%	+1.4%

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	3.3%	2.6%	+0.7%
TTM	3.6%	2.8%	+0.8%
YOY	3.2%	3.7%	-0.5%
5Y	3.0%	3.9%	-0.9%
10Y	1.6%	3.9%	-2.3%

Shows how efficient Haemonetics is using its investors money to generate profit.

A publicly traded company (any company that issues shares to the public) is owned by its shareholders. Return on equity calculates the amount of profit for every $1 the shareholders invested.

How to use return on equity

Higher is better.
Above 15%-20% is considered healthy but always compare Haemonetics to the Medical Instruments & Supplies industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on equity in their analysis

To find out the owners/management's attitude toward their company. You typically want the owners/management to invest in the company and focus on generating profit. If not enough profit is generated (compared to the Medical Instruments & Supplies industry mean), the company might not be investing their money efficiently.

The three steps every investor should look at:

What is the current return on equity?
The current most recent quarter (MRQ) Return on Equity of Haemonetics is 3.3%. This means Haemonetics generated $0.03 for each $1 the owners (shareholders) invested.
How does it compare to the industry?
The mean MRQ Return on Equity of the Medical Instruments & Supplies industry is 2.6%.
What is the trend?
The trend is important because it shows you how Haemonetics is performing over time. The most recent quarter might be important if Haemonetics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Haemonetics up to 10 years back (depending if Haemonetics existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Does not include intangible assets (non physical assets like licences, computer software, etc.).
Stockholders equity and shareholders equity refer to the same thing.
Liabilities should not be more than three times return on equity.

How to calculate return on equity

Return on equity = net profit / shareholders equity * 100%

Real example of Haemonetics

You need the following data to determine ROE:

Income statement
Balance sheet
Net profit MRQ (income statement) Haemonetics = 31,241
Shareholders equity (balance sheet) MRQ Haemonetics = 943,319
31,241 / 943,319 = 0.03 or 3.3%

A negative shareholder equity is a warning sign. It means the company has more liabilities than assets. It might also mean that the owners did not invest enough money or they are taking money out of the business.

1.2. Operating Efficiency of Haemonetics Corporation.

1.2. Operating Efficiency

1.2.1. Operating Margin

Measures how efficient Haemonetics is operating .

Measures how much profit Haemonetics makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
Above 15% is considered healthy but always compare Haemonetics to the Medical Instruments & Supplies industry mean.
An Operating Margin of 13.7% means the company generated $0.14 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Haemonetics Corporation:

The MRQ is 13.7%. The company is operating less efficient.
The TTM is 14.2%. The company is operating less efficient.

Trends

Current period		Compared to		+/-
MRQ	13.7%	TTM	14.2%	-0.5%
TTM	14.2%	YOY	12.2%	+2.0%
TTM	14.2%	5Y	10.0%	+4.2%
5Y	10.0%	10Y	5.7%	+4.3%

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	13.7%	7.9%	+5.8%
TTM	14.2%	7.6%	+6.6%
YOY	12.2%	10.9%	+1.3%
5Y	10.0%	10.1%	-0.1%
10Y	5.7%	10.5%	-4.8%

Measures how efficient Haemonetics is operating .

The more effecient a company creates products or provides services, the more profit it generates.

How to use operating margin

Higher is better
Above 15% is considered healthy but always compare Haemonetics to the Medical Instruments & Supplies industry mean.
Can be very different between industries
Can be used to compare companies

Why do investors use operating margin in their analysis

To determine how much profit Haemonetics is making from it’s core business.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Operating Margin of Haemonetics is 13.7%. This means that Haemonetics earned $0.14 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Margin of the Medical Instruments & Supplies industry is 7.9%.
What is the trend?
The trend is important because it shows you how Haemonetics is performing over time. The most recent quarter might be important if Haemonetics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Haemonetics up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Can be calculated in different ways

How to calculate operating margin

Operating margin = operating earnings / total revenue

Real example of Haemonetics

You need the following data to determine operating margin:

Income statement
Operating earnings MRQ Haemonetics = 45,978
Total revenue MRQ Haemonetics = 336,250
$45,978 / $336,250 = 0.14 or 13.7%

Operating margin is used to calculate how much profit a company makes after variable costs of production but before paying interest and taxes. Some variable costs examples are wages, raw materials, packaging, and transaction fees. The amount of variable costs is different for each company and industry. In general, a higher operating margin is better as this implicates that a company is running efficiently.

For investors, a higher operating margin is a good sign. Although you should always look at operating margin in the long term. If operating margin is fluctuating over the years this might be a sign that things are not running efficiently enough. It’s a way to check how much profit a company is making from its core business.

Operation earnings can be calculated in multiple ways:

Operation earnings = EBIT - non operating income + non operating expense
Operation earnings = Gross profit - operating expense - depreciation and amortisation
Operation earnings = Total revenue - COGS (costs of goods sold) - indirect costs

1.2.2. Operating Ratio

Measures how efficient Haemonetics is keeping operating costs low.

Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
An Operation Ratio of 0.86 means that the operating costs are $0.86 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Haemonetics Corporation:

The MRQ is 0.863. The company is less efficient in keeping operating costs low.
The TTM is 0.858. The company is less efficient in keeping operating costs low.

Trends

Current period		Compared to		+/-
MRQ	0.863	TTM	0.858	+0.005
TTM	0.858	YOY	0.878	-0.020
TTM	0.858	5Y	0.888	-0.030
5Y	0.888	10Y	0.918	-0.030

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	0.863	1.152	-0.289
TTM	0.858	1.146	-0.288
YOY	0.878	1.082	-0.204
5Y	0.888	1.097	-0.209
10Y	0.918	1.056	-0.138

Measures how efficient Haemonetics is keeping operating costs low.

If the operating ratio is below 1 that means the company is making money. The lower the operating ratio, the more efficient the company.

How to use operating ratio

Lower is better.
Below 1 is considered healthy but always compare Haemonetics to the Medical Instruments & Supplies industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use operating ratio in their analysis

Shows if costs of creating products and or services is increasing or decreasing. The lower the operating ratio, the more efficient the company is creating products and services.

The three steps every investor should look at:

What is the current Operatin ratio?
The current most recent quarter (MRQ) Operating Ratio of Haemonetics is 86.3%. This means that Haemonetics earned $0.86 for each $1 in net sales in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Ratio of the Medical Instruments & Supplies industry is 1.15.
What is the trend?
The trend is important because it shows you how Haemonetics is performing over time. The most recent quarter might be important if Haemonetics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Haemonetics up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
You need COGS to calculate operating ratio which is not always shown in the income statement.
Does not consider debt.

How to calculate operating ratio

Operating ratio = Operating expenses + COGS \ Net sales

Real life example Haemonetics

You need the following data to determine operating ratio:

Income statement

COGS is not always specified on the income statement. If so you can use the following calculation:

(cost of revenue + total operating expenses) \ total revenue
(158,383 +131,889) \ 336,250 = 0.86

The operating ratio measures the efficiency of a company at keeping low costs while generating profits from sales. It compares the total operating expenses to the net amount of sales. The total operating expenses exists of:

COGS (materials, labour, rent of facility, repairs)
Operating expenses (legal fees, marketing, wages, rent, maintenance/repairs)

Operating expenses are all the costs the company makes that are not directly tied to the production of the service or product. Where COGS are costs that are directly tied to the production of a product or service.

Do note that COGS is not always available in the income statement. Some companies include COGS in the operating expenses while others list COGS separately. To make it even more confusing, COGS is also known as “costs of sales” and costs of sales is the same as costs of revenue.

The operating ratio tells you how efficient the company is creating its products or services while keeping prices low. In this case, a lower ratio is better. Higher or rising operating ratios might tell you that costs are rising while sales are not improving or staying the same.

1.3. Liquidity of Haemonetics Corporation.

1.3. Liquidity

1.3.1. Current Ratio

Measures if Haemonetics is able to pay off Short-term Debt.

Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
A Current Ratio of 2.92 means the company has $2.92 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Haemonetics Corporation:

The MRQ is 2.923. The company is able to pay all its short-term debts. +1
The TTM is 3.160. The company is very able to pay all its short-term debts. +2

Trends

Current period		Compared to		+/-
MRQ	2.923	TTM	3.160	-0.237
TTM	3.160	YOY	2.841	+0.319
TTM	3.160	5Y	2.653	+0.507
5Y	2.653	10Y	2.654	-0.001

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	2.923	2.310	+0.613
TTM	3.160	2.339	+0.821
YOY	2.841	2.575	+0.266
5Y	2.653	2.627	+0.026
10Y	2.654	2.623	+0.031

Measures if Haemonetics is able to pay off Short-term Debt.

How to use current ratio

Higher is better
Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
Can be very different between industries
Can be used to compare companies

Why do investors use current ratio in their analysis

Shows if the company can pay of short term debts if needed. A company that can't pay off it's short term debts might get in trouble if they have to pay off their short term debts for whatever reason. For example, markets can change due to global events like covid-19 or the war in Ukraine versus Russia. Because debts are always taken based on future income, it might become troublesome for Haemonetics if something happens in the market that will cause sales to plummet.

The three steps every investor should look at:

What is the current current Ratio?
The current most recent quarter (MRQ) Current Ratio of Haemonetics is 2.92. This means Haemonetics has $2.92 in assets for each $1 in short-term debts.
How does it compare to the industry?
The mean MRQ Current Ratio of the Medical Instruments & Supplies industry is 2.31.
What is the trend?
The trend is important because it shows you how Haemonetics is performing over time. The most recent quarter might be important if Haemonetics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Haemonetics up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Might be deluded.
Not all assets can always be quickly sold.
Can be manipulated by increasing or decreasing the assets and/or liabilities.

How to calculate current ratio

Current ratio = current assets \ current liabilities

Real life example Haemonetics

You need the following data to determine operating ratio:

Balance sheet
Current ratio = current assets \ current liabilities
764,982 \ 261,755) = 2.92

The current ratio measures if Haemonetics is able to pay short-term debts (obligations). Short term in this context means all debt obligations that are about to expire within one year. The current ratio incorporates current liabilities and current assets. Current assets are all the assets a company has that are expected to be consumed or sold within standard business operations. You can find the current assets in the balance sheet. They consist of:

Inventory
Accounts receivable
Marketable securities
Prepaid expenses
Cash
Cash equivalents
liquid assets

The current liabilities are short term obligations that are due within one year. These consist of:

Short term debts
Dividends
Income taxes
Short-term debts
Accounts payable
Interest payments

The result shows an investor if Haemonetics is able to pay all its short-term debts if they were due all at once. When the result of the above formula is below 1, then Haemonetics does not have enough capital after selling all its assets to pay all short-term debts. If the ratio drops far below 1 that might indicate Haemonetics is or will be in financial trouble anytime soon.

Although this gives an investor some clues, the current ratio may also be deluded. Because owning assets does not mean the company can easily sell them. Also, Accounts receivable may be quite old (they will probably never pay) which deludes the current ratio. As with all ratios, you should only compare them between the same industries and companies.

1.3.2. Quick Ratio

Measures if Haemonetics is able to pay off Short-term Debt but only using the most liquid assets.

Above 1 is considered healthy but always compare Haemonetics to the Medical Instruments & Supplies industry mean.
A Quick Ratio of 1.55 means the company can pay off $1.55 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Haemonetics Corporation:

The MRQ is 1.549. The company is very able to pay all its short-term debts with the most liquid assets. +2
The TTM is 1.839. The company is very able to pay all its short-term debts with the most liquid assets. +2

Trends

Current period		Compared to		+/-
MRQ	1.549	TTM	1.839	-0.290
TTM	1.839	YOY	1.580	+0.259
TTM	1.839	5Y	1.433	+0.406
5Y	1.433	10Y	1.463	-0.029

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	1.549	1.105	+0.444
TTM	1.839	1.137	+0.702
YOY	1.580	1.306	+0.274
5Y	1.433	1.430	+0.003
10Y	1.463	1.533	-0.070

Measures if Haemonetics is able to pay off Short-term Debt but only using the most liquid assets.

How to use quick ratio

Higher is better.
Above 1 is considered healthy but always compare Haemonetics to the Medical Instruments & Supplies industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use quick ratio in their analysis

Shows how fast Haemonetics can pay off its short term debts. This shows if Haemonetics can survive emergencies due to market changes or other reasons.

The three steps every investor should look at:

What is the current Quick Ratio?
The current most recent quarter (MRQ) quickRatio of Haemonetics is 1.55. This means that Haemonetics can pay off $1.55 for each $1 in debt (using most liquid assets).
How does it compare to the industry?
The mean MRQ Quick Ratio of the Medical Instruments & Supplies industry is 1.11.
What is the trend?
The trend is important because it shows you how Haemonetics is performing over time. The most recent quarter might be important if Haemonetics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Haemonetics up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Incorporates only most liquid assets.

How to calculate quick ratio

Quick ratio = cash and equivalents + marketable securities + accounts receivable / current liabilities

Real life example Haemonetics

You need the following data to determine operating ratio:

Balance sheet
Quick ratio = cash and short-term investments + short-term investments + netReceivables / total current liabilities
MRQ quick ratio Haemonetics: (193,978 + 0 +211,611) / 261,755 = 1.55

The quick ratio measures the same thing as the current ratio, only it uses the most liquid assets a company has. Meaning, the assets that can be sold for cash the easiest and fastest.

As the quick ratio only incorporates the most liquid assets, you should also check the current ratio which also includes less liquid assets. But they may be harder to sell.

1.4. Solvency of Haemonetics Corporation.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Measures how much % of Haemonetics assets are financed with debt.

Below 1 (100%) is considered healthy but always compare Haemonetics to Medical Instruments & Supplies industry mean.
A Debt to Asset Ratio of 0.57 means that Haemonetics assets are financed with 57.1% credit (debt) and the remaining percentage (100% - 57.1%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Haemonetics Corporation:

The MRQ is 0.571. The company is able to pay all its debts by selling its assets. +1
The TTM is 0.566. The company is able to pay all its debts by selling its assets. +1

Trends

Current period		Compared to		+/-
MRQ	0.571	TTM	0.566	+0.005
TTM	0.566	YOY	0.592	-0.027
TTM	0.566	5Y	0.561	+0.005
5Y	0.561	10Y	0.496	+0.065

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	0.571	0.357	+0.214
TTM	0.566	0.360	+0.206
YOY	0.592	0.358	+0.234
5Y	0.561	0.365	+0.196
10Y	0.496	0.375	+0.121

Measures how much % of Haemonetics assets are financed with debt.

When there are more debts than assets, that means creditors have a larger stake Haemonetics than its shareholders.

How to use debt to asset ratio

Lower is better.
below 1 (100%) is considered healthy but always compare Haemonetics to Medical Instruments & Supplies industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to asset ratio in their analysis

It shows how much debt the company used to finance its assets. If a company is almost entirely financed with debt that means the company might get into serious trouble when emergencies arise like a raise in interest.

The three steps every investor should look at:

What is the current debt to asset ratio?
The current most recent quarter (MRQ) Debt to Asset Ratio of Haemonetics is 0.57. This means means that Haemonetics is financed with 57.1% credit and the remaining percentage is financed by it's owners (shareholders).
How does it compare to the industry?
The mean MRQ Current Ratio of the Medical Instruments & Supplies industry is 231.0%.
What is the trend?
The trend is important because it shows you how Haemonetics is performing over time. The most recent quarter might be important if Haemonetics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Haemonetics up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Some companies can have higher debt to assets ratio's (for example, banks).
Debt to asset ratio should improve over the years.
If the debt to asset ratio is above 1, look at the industry mean and find out why Haemonetics has so much debt.

How to calculate debt to asset ratio

Debt to asset ratio = total debt \ total assets

Real life example Haemonetics

You need the following data to determine debt to asset ratio:

Balance sheet
Debt to asset ratio = total debt \ total assets
1,257,109 \ 2,200,428 = 57.1% or 0.57.

The debt to total assets ratio shows if the company is owned by creditors or shareholders. Or in other words, the total debt in relation to the total amount of assets. It shows how much debt the company used to finance its assets.

1.4.2. Debt to Equity Ratio

Measures if Haemonetics is able to pay off its debts by using shareholders equity.

Below 2 is considered healthy but always compare Haemonetics to the Medical Instruments & Supplies industry mean.
A Debt to Equity ratio of 133.3% means that company has $1.33 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Haemonetics Corporation:

The MRQ is 1.333. The company is able to pay all its debts with equity. +1
The TTM is 1.305. The company is able to pay all its debts with equity. +1

Trends

Current period		Compared to		+/-
MRQ	1.333	TTM	1.305	+0.028
TTM	1.305	YOY	1.456	-0.151
TTM	1.305	5Y	1.298	+0.006
5Y	1.298	10Y	1.031	+0.267

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	1.333	0.541	+0.792
TTM	1.305	0.561	+0.744
YOY	1.456	0.561	+0.895
5Y	1.298	0.648	+0.650
10Y	1.031	0.669	+0.362

Measures if Haemonetics is able to pay off its debts by using shareholders equity.

How to use debt to equity ratio

Lower is better.
Below 2 is considered healthy (always use industry average).
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to shareholders equity ratio in their analysis

It shows how much debt the company uses to finance their operations. Shareholders equity is whats left over when you subtract total liabilities from total assets. It's another way to meassure how much of Haemonetics is financed with debt or own resources.

The three steps every investor should look at:

What is the current debt to equity ratio?
The current most recent quarter (MRQ) quickRatio of Haemonetics is 1.33. This means that Haemonetics can pay off $1.33 for each $1 in debt.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Medical Instruments & Supplies industry is 0.54.
What is the trend?
The trend is important because it shows you how Haemonetics is performing over time. The most recent quarter might be important if Haemonetics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Haemonetics up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Not all debt is equally risky (for example, short term risk is less risky).

How to calculate debt to equity ratio

Debt to equity ratio = total debt \ shareholders equity.

Real life example Haemonetics

You need the following data to determine equity ratio:

Balance sheet
Debt to equity ratio = total debt \ shareholders equity
1,257,109 \ 943,319 = 1.33 or 133.3%

Debt to equity measures the total debt versus the total shareholders equity. While the total debts to total assets ratio uses total assets, the debt to equity ratio looks at the total equity of shareholders. Where equity of shareholders are:

Common shares.
Preferred shares.
Retained earnings.

You can find the shareholders' equity in the balance sheet. A ratio between 0,5 and 1,5 is preferred. If the ratio is above 1.5, that would indicate creditors have significantly more stake (debt) in the company than the shareholders. In other words, the company is using a lot of debt to finance their operations.

Not all debt is equally risky. Meaning you can adjust the ratio by including or excluding certain amounts of debt. Short term debts are less risky because they have to be paid back within one year anyway. It’s much easier to plan one year ahead versus five or ten years.

2. Market Valuation of Haemonetics Corporation

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Haemonetics generates.

Above 15 is considered overpriced but always compare Haemonetics to the Medical Instruments & Supplies industry mean.
A PE ratio of 35.20 means the investor is paying $35.20 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Haemonetics Corporation:

The EOD is 35.021. Based on the earnings, the company is overpriced. -1
The MRQ is 35.203. Based on the earnings, the company is overpriced. -1
The TTM is 36.025. Based on the earnings, the company is overpriced. -1

Trends

Current period		Compared to		+/-
EOD	35.021	MRQ	35.203	-0.181
MRQ	35.203	TTM	36.025	-0.823
TTM	36.025	YOY	46.252	-10.226
TTM	36.025	5Y	16.045	+19.981
5Y	16.045	10Y	-52.794	+68.839

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
EOD	35.021	14.579	+20.442
MRQ	35.203	16.584	+18.619
TTM	36.025	17.443	+18.582
YOY	46.252	22.147	+24.105
5Y	16.045	20.830	-4.785
10Y	-52.794	25.069	-77.863

Measures how much money you pay for each share for every $1 in earnings Haemonetics generates.

Indicates if the company’s shares are under or overvalued.

How to use PE ratio

Above 15 is considered overpriced but is hard to determine. Always compare Haemonetics to the Medical Instruments & Supplies industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use PE ratio in their analysis

The PE ratio tells investors the current sentiment in the market for that company. As with every stock, the stock price never shows the real valuation of a company but rather how the market thinks how much the stock is worth.

In other words, the current stock price also incorporates any future earnings or business opportunities in the future. The best example is the stock market crash in 2000. The PE ratio for any internet based company was going through the roof. Only based on the general assumption the internet and all associated businesses would thrive in the future. But this was based on nothing. A business still needs a good product or service to be able to survive. Instead, every investor bought any stock which did something related to the internet. Result: huge market crash.

Many investors were willing to pay premium prices and that was causing the PE ratio to rise. A high PE ratio is a warning sign that investors might be overvaluing a stock based on future earnings.

The three steps every investor should look at:

What is the current PE Ratio?
The current most recent quarter (MRQ) PE Ratio of Haemonetics is 35.20. This means the investor is paying $35.20 for every $1 in earnings.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Medical Instruments & Supplies industry is 16.58.
What is the trend?
The trend is important because it shows you how Haemonetics is performing over time. The most recent quarter might be important if Haemonetics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Haemonetics up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Some industries might have very high or very low PE ratios in general.
PE ratios can be high for several years, it does not mean a sudden collapse is imminent.
Earnings growth is not included in the PE ratio.

How to calculate PE ratio

PE ratio = market value per share \ earnings per share

Real life example Haemonetics

You need the following data to determine the PE ratio:

Balance sheet
Income statement

The PE ratio is a very commonly used ratio to determine the value of a company by comparing the current stock price relative to its earnings per share (EPS). Before we can calculate the PE ratio we need to know the EPS. EPS is calculated as follows:

EPS = (net profit - preferred dividends) \ end of period outstanding shares*
Net profit = revenue - expenses
0 \ 51,445 = EPS
PE ratio MRQ = 35.20

* The net profit minus preferred dividends can be found in the incomestatement as netIncomeApplicableToCommonShares.

The PE value helps investors to determine if the current stock price is under or overvalued. It also projects future growth.

In general, a higher PE ratio means that investors predict higher future growth. If the PE ratio is too high, then investors expect way too much future growth the company can never fulfil. This is most likely to happen in faster moving companies like tech companies or automobile companies like Tesla. These are hot and booming markets where investors expect much future growth driven by new technology (electric cars). When looking at the current MRQ (most recent quarter) PE ratio of Tesla ( jan. 2021) it's about 247 while the average in the industry is only 6. That might be a clue that Tesla is trading for way too high prices compared to their current assets and is more based on future growth.

2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Haemonetics Corporation:

The EOD is -47.916. Based on how much money comes from the company's main activities, the company is expensive. -2
The MRQ is -48.164. Based on how much money comes from the company's main activities, the company is expensive. -2
The TTM is 24.729. Based on how much money comes from the company's main activities, the company is underpriced. +1

Trends

Current period		Compared to		+/-
EOD	-47.916	MRQ	-48.164	+0.248
MRQ	-48.164	TTM	24.729	-72.892
TTM	24.729	YOY	-44.482	+69.210
TTM	24.729	5Y	8.905	+15.824
5Y	8.905	10Y	6.778	+2.128

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
EOD	-47.916	9.822	-57.738
MRQ	-48.164	10.068	-58.232
TTM	24.729	1.387	+23.342
YOY	-44.482	3.453	-47.935
5Y	8.905	5.897	+3.008
10Y	6.778	-0.177	+6.955

2. Book Value per Share

2.3. Price to Book Ratio

Measures if the stock price of Haemonetics is to cheap or to expensive compared to its book value.

At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
A PB ratio of 4.66 means the investor is paying $4.66 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Haemonetics Corporation:

The EOD is 4.639. Based on the equity, the company is fair priced.
The MRQ is 4.663. Based on the equity, the company is fair priced.
The TTM is 5.013. Based on the equity, the company is overpriced. -1

Trends

Current period		Compared to		+/-
EOD	4.639	MRQ	4.663	-0.024
MRQ	4.663	TTM	5.013	-0.350
TTM	5.013	YOY	4.783	+0.230
TTM	5.013	5Y	6.552	-1.539
5Y	6.552	10Y	5.022	+1.530

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
EOD	4.639	2.398	+2.241
MRQ	4.663	2.753	+1.910
TTM	5.013	2.690	+2.323
YOY	4.783	3.294	+1.489
5Y	6.552	3.563	+2.989
10Y	5.022	4.227	+0.795

2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Haemonetics Corporation.

3.1. Institutions holding Haemonetics Corporation

Institutions are holding 101.077% of the shares of Haemonetics Corporation.

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2023-12-31	Capital Research Global Investors	12.8452	0.1372	6523568	-99580	-1.5035
2023-12-31	BlackRock Inc	11.893	0.0132	6040017	258268	4.467
2023-12-31	Vanguard Group Inc	10.6452	0.0101	5406309	25451	0.473
2023-12-31	Neuberger Berman Group LLC	6.953	0.2633	3531181	-36600	-1.0258
2023-12-31	Wellington Management Company LLP	6.435	0.0521	3268083	101029	3.19
2023-12-31	State Street Corporation	3.5239	0.0074	1789636	48151	2.7649
2023-12-31	Franklin Resources Inc	3.3353	0.0677	1693880	-505	-0.0298
2023-12-31	FMR Inc	3.1126	0.0104	1580793	-39758	-2.4534
2023-12-31	T. Rowe Price Investment Management,Inc.	2.1508	0.0607	1092299	245382	28.9736
2023-12-31	Geode Capital Management, LLC	2.1366	0.0097	1085076	51474	4.9801
2023-12-31	Royce & Associates, LP	1.9028	0.7632	966355	18805	1.9846
2023-12-31	Dimensional Fund Advisors, Inc.	1.6279	0.0206	826731	59670	7.779
2023-12-31	BTIM Corp	1.4108	0.4622	716466	-4063	-0.5639
2023-12-31	Amvescap Plc.	1.4096	0.0146	715868	-1020	-0.1423
2023-12-31	Westfield Capital Management Company, LP	1.4021	0.3549	712061	152098	27.1622
2023-12-31	Fisher Asset Management, LLC	1.4013	0.0322	711667	-150953	-17.4994
2023-12-31	Boston Partners Global Investors, Inc	1.393	0.08	707434	-24168	-3.3034
2023-12-31	Schroder Investment Management Group	1.2933	0.0728	656810	-115131	-14.9145
2023-12-31	Northern Trust Corp	1.2376	0.0097	628512	-11152	-1.7434
2023-12-31	Charles Schwab Investment Management Inc	1.0528	0.0116	534694	8901	1.6929
Total		77.1618	2.4536	39187440	+486299	+1.2%

3.2. Funds holding Haemonetics Corporation

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2023-12-31	American Funds SMALLCAP World A	6.2438	0.3768	3170964	100000	3.2563
2023-12-31	VA CollegeAmerica Amcap 529A	4.7778	0.2583	2426463	-197239	-7.5176
2023-12-31	Capital Group AMCAP Composite	4.7778	0.2583	2426463	-197239	-7.5176
2023-12-31	Neuberger Berman Genesis Inv	3.8661	1.6319	1963456	-4573	-0.2324
2024-02-29	Vanguard Total Stock Mkt Idx Inv	3.1266	0.0075	1587880	-3965	-0.2491
2024-02-29	iShares Core S&P Mid-Cap ETF	3.0416	0.1399	1544689	-4162	-0.2687
2024-02-29	Vanguard Small Cap Index	2.5756	0.0679	1308031	12194	0.941
2024-02-29	iShares Russell 2000 ETF	2.3913	0.1421	1214444	-198	-0.0163
2023-12-31	Vanguard Explorer Inv	2.0012	0.4064	1016319	-15400	-1.4927
2023-12-31	American Funds IS® Global Small Cap 1	1.7561	2.3948	891864	0	0
2024-02-29	Vanguard Institutional Extnd Mkt Idx Tr	1.4771	0.0537	750185	-1546	-0.2057
2023-12-31	Franklin U.S. Large Cap Gr Eq	1.4517	0.3625	737264	0	0
2024-02-29	Franklin Growth A	1.4517	0.2892	737264	0	0
2024-02-29	Vanguard Small Cap Growth Index Inv	1.4473	0.1537	735029	12479	1.7271
2023-12-31	Fidelity Small Cap Index	0.981	0.1676	498234	6214	1.263
2023-12-31	Franklin US Small Cap Growth Equity	0.9562	1.4979	485600	0	0
2024-02-29	Franklin Small Cap Growth Adv	0.9562	1.2221	485600	0	0
2023-12-31	Fidelity Small Cap Growth	0.9107	0.6925	462491	10600	2.3457
2024-02-29	iShares Russell 2000 Growth ETF	0.8677	0.2833	440695	996	0.2265
2024-02-29	SPDR® S&P MIDCAP 400 ETF Trust	0.798	0.1407	405278	1524	0.3775
Total		45.8555	10.5471	23288213	-280315	-1.2%

3.3. Insider Transactions

Insiders are holding 0.764% of the shares of Haemonetics Corporation.

Date	Owner	Type	Amount	Price
2023-09-12	Stewart W Strong	SELL	228	90.65
2023-09-11	Anila Lingamneni	SELL	2305	90
2023-07-18	Josep Llorens	SELL	4928	90
2023-05-30	Anila Lingamneni	SELL	2304	83.33

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Haemonetics Corporation compared to the Most Recent Quarter (MRQ).

	End of day	+/-	Most Recent Quarter	Trailing 12 Months	+/-	Year-Over-Year	+/-	5 Year	+/-	10 Year	+/-
Book Value Change Per Share	-	-	0.949	0.797	+19%	0.229	+314%	0.308	+208%	0.066	+1348%
Book Value Per Share	-	-	18.336	17.134	+7%	14.697	+25%	13.997	+31%	14.336	+28%
Current Ratio	-	-	2.923	3.160	-8%	2.841	+3%	2.653	+10%	2.654	+10%
Debt To Asset Ratio	-	-	0.571	0.566	+1%	0.592	-4%	0.561	+2%	0.496	+15%
Debt To Equity Ratio	-	-	1.333	1.305	+2%	1.456	-8%	1.298	+3%	1.031	+29%
Dividend Per Share	-	-	-	0.028	-100%	0.353	-100%	0.076	-100%	0.038	-100%
Eps	-	-	0.607	0.616	-1%	0.465	+31%	0.420	+44%	0.221	+175%
Free Cash Flow Per Share	-	-	-0.444	0.628	-171%	0.623	-171%	0.474	-194%	0.384	-216%
Free Cash Flow To Equity Per Share	-	-	1.683	1.114	+51%	0.101	+1575%	0.703	+139%	0.337	+400%
Gross Profit Margin	-	-	1.000	0.939	+7%	1.000	0%	0.988	+1%	0.994	+1%
Intrinsic Value_10Y_max	-	-	-0.812	-	-	-	-	-	-	-	-
Intrinsic Value_10Y_min	-	-	-60.729	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_max	-	-	1.597	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_min	-	-	0.242	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_max	-	-	3.520	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_min	-	-	-4.748	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_max	-	-	3.900	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_min	-	-	-15.702	-	-	-	-	-	-	-	-
Market Cap	4320373527.000	-2%	4399061950.000	4403185245.000	0%	3615127727.500	+22%	4546491267.500	-3%	3571229230.100	+23%
Net Profit Margin	-	-	0.093	0.100	-7%	0.083	+12%	0.081	+15%	0.043	+115%
Operating Margin	-	-	0.137	0.142	-4%	0.122	+12%	0.100	+36%	0.057	+138%
Operating Ratio	-	-	0.863	0.858	+1%	0.878	-2%	0.888	-3%	0.918	-6%
Pb Ratio	4.639	-1%	4.663	5.013	-7%	4.783	-2%	6.552	-29%	5.022	-7%
Pe Ratio	35.021	-1%	35.203	36.025	-2%	46.252	-24%	16.045	+119%	-52.794	+250%
Price Per Share	85.070	-1%	85.510	85.745	0%	70.270	+22%	88.471	-3%	69.033	+24%
Price To Free Cash Flow Ratio	-47.916	+1%	-48.164	24.729	-295%	-44.482	-8%	8.905	-641%	6.778	-811%
Price To Total Gains Ratio	89.668	-1%	90.132	107.385	-16%	143.998	-37%	34.550	+161%	-65.831	+173%
Quick Ratio	-	-	1.549	1.839	-16%	1.580	-2%	1.433	+8%	1.463	+6%
Return On Assets	-	-	0.014	0.016	-9%	0.013	+10%	0.014	+5%	0.007	+97%
Return On Equity	-	-	0.033	0.036	-8%	0.032	+4%	0.030	+11%	0.016	+112%
Total Gains Per Share	-	-	0.949	0.824	+15%	0.582	+63%	0.384	+147%	0.104	+816%
Usd Book Value	-	-	943319000.000	879898000.000	+7%	756208750.000	+25%	719121100.000	+31%	741721975.000	+27%
Usd Book Value Change Per Share	-	-	0.949	0.797	+19%	0.229	+314%	0.308	+208%	0.066	+1348%
Usd Book Value Per Share	-	-	18.336	17.134	+7%	14.697	+25%	13.997	+31%	14.336	+28%
Usd Dividend Per Share	-	-	-	0.028	-100%	0.353	-100%	0.076	-100%	0.038	-100%
Usd Eps	-	-	0.607	0.616	-1%	0.465	+31%	0.420	+44%	0.221	+175%
Usd Free Cash Flow	-	-	-22834000.000	32187750.000	-171%	32027500.000	-171%	24391300.000	-194%	19908500.000	-215%
Usd Free Cash Flow Per Share	-	-	-0.444	0.628	-171%	0.623	-171%	0.474	-194%	0.384	-216%
Usd Free Cash Flow To Equity Per Share	-	-	1.683	1.114	+51%	0.101	+1575%	0.703	+139%	0.337	+400%
Usd Market Cap	4320373527.000	-2%	4399061950.000	4403185245.000	0%	3615127727.500	+22%	4546491267.500	-3%	3571229230.100	+23%
Usd Price Per Share	85.070	-1%	85.510	85.745	0%	70.270	+22%	88.471	-3%	69.033	+24%
Usd Profit	-	-	31241000.000	31643500.000	-1%	23939750.000	+30%	21639850.000	+44%	11443625.000	+173%
Usd Revenue	-	-	336250000.000	317545250.000	+6%	282311500.000	+19%	261792900.000	+28%	245133000.000	+37%
Usd Total Gains Per Share	-	-	0.949	0.824	+15%	0.582	+63%	0.384	+147%	0.104	+816%
	EOD	+3 -5	MRQ	TTM	+15 -21	YOY	+27 -8	5Y	+25 -11	10Y	+27 -9

4.2. Fundamental Score

Let's check the fundamental score of Haemonetics Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

Indicator	Condition		Value
Price to Earnings Ratio (EOD)	Between	0-15	35.021
Price to Book Ratio (EOD)	Between	0-1	4.639
Net Profit Margin (MRQ)	Greater than	0	0.093
Operating Margin (MRQ)	Greater than	0	0.137
Quick Ratio (MRQ)	Greater than	1	1.549
Current Ratio (MRQ)	Greater than	1	2.923
Debt to Asset Ratio (MRQ)	Less than	1	0.571
Debt to Equity Ratio (MRQ)	Less than	1	1.333
Return on Equity (MRQ)	Greater than	0.15	0.033
Return on Assets (MRQ)	Greater than	0.05	0.014
Total			5/10 (50.0%)

Create your own Stock Scanner

Investing is personal. The best investors buy stocks based on their own analysis. Create your personal Stock Scanner with the key performance indicators that are important to you.
Create your own Stock Scanner

4.3. Technical Score

Let's check the technical score of Haemonetics Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	57.347
Ma 20	Greater than	Ma 50	84.555
Ma 50	Greater than	Ma 100	79.185
Ma 100	Greater than	Ma 200	81.078
Open	Greater than	Close	84.200
Total			2/5 (40.0%)

Create your own Symbol Scanner

Trading is personal. The best traders buy and sell based on their own technical analysis. Create your personal Symbol Scanner with the technical indicators that are important to you.
Create your own Symbol Scanner

Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary

Total Assets	2,200,428
Total Liabilities	1,257,109
Total Stockholder Equity	943,319

	As reported
Total Liabilities	1,257,109
Total Stockholder Equity	+ 943,319
Total Assets	= 2,200,428

Assets

Total Assets	2,200,428
Total Current Assets	764,982
Long-term Assets	1,435,446

Total Current Assets

Total Current Assets (as reported)	764,982
Cash And Cash Equivalents	193,978
Net Receivables	211,611
Inventory	304,024
Other Current Assets	55,369
Total Current Assets (calculated)	764,982
+/-	0

Long-term Assets

Long-term Assets (as reported)	1,435,446
Property Plant Equipment	318,665
Goodwill	554,999
Intangible Assets	429,270
Long-term Assets Other	127,442
Long-term Assets (calculated)	1,430,376
+/-	5,070

Liabilities & Shareholders' Equity

Total Current Liabilities	261,755
Long-term Liabilities	995,354
Total Stockholder Equity	943,319

Total Current Liabilities

Total Current Liabilities (as reported)	261,755
Short-term Debt	13,736
Short Long Term Debt	13,736
Accounts payable	56,845
Other Current Liabilities	132,412
Total Current Liabilities (calculated)	216,729
+/-	45,026

Long-term Liabilities

Long-term Liabilities (as reported)	995,354
Long term Debt	856,849
Long-term Liabilities Other	76,259
Long-term Liabilities (calculated)	933,108
+/-	62,246

Total Stockholder Equity

Total Stockholder Equity (as reported)	943,319
Common Stock	508
Retained Earnings	340,099
Accumulated Other Comprehensive Income	-24,382
Other Stockholders Equity	627,094
Total Stockholder Equity (calculated)	943,319
+/-	0

Other

Capital Stock	508
Cash and Short Term Investments	193,978
Common Stock Shares Outstanding	51,445
Current Deferred Revenue	58,762
Liabilities and Stockholders Equity	2,200,428
Net Debt	676,607
Net Invested Capital	1,813,904
Net Working Capital	503,227
Property Plant and Equipment Gross	979,291
Short Long Term Debt Total	870,585

Balance Sheet

Currency in USD. All numbers in thousands.

Trend

2023-12-31

2023-09-30

2023-06-30

2023-03-31

2022-12-31

2022-09-30

2022-06-30

2022-03-31

2021-12-31

2021-09-30

2021-06-30

2021-03-31

2020-12-31

2020-09-30

2020-06-30

2020-03-31

2019-12-31

2019-09-30

2019-06-30

2019-03-31

2018-12-31

2018-09-30

2018-06-30

2018-03-31

2017-12-31

2017-09-30

2017-06-30

2017-03-31

2016-12-31

2016-09-30

2016-06-30

2016-03-31

2015-12-31

2015-09-30

2015-06-30

2015-03-31

2014-12-31

2014-09-30

2014-06-30

2014-03-31

2013-12-31

2013-09-30

2013-06-30

2013-03-31

2012-12-31

2012-09-30

2012-06-30

2012-03-31

2011-12-31

2011-09-30

2011-06-30

2011-03-31

2010-12-31

2010-09-30

2010-06-30

2010-03-31

2009-12-31

2009-09-30

2009-06-30

2009-03-31

2008-12-31

2008-09-30

2008-06-30

2008-03-31

2007-12-31

2007-09-30

2007-06-30

2007-03-31

2006-12-31

2006-09-30

2006-06-30

2006-03-31

2005-12-31

2005-09-30

2005-06-30

2005-03-31

2004-12-31

2004-09-30

2004-06-30

2004-03-31

2003-12-31

2003-09-30

2003-06-30

2003-03-31

2002-12-31

2002-09-30

2002-06-30

2002-03-31

2001-12-31

2001-09-30

2001-06-30

2001-03-31

2000-12-31

2000-09-30

2000-06-30

2000-03-31

1999-12-31

1999-09-30

1999-06-30

1999-03-31

1998-12-31

1998-09-30

1998-06-30

1998-03-31

1997-12-31

1997-09-30

1997-06-30

1997-03-31

1996-12-31

1996-09-30

1996-06-30

1996-03-31

1995-12-31

1995-09-30

1995-06-30

1995-03-31

1994-12-31

1994-09-30

1994-06-30

1994-03-31

1993-12-31

1993-09-30

1993-06-30

1993-03-31

1992-12-31

1992-09-30

1992-06-30

1992-03-31

1991-12-31

1991-09-30

1991-06-30

1991-03-31

1990-12-31

1990-09-30

1990-06-30

> Total Assets

0
0
0
0
119,700
130,500
144,300
144,800
152,200
160,700
162,200
180,300
184,600
201,100
207,100
230,700
235,700
252,300
260,800
280,500
283,900
289,800
288,400
287,800
296,200
308,800
311,900
323,500
347,600
366,900
359,400
336,700
331,400
342,700
353,200
356,400
341,800
347,400
361,900
349,110
337,911
323,139
342,443
345,314
369,648
392,012
389,000
364,921
355,072
355,880
365,922
359,208
366,183
374,387
396,564
407,394
416,383
427,535
456,774
467,757
485,862
499,223
523,136
546,543
568,234
561,432
549,868
572,735
578,104
548,690
565,532
608,950
608,229
600,710
622,348
649,693
691,943
714,294
702,212
760,660
694,164
737,737
783,389
833,264
853,406
823,722
847,773
911,135
928,123
1,454,555
1,474,373
1,461,871
1,479,630
1,483,592
1,490,083
1,520,847
1,476,731
1,474,545
1,471,799
1,483,119
1,427,411
1,418,944
1,336,422
1,317,105
1,317,391
1,334,826
1,306,421
1,238,709
1,251,382
1,271,163
1,311,714
1,237,339
1,241,168
1,265,711
1,227,637
1,274,767
1,259,610
1,190,541
1,237,749
1,267,110
1,433,173
1,418,174
1,318,068
1,819,923
1,794,187
1,801,497
1,831,376
1,859,734
1,820,526
1,865,112
1,878,066
1,934,825
1,962,258
2,011,275
2,200,428

2,200,428

2,011,275

1,962,258

1,934,825

1,878,066

1,865,112

1,820,526

1,859,734

1,831,376

1,801,497

1,794,187

1,819,923

1,318,068

1,418,174

1,433,173

1,267,110

1,237,749

1,190,541

1,259,610

1,274,767

1,227,637

1,265,711

1,241,168

1,237,339

1,311,714

1,271,163

1,251,382

1,238,709

1,306,421

1,334,826

1,317,391

1,317,105

1,336,422

1,418,944

1,427,411

1,483,119

1,471,799

1,474,545

1,476,731

1,520,847

1,490,083

1,483,592

1,479,630

1,461,871

1,474,373

1,454,555

928,123

911,135

847,773

823,722

853,406

833,264

783,389

737,737

694,164

760,660

702,212

714,294

691,943

649,693

622,348

600,710

608,229

608,950

565,532

548,690

578,104

572,735

549,868

561,432

568,234

546,543

523,136

499,223

485,862

467,757

456,774

427,535

416,383

407,394

396,564

374,387

366,183

359,208

365,922

355,880

355,072

364,921

389,000

392,012

369,648

345,314

342,443

323,139

337,911

349,110

361,900

347,400

341,800

356,400

353,200

342,700

331,400

336,700

359,400

366,900

347,600

323,500

311,900

308,800

296,200

287,800

288,400

289,800

283,900

280,500

260,800

252,300

235,700

230,700

207,100

201,100

184,600

180,300

162,200

160,700

152,200

144,800

144,300

130,500

119,700

> Total Current Assets

0
0
0
0
66,200
65,900
77,700
78,500
81,300
86,000
85,700
95,500
93,300
107,000
113,200
130,100
130,800
142,900
144,800
157,600
159,500
163,800
163,200
158,900
164,300
166,800
163,300
167,700
177,000
184,900
187,800
191,200
188,100
207,300
217,400
231,300
218,000
222,800
225,200
209,918
200,481
181,558
202,998
219,164
242,127
264,506
261,632
232,835
221,955
226,296
237,926
223,255
231,225
241,569
265,992
281,449
295,667
304,255
328,456
343,611
364,865
379,060
402,098
418,404
433,277
413,805
398,513
403,671
403,066
361,001
327,256
359,434
353,810
341,468
353,892
382,393
396,154
406,125
394,107
386,143
323,546
362,223
406,017
448,831
468,269
441,100
467,173
527,129
540,187
576,800
598,882
596,965
591,372
591,427
605,522
629,645
569,305
556,959
547,485
567,979
508,361
500,724
501,363
487,202
489,595
512,387
496,562
510,029
528,089
553,389
589,713
521,177
551,017
552,805
515,897
576,121
615,278
567,789
582,575
603,639
759,410
760,279
668,348
693,546
684,368
699,246
729,455
756,031
687,783
715,789
706,309
769,722
801,607
865,744
764,982

764,982

865,744

801,607

769,722

706,309

715,789

687,783

756,031

729,455

699,246

684,368

693,546

668,348

760,279

759,410

603,639

582,575

567,789

615,278

576,121

515,897

552,805

551,017

521,177

589,713

553,389

528,089

510,029

496,562

512,387

489,595

487,202

501,363

500,724

508,361

567,979

547,485

556,959

569,305

629,645

605,522

591,427

591,372

596,965

598,882

576,800

540,187

527,129

467,173

441,100

468,269

448,831

406,017

362,223

323,546

386,143

394,107

406,125

396,154

382,393

353,892

341,468

353,810

359,434

327,256

361,001

403,066

403,671

398,513

413,805

433,277

418,404

402,098

379,060

364,865

343,611

328,456

304,255

295,667

281,449

265,992

241,569

231,225

223,255

237,926

226,296

221,955

232,835

261,632

264,506

242,127

219,164

202,998

181,558

200,481

209,918

225,200

222,800

218,000

231,300

217,400

207,300

188,100

191,200

187,800

184,900

177,000

167,700

163,300

166,800

164,300

158,900

163,200

163,800

159,500

157,600

144,800

142,900

130,800

130,100

113,200

107,000

93,300

95,500

85,700

86,000

81,300

78,500

77,700

65,900

66,200

Cash And Cash Equivalents

0
0
0
0
1,200
700
300
2,900
900
2,200
7,500
10,300
4,400
10,300
13,800
16,200
6,300
8,400
3,700
4,200
3,700
8,400
13,900
13,400
10,900
13,200
16,600
8,300
5,600
6,600
7,300
21,800
24,300
37,200
42,300
56,300
53,300
56,200
46,500
61,328
52,195
38,617
59,212
41,441
40,959
57,847
52,900
34,913
42,006
43,615
49,666
49,885
50,190
66,771
97,182
118,117
130,356
143,829
160,276
185,815
198,067
209,981
229,351
250,667
260,031
242,200
227,707
229,227
216,056
154,983
116,857
133,553
120,287
111,331
125,325
156,721
173,822
178,322
168,993
141,562
83,467
115,049
169,538
196,707
216,891
183,421
205,372
228,861
236,047
187,051
193,181
179,120
166,328
159,148
177,846
192,469
139,943
129,971
125,200
160,662
112,204
100,247
105,167
115,123
118,248
138,870
129,639
139,564
171,739
203,622
251,591
180,169
192,106
199,763
154,871
169,351
190,234
112,030
126,417
137,311
275,725
279,169
189,002
192,305
173,462
192,420
236,877
259,496
214,948
241,200
224,002
284,466
285,719
351,005
193,978

193,978

351,005

285,719

284,466

224,002

241,200

214,948

259,496

236,877

192,420

173,462

192,305

189,002

279,169

275,725

137,311

126,417

112,030

190,234

169,351

154,871

199,763

192,106

180,169

251,591

203,622

171,739

139,564

129,639

138,870

118,248

115,123

105,167

100,247

112,204

160,662

125,200

129,971

139,943

192,469

177,846

159,148

166,328

179,120

193,181

187,051

236,047

228,861

205,372

183,421

216,891

196,707

169,538

115,049

83,467

141,562

168,993

178,322

173,822

156,721

125,325

111,331

120,287

133,553

116,857

154,983

216,056

229,227

227,707

242,200

260,031

250,667

229,351

209,981

198,067

185,815

160,276

143,829

130,356

118,117

97,182

66,771

50,190

49,885

49,666

43,615

42,006

34,913

52,900

57,847

40,959

41,441

59,212

38,617

52,195

61,328

46,500

56,200

53,300

56,300

42,300

37,200

24,300

21,800

7,300

6,600

5,600

8,300

16,600

13,200

10,900

13,400

13,900

8,400

3,700

4,200

3,700

8,400

6,300

16,200

13,800

10,300

4,400

10,300

7,500

2,200

900

2,900

300

700

1,200

Short-term Investments

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,100
12,900
13,200
13,600
14,600
14,400
14,300
11,900
11,800
11,800
12,400
12,300
11,200
10,600
9,700
43,500
7,500
0
6,400
33,042
45,454
45,804
46,538
32,636
2,700
2,500
2,700
2,700
2,500
2,200
2,100
1,900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,114
1,687
1,110
2,442
2,576
0

2,576

2,442

1,110

1,687

1,114

1,900

2,100

2,200

2,500

2,700

2,500

2,700

32,636

46,538

45,804

45,454

33,042

6,400

7,500

43,500

9,700

10,600

11,200

12,300

12,400

11,800

11,900

14,300

14,400

14,600

13,600

13,200

12,900

12,100

Net Receivables

0
0
0
0
27,100
27,300
33,500
33,400
36,900
39,400
34,700
38,800
42,200
45,200
43,600
47,500
51,400
55,800
58,200
63,300
65,500
67,500
63,200
60,300
65,000
67,800
67,400
72,200
77,900
78,400
78,400
58,900
57,100
60,500
65,300
63,000
58,600
59,600
72,000
59,140
58,814
59,849
60,253
59,842
61,800
66,800
64,115
63,743
69,417
77,842
79,198
77,913
84,326
84,162
84,399
82,640
84,046
83,347
87,578
80,719
83,625
83,409
86,262
86,901
89,281
84,001
85,988
91,832
91,917
100,896
108,811
120,252
127,931
122,500
124,575
113,598
114,161
118,668
114,732
118,684
114,834
121,767
120,373
127,166
120,759
129,242
127,443
135,464
126,130
158,175
167,347
170,111
155,958
162,084
149,585
164,961
156,733
151,055
143,635
145,827
139,103
145,411
148,774
157,093
149,668
151,600
150,557
152,683
151,507
143,693
146,718
151,226
151,336
161,590
167,641
185,027
163,339
176,535
170,753
165,207
141,094
141,533
146,939
127,555
132,908
141,305
154,980
159,376
146,463
171,532
181,100
179,142
177,117
174,249
211,611

211,611

174,249

177,117

179,142

181,100

171,532

146,463

159,376

154,980

141,305

132,908

127,555

146,939

141,533

141,094

165,207

170,753

176,535

163,339

185,027

167,641

161,590

151,336

151,226

146,718

143,693

151,507

152,683

150,557

151,600

149,668

157,093

148,774

145,411

139,103

145,827

143,635

151,055

156,733

164,961

149,585

162,084

155,958

170,111

167,347

158,175

126,130

135,464

127,443

129,242

120,759

127,166

120,373

121,767

114,834

118,684

114,732

118,668

114,161

113,598

124,575

122,500

127,931

120,252

108,811

100,896

91,917

91,832

85,988

84,001

89,281

86,901

86,262

83,409

83,625

80,719

87,578

83,347

84,046

82,640

84,399

84,162

84,326

77,913

79,198

77,842

69,417

63,743

64,115

66,800

61,800

59,842

60,253

59,849

58,814

59,140

72,000

59,600

58,600

63,000

65,300

60,500

57,100

58,900

78,400

77,900

72,200

67,400

67,800

65,000

60,300

63,200

67,500

65,500

63,300

58,200

55,800

51,400

47,500

43,600

45,200

42,200

38,800

34,700

39,400

36,900

33,400

33,500

27,300

27,100

Other Current Assets

0
0
0
0
11,400
10,200
11,200
11,600
13,400
14,400
14,100
16,100
15,500
16,100
15,300
25,100
26,400
27,400
26,900
30,100
30,500
29,500
28,900
28,500
30,100
33,300
32,500
32,100
34,500
34,800
41,300
48,800
42,200
41,900
45,800
52,200
48,300
47,500
47,500
29,633
31,857
30,123
30,765
5,680
5,616
12,052
16,975
2,783
2,700
2,478
2,661
2,681
2,488
31,910
2,102
1,859
28,676
26,367
28,117
23,989
27,175
28,089
30,172
26,265
28,404
28,679
25,138
20,815
26,884
39,053
37,741
40,241
34,396
34,456
30,435
35,552
32,074
31,999
31,576
45,944
40,674
39,398
34,191
40,571
35,659
26,993
26,445
45,641
51,167
58,068
58,317
63,950
72,413
64,944
68,760
74,554
65,142
66,515
66,157
50,413
45,923
35,444
43,559
28,842
32,248
27,406
27,877
40,853
30,949
37,482
32,564
28,983
32,246
27,868
24,449
27,406
39,752
34,720
31,238
30,845
48,081
34,353
32,697
51,072
51,498
42,860
31,857
44,132
48,485
48,377
45,451
46,735
49,564
54,660
55,369

55,369

54,660

49,564

46,735

45,451

48,377

48,485

44,132

31,857

42,860

51,498

51,072

32,697

34,353

48,081

30,845

31,238

34,720

39,752

27,406

24,449

27,868

32,246

28,983

32,564

37,482

30,949

40,853

27,877

27,406

32,248

28,842

43,559

35,444

45,923

50,413

66,157

66,515

65,142

74,554

68,760

64,944

72,413

63,950

58,317

58,068

51,167

45,641

26,445

26,993

35,659

40,571

34,191

39,398

40,674

45,944

31,576

31,999

32,074

35,552

30,435

34,456

34,396

40,241

37,741

39,053

26,884

20,815

25,138

28,679

28,404

26,265

30,172

28,089

27,175

23,989

28,117

26,367

28,676

1,859

2,102

31,910

2,488

2,681

2,661

2,478

2,700

2,783

16,975

12,052

5,616

5,680

30,765

30,123

31,857

29,633

47,500

48,300

52,200

45,800

41,900

42,200

48,800

41,300

34,800

34,500

32,100

32,500

33,300

30,100

28,500

28,900

29,500

30,500

30,100

26,900

27,400

26,400

25,100

15,300

16,100

15,500

16,100

14,100

14,400

13,400

11,600

11,200

10,200

11,400

> Long-term Assets

0
0
0
0
53,500
64,600
66,600
66,300
70,900
74,700
76,500
84,800
91,300
94,100
93,900
100,600
104,900
109,400
116,000
122,900
124,400
126,000
125,200
128,900
131,900
142,000
148,600
155,800
170,600
182,000
171,600
145,500
143,300
135,400
135,800
125,100
123,800
124,600
136,700
139,192
137,430
141,581
139,445
126,150
127,521
127,506
127,368
132,086
133,117
129,584
127,996
135,953
134,958
132,818
130,572
125,945
120,716
123,280
128,318
124,146
120,997
120,163
121,038
128,139
134,957
147,627
151,355
169,064
175,038
187,689
238,276
249,516
254,419
259,242
268,456
267,300
295,789
308,169
308,105
374,517
370,618
375,514
377,372
384,433
385,137
382,622
380,600
384,006
387,936
877,755
875,491
864,906
888,258
892,165
884,561
891,202
907,426
917,586
924,314
915,140
919,050
918,220
835,059
829,903
827,796
822,439
809,859
728,680
723,293
717,774
722,001
716,162
690,151
712,906
711,740
698,646
644,332
622,752
655,174
663,471
673,763
657,895
649,720
1,126,377
1,109,819
1,102,251
1,101,921
1,103,703
1,132,743
1,149,323
1,171,757
1,165,103
1,160,651
1,145,531
1,435,446

1,435,446

1,145,531

1,160,651

1,165,103

1,171,757

1,149,323

1,132,743

1,103,703

1,101,921

1,102,251

1,109,819

1,126,377

649,720

657,895

673,763

663,471

655,174

622,752

644,332

698,646

711,740

712,906

690,151

716,162

722,001

717,774

723,293

728,680

809,859

822,439

827,796

829,903

835,059

918,220

919,050

915,140

924,314

917,586

907,426

891,202

884,561

892,165

888,258

864,906

875,491

877,755

387,936

384,006

380,600

382,622

385,137

384,433

377,372

375,514

370,618

374,517

308,105

308,169

295,789

267,300

268,456

259,242

254,419

249,516

238,276

187,689

175,038

169,064

151,355

147,627

134,957

128,139

121,038

120,163

120,997

124,146

128,318

123,280

120,716

125,945

130,572

132,818

134,958

135,953

127,996

129,584

133,117

132,086

127,368

127,506

127,521

126,150

139,445

141,581

137,430

139,192

136,700

124,600

123,800

125,100

135,800

135,400

143,300

145,500

171,600

182,000

170,600

155,800

148,600

142,000

131,900

128,900

125,200

126,000

124,400

122,900

116,000

109,400

104,900

100,600

93,900

94,100

91,300

84,800

76,500

74,700

70,900

66,300

66,600

64,600

53,500

Property Plant Equipment

0
0
0
0
44,300
46,000
46,000
46,800
48,600
49,700
52,000
56,000
61,200
63,300
64,600
68,300
71,900
76,400
78,300
82,100
82,300
84,900
84,500
86,400
87,800
95,900
102,200
103,600
106,700
112,000
107,700
84,200
82,800
81,100
83,500
83,000
82,200
84,200
83,100
81,608
80,305
82,121
82,256
83,251
82,109
82,410
83,700
84,877
85,846
82,926
81,756
83,987
82,923
81,345
79,320
78,030
73,810
72,224
72,684
69,337
67,910
67,075
70,294
75,266
79,920
80,757
84,050
90,775
95,330
103,792
110,439
116,484
119,078
124,905
129,470
137,807
150,387
152,954
154,006
153,298
157,365
157,297
156,116
155,528
156,978
156,866
157,703
161,657
166,240
239,160
263,128
256,953
254,976
258,267
260,105
271,437
294,100
311,999
323,491
321,948
328,882
328,233
332,772
337,634
339,666
339,843
335,957
323,862
321,953
320,221
330,026
332,156
315,873
344,560
351,108
343,979
276,748
264,238
268,104
253,399
242,969
240,405
240,009
217,559
214,782
223,747
238,841
258,482
288,321
307,844
313,138
310,885
304,467
307,766
318,665

318,665

307,766

304,467

310,885

313,138

307,844

288,321

258,482

238,841

223,747

214,782

217,559

240,009

240,405

242,969

253,399

268,104

264,238

276,748

343,979

351,108

344,560

315,873

332,156

330,026

320,221

321,953

323,862

335,957

339,843

339,666

337,634

332,772

328,233

328,882

321,948

323,491

311,999

294,100

271,437

260,105

258,267

254,976

256,953

263,128

239,160

166,240

161,657

157,703

156,866

156,978

155,528

156,116

157,297

157,365

153,298

154,006

152,954

150,387

137,807

129,470

124,905

119,078

116,484

110,439

103,792

95,330

90,775

84,050

80,757

79,920

75,266

70,294

67,075

67,910

69,337

72,684

72,224

73,810

78,030

79,320

81,345

82,923

83,987

81,756

82,926

85,846

84,877

83,700

82,410

82,109

83,251

82,256

82,121

80,305

81,608

83,100

84,200

82,200

83,000

83,500

81,100

82,800

84,200

107,700

112,000

106,700

103,600

102,200

95,900

87,800

86,400

84,500

84,900

82,300

82,100

78,300

76,400

71,900

68,300

64,600

63,300

61,200

56,000

52,000

49,700

48,600

46,800

46,000

44,300

Goodwill

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,000
2,000
0
0
13,200
1,800
0
4,700
14,426
12,388
12,771
12,100
14,168
15,000
14,700
14,900
16,000
16,200
16,600
17,000
17,200
16,900
17,800
18,500
18,200
17,936
18,730
18,437
18,483
18,625
33,494
33,548
34,958
34,703
35,242
55,828
54,222
54,786
54,556
55,434
56,426
64,730
72,157
71,255
120,543
117,739
112,383
111,268
115,367
115,707
115,582
115,320
115,058
115,048
322,114
321,284
330,474
341,509
341,673
337,029
336,768
337,237
336,301
334,990
334,310
334,187
333,575
266,945
267,840
268,589
268,546
267,314
210,841
210,930
211,125
211,086
211,395
210,903
210,844
210,723
210,819
211,140
211,041
211,062
210,652
217,298
214,594
215,508
466,444
466,314
468,590
468,199
467,287
466,115
464,987
466,112
466,231
465,910
465,405
554,999

554,999

465,405

465,910

466,231

466,112

464,987

466,115

467,287

468,199

468,590

466,314

466,444

215,508

214,594

217,298

210,652

211,062

211,041

211,140

210,819

210,723

210,844

210,903

211,395

211,086

211,125

210,930

210,841

267,314

268,546

268,589

267,840

266,945

333,575

334,187

334,310

334,990

336,301

337,237

336,768

337,029

341,673

341,509

330,474

321,284

322,114

115,048

115,058

115,320

115,582

115,707

115,367

111,268

112,383

117,739

120,543

71,255

72,157

64,730

56,426

55,434

54,556

54,786

54,222

55,828

35,242

34,703

34,958

33,548

33,494

18,625

18,483

18,437

18,730

17,936

18,200

18,500

17,800

16,900

17,200

17,000

16,600

16,200

16,000

14,900

14,700

15,000

14,168

12,100

12,771

12,388

14,426

4,700

1,800

13,200

2,000

Intangible Assets

0
0
0
0
0
0
0
6,900
0
0
0
7,600
9,300
9,400
9,400
9,300
9,500
10,100
14,000
0
0
0
0
0
11,900
11,700
11,200
10,300
11,400
11,900
10,900
10,700
10,000
9,900
11,100
11,000
10,400
11,300
11,800
1,832
1,788
4,836
4,739
15,842
19,063
18,696
30,440
24,204
38,874
38,083
37,843
42,349
42,316
42,258
42,196
42,026
41,161
45,722
44,862
44,020
43,227
43,594
41,069
22,945
23,321
25,915
25,927
33,857
35,059
37,580
60,153
64,333
65,520
65,095
63,936
65,261
72,008
74,872
74,496
86,102
84,214
94,544
99,649
101,789
100,892
98,847
97,060
96,549
94,913
297,972
273,695
264,388
279,098
277,065
275,287
271,159
264,560
257,544
251,221
244,588
241,873
237,685
214,809
204,458
198,121
192,451
185,427
177,540
173,420
169,379
163,946
156,589
148,730
141,483
134,724
127,693
120,340
113,540
107,307
133,106
137,520
127,210
119,716
365,483
353,688
337,249
323,951
310,261
302,710
292,595
284,383
275,771
268,146
250,504
429,270

429,270

250,504

268,146

275,771

284,383

292,595

302,710

310,261

323,951

337,249

353,688

365,483

119,716

127,210

137,520

133,106

107,307

113,540

120,340

127,693

134,724

141,483

148,730

156,589

163,946

169,379

173,420

177,540

185,427

192,451

198,121

204,458

214,809

237,685

241,873

244,588

251,221

257,544

264,560

271,159

275,287

277,065

279,098

264,388

273,695

297,972

94,913

96,549

97,060

98,847

100,892

101,789

99,649

94,544

84,214

86,102

74,496

74,872

72,008

65,261

63,936

65,095

65,520

64,333

60,153

37,580

35,059

33,857

25,927

25,915

23,321

22,945

41,069

43,594

43,227

44,020

44,862

45,722

41,161

42,026

42,196

42,258

42,316

42,349

37,843

38,083

38,874

24,204

30,440

18,696

19,063

15,842

4,739

4,836

1,788

1,832

11,800

11,300

10,400

11,000

11,100

9,900

10,000

10,700

10,900

11,900

11,400

10,300

11,200

11,700

11,900

14,000

10,100

9,500

9,300

9,400

9,300

7,600

6,900

Other Assets

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
57,584
57,125
59,460
57,189
42,899
45,412
45,096
43,668
47,209
47,271
46,658
46,240
51,966
52,035
51,473
51,252
47,915
46,906
51,056
55,634
54,809
53,087
53,088
50,744
52,873
55,037
66,870
67,305
78,289
79,708
83,897
127,837
133,032
135,341
134,337
138,986
129,493
145,402
155,215
154,099
221,219
216,714
218,218
221,255
228,905
228,159
225,756
222,897
222,349
221,696
638,595
612,363
607,954
633,282
633,898
624,456
619,765
613,326
605,587
600,823
593,192
590,168
589,987
502,287
493,408
488,130
482,596
473,902
404,818
401,340
397,553
391,975
16,022
14,645
16,019
15,185
16,155
14,887
14,577
14,543
14,078
75,976
75,686
74,487
17,035
75,035
72,665
70,930
67,673
75,597
83,897
108,124
112,216
122,128
121,856
0

121,856

122,128

112,216

108,124

83,897

75,597

67,673

70,930

72,665

75,035

17,035

74,487

75,686

75,976

14,078

14,543

14,577

14,887

16,155

15,185

16,019

14,645

16,022

391,975

397,553

401,340

404,818

473,902

482,596

488,130

493,408

502,287

589,987

590,168

593,192

600,823

605,587

613,326

619,765

624,456

633,898

633,282

607,954

612,363

638,595

221,696

222,349

222,897

225,756

228,159

228,905

221,255

218,218

216,714

221,219

154,099

155,215

145,402

129,493

138,986

134,337

135,341

133,032

127,837

83,897

79,708

78,289

67,305

66,870

55,037

52,873

50,744

53,088

53,087

54,809

55,634

51,056

46,906

47,915

51,252

51,473

52,035

51,966

46,240

46,658

47,271

47,209

43,668

45,096

45,412

42,899

57,189

59,460

57,125

57,584

Deferred Long Term Asset Charges

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,433
1,372
937
1,291
1,357
1,353
757
23
0
1,974
733
1,751
1,751
1,751
1,751
1,184
1,119
1,071
1,031
3,023
3,080
3,053
5,290
7,055
7,572
7,942
7,575
3,988
4,399
4,478
4,510
3,961
3,774
3,765
3,702
4,359
4,622
4,328
4,428
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

4,428

4,328

4,622

4,359

3,702

3,765

3,774

3,961

4,510

4,478

4,399

3,988

7,575

7,942

7,572

7,055

5,290

3,053

3,080

3,023

1,031

1,071

1,119

1,184

1,751

733

1,974

757

1,353

1,357

1,291

937

1,372

5,433

> Total Liabilities

0
0
0
0
46,300
54,100
61,900
54,200
52,100
50,300
46,400
53,600
51,200
58,100
57,400
69,900
64,400
72,200
74,200
87,300
86,400
83,600
73,500
70,800
70,300
73,700
78,400
98,200
119,400
135,500
140,300
142,000
132,200
132,200
131,500
134,500
125,700
133,600
149,800
142,667
129,053
133,472
141,238
129,798
134,408
144,675
133,134
128,097
136,306
142,484
144,658
135,971
133,746
134,539
132,336
127,645
121,751
117,869
120,835
112,622
113,293
111,973
104,163
104,893
106,399
104,442
96,524
93,087
101,549
100,964
91,832
114,762
114,299
103,895
106,560
109,809
128,090
134,862
129,132
167,536
129,208
143,345
134,865
147,128
140,950
145,445
142,540
178,504
170,656
682,589
695,215
692,689
705,252
687,119
664,863
681,233
661,659
653,827
637,891
656,997
635,764
642,064
616,870
597,127
601,831
585,712
535,524
499,099
478,612
469,910
488,907
484,910
567,109
564,373
584,508
606,899
668,644
606,787
663,169
680,001
824,604
750,251
598,916
1,088,253
1,117,107
1,102,948
1,100,601
1,110,310
1,050,103
1,136,103
1,102,087
1,116,828
1,097,642
1,117,615
1,257,109

1,257,109

1,117,615

1,097,642

1,116,828

1,102,087

1,136,103

1,050,103

1,110,310

1,100,601

1,102,948

1,117,107

1,088,253

598,916

750,251

824,604

680,001

663,169

606,787

668,644

606,899

584,508

564,373

567,109

484,910

488,907

469,910

478,612

499,099

535,524

585,712

601,831

597,127

616,870

642,064

635,764

656,997

637,891

653,827

661,659

681,233

664,863

687,119

705,252

692,689

695,215

682,589

170,656

178,504

142,540

145,445

140,950

147,128

134,865

143,345

129,208

167,536

129,132

134,862

128,090

109,809

106,560

103,895

114,299

114,762

91,832

100,964

101,549

93,087

96,524

104,442

106,399

104,893

104,163

111,973

113,293

112,622

120,835

117,869

121,751

127,645

132,336

134,539

133,746

135,971

144,658

142,484

136,306

128,097

133,134

144,675

134,408

129,798

141,238

133,472

129,053

142,667

149,800

133,600

125,700

134,500

131,500

132,200

142,000

140,300

135,500

119,400

98,200

78,400

73,700

70,300

70,800

73,500

83,600

86,400

87,300

74,200

72,200

64,400

69,900

57,400

58,100

51,200

53,600

46,400

50,300

52,100

54,200

61,900

54,100

46,300

> Total Current Liabilities

0
0
0
0
32,000
35,700
36,800
37,500
33,500
38,600
33,600
38,500
36,400
42,600
43,600
48,600
43,200
48,000
48,400
49,100
43,000
45,900
48,100
46,400
48,500
52,500
56,200
73,600
69,300
68,800
73,900
78,400
66,800
66,900
65,400
69,100
60,500
66,900
90,500
88,475
71,551
73,817
72,092
79,447
84,101
94,236
88,999
84,098
94,202
100,686
109,580
100,375
98,144
98,940
102,354
95,843
90,228
86,629
94,945
87,922
89,143
87,899
86,070
88,116
89,582
88,115
85,949
82,017
86,115
89,935
80,382
97,677
97,280
87,186
85,534
92,863
104,052
112,823
107,145
136,497
102,688
113,751
105,530
108,671
103,018
110,806
109,368
130,744
121,906
156,194
177,610
179,798
187,795
197,534
189,008
217,815
165,868
165,056
161,994
189,092
169,765
188,105
175,334
184,712
198,973
198,664
216,221
211,179
205,523
254,999
324,178
384,703
193,995
189,167
211,282
235,759
293,665
240,066
256,692
284,298
407,827
338,568
194,384
253,495
228,339
288,470
355,411
442,266
180,487
262,175
226,889
251,816
236,939
264,215
261,755

261,755

264,215

236,939

251,816

226,889

262,175

180,487

442,266

355,411

288,470

228,339

253,495

194,384

338,568

407,827

284,298

256,692

240,066

293,665

235,759

211,282

189,167

193,995

384,703

324,178

254,999

205,523

211,179

216,221

198,664

198,973

184,712

175,334

188,105

169,765

189,092

161,994

165,056

165,868

217,815

189,008

197,534

187,795

179,798

177,610

156,194

121,906

130,744

109,368

110,806

103,018

108,671

105,530

113,751

102,688

136,497

107,145

112,823

104,052

92,863

85,534

87,186

97,280

97,677

80,382

89,935

86,115

82,017

85,949

88,115

89,582

88,116

86,070

87,899

89,143

87,922

94,945

86,629

90,228

95,843

102,354

98,940

98,144

100,375

109,580

100,686

94,202

84,098

88,999

94,236

84,101

79,447

72,092

73,817

71,551

88,475

90,500

66,900

60,500

69,100

65,400

66,900

66,800

78,400

73,900

68,800

69,300

73,600

56,200

52,500

48,500

46,400

48,100

45,900

43,000

49,100

48,400

48,000

43,200

48,600

43,600

42,600

36,400

38,500

33,600

38,600

33,500

37,500

36,800

35,700

32,000

Short-term Debt

0
0
0
0
5,000
4,700
4,600
8,400
6,200
8,000
3,200
3,000
3,200
7,000
4,400
4,500
4,500
7,200
7,700
8,300
4,200
3,600
4,700
3,400
6,900
10,800
12,400
19,500
22,300
23,600
22,600
17,500
20,000
12,700
12,600
6,600
9,000
10,100
32,400
32,896
24,823
17,763
19,172
22,438
28,403
33,180
34,220
31,356
36,369
40,598
44,878
39,005
38,633
38,388
41,016
32,818
30,647
28,298
29,862
26,612
26,258
27,643
25,796
26,176
22,226
21,922
23,248
22,201
18,601
17,917
6,206
6,326
9,028
8,055
4,434
695
17,200
15,181
15,132
16,062
6,418
11,702
8,244
913
906
3,080
2,545
894
2,417
4,249
14,197
23,150
32,434
43,687
40,810
45,630
1,931
1,655
7,748
21,522
32,396
46,593
46,293
43,471
46,804
51,549
66,271
61,022
65,876
108,589
151,465
194,259
17,043
12,664
17,199
27,666
117,548
56,934
61,966
76,980
231,364
167,001
17,055
17,016
17,025
82,733
144,064
214,148
6,853
58,194
9,949
11,784
13,572
13,566
13,736

13,736

13,566

13,572

11,784

9,949

58,194

6,853

214,148

144,064

82,733

17,025

17,016

17,055

167,001

231,364

76,980

61,966

56,934

117,548

27,666

17,199

12,664

17,043

194,259

151,465

108,589

65,876

61,022

66,271

51,549

46,804

43,471

46,293

46,593

32,396

21,522

7,748

1,655

1,931

45,630

40,810

43,687

32,434

23,150

14,197

4,249

2,417

894

2,545

3,080

906

913

8,244

11,702

6,418

16,062

15,132

15,181

17,200

695

4,434

8,055

9,028

6,326

6,206

17,917

18,601

22,201

23,248

21,922

22,226

26,176

25,796

27,643

26,258

26,612

29,862

28,298

30,647

32,818

41,016

38,388

38,633

39,005

44,878

40,598

36,369

31,356

34,220

33,180

28,403

22,438

19,172

17,763

24,823

32,896

32,400

10,100

9,000

6,600

12,600

12,700

20,000

17,500

22,600

23,600

22,300

19,500

12,400

10,800

6,900

3,400

4,700

3,600

4,200

8,300

7,700

7,200

4,500

4,400

7,000

3,200

3,000

3,200

8,000

6,200

8,400

4,600

4,700

5,000

Short Long Term Debt

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
437,687
0
0
0
21,681
0
0
0
43,625
46,804
51,549
66,271
61,022
303,043
108,589
151,465
194,259
17,043
12,664
20,040
27,666
117,548
56,934
61,966
76,980
231,364
167,001
17,055
17,016
17,025
82,733
144,064
214,148
6,853
58,194
9,949
11,784
13,572
13,566
13,736

13,736

13,566

13,572

11,784

9,949

58,194

6,853

214,148

144,064

82,733

17,025

17,016

17,055

167,001

231,364

76,980

61,966

56,934

117,548

27,666

20,040

12,664

17,043

194,259

151,465

108,589

303,043

61,022

66,271

51,549

46,804

43,625

21,681

437,687

Accounts payable

0
0
0
0
25,300
29,500
30,600
9,100
24,300
28,200
28,600
13,200
31,100
33,500
37,500
14,700
36,900
39,100
39,400
15,600
15,200
17,300
16,700
16,900
12,100
19,000
19,200
27,900
22,600
26,400
21,700
21,700
15,100
13,900
11,500
10,700
9,500
13,400
14,200
17,224
8,323
11,078
9,726
13,350
11,923
12,254
12,054
12,536
12,309
11,927
11,296
13,677
14,759
13,682
13,922
14,249
13,344
15,105
12,305
11,111
15,123
13,252
14,734
14,217
15,477
17,293
16,514
17,187
17,740
17,665
15,790
19,724
21,300
20,292
17,201
20,652
23,448
24,804
23,740
25,590
23,418
21,628
19,608
28,323
28,155
29,759
28,891
35,425
33,978
42,987
53,077
49,893
47,915
45,380
43,106
53,562
55,213
44,173
46,830
48,425
42,155
42,088
39,636
39,674
36,799
42,013
48,848
42,973
39,389
41,764
41,496
55,265
65,393
57,857
62,579
63,361
60,792
57,449
52,298
50,730
48,459
49,071
42,979
50,293
49,131
44,969
51,175
58,371
57,907
61,484
63,769
63,929
78,134
80,160
56,845

56,845

80,160

78,134

63,929

63,769

61,484

57,907

58,371

51,175

44,969

49,131

50,293

42,979

49,071

48,459

50,730

52,298

57,449

60,792

63,361

62,579

57,857

65,393

55,265

41,496

41,764

39,389

42,973

48,848

42,013

36,799

39,674

39,636

42,088

42,155

48,425

46,830

44,173

55,213

53,562

43,106

45,380

47,915

49,893

53,077

42,987

33,978

35,425

28,891

29,759

28,155

28,323

19,608

21,628

23,418

25,590

23,740

24,804

23,448

20,652

17,201

20,292

21,300

19,724

15,790

17,665

17,740

17,187

16,514

17,293

15,477

14,217

14,734

13,252

15,123

11,111

12,305

15,105

13,344

14,249

13,922

13,682

14,759

13,677

11,296

11,927

12,309

12,536

12,054

12,254

11,923

13,350

9,726

11,078

8,323

17,224

14,200

13,400

9,500

10,700

11,500

13,900

15,100

21,700

26,400

22,600

27,900

19,200

19,000

12,100

16,900

16,700

17,300

15,200

15,600

39,400

39,100

36,900

14,700

37,500

33,500

31,100

13,200

28,600

28,200

24,300

9,100

30,600

29,500

25,300

Other Current Liabilities

0
0
0
0
1,700
1,500
1,600
20,000
3,000
2,400
1,800
22,300
2,100
2,100
1,700
29,400
1,800
1,700
1,300
25,200
23,600
25,000
26,700
26,100
29,500
22,700
24,600
26,200
24,400
18,800
29,600
39,200
31,700
40,300
41,300
51,800
42,000
43,400
43,900
38,355
38,405
44,976
43,194
43,659
43,775
48,802
42,725
40,206
45,524
48,161
53,406
47,693
44,752
46,870
47,416
48,776
46,237
43,226
52,778
50,199
47,762
47,004
45,540
19,141
51,879
48,900
46,187
26,944
33,839
37,539
24,807
46,518
39,088
29,126
32,466
71,516
86,852
97,642
92,013
94,845
96,270
102,049
97,286
46,256
102,112
107,726
106,823
56,835
119,489
151,945
163,413
83,018
155,361
153,847
148,198
93,846
163,937
163,401
154,246
96,783
137,369
54,363
129,041
74,514
71,040
64,294
59,546
80,699
68,324
67,282
68,151
109,365
65,731
69,514
79,693
117,453
83,973
183,132
194,726
127,745
91,595
93,270
177,329
159,914
127,811
119,701
121,126
137,921
115,727
142,497
153,171
145,894
112,263
250,649
132,412

132,412

250,649

112,263

145,894

153,171

142,497

115,727

137,921

121,126

119,701

127,811

159,914

177,329

93,270

91,595

127,745

194,726

183,132

83,973

117,453

79,693

69,514

65,731

109,365

68,151

67,282

68,324

80,699

59,546

64,294

71,040

74,514

129,041

54,363

137,369

96,783

154,246

163,401

163,937

93,846

148,198

153,847

155,361

83,018

163,413

151,945

119,489

56,835

106,823

107,726

102,112

46,256

97,286

102,049

96,270

94,845

92,013

97,642

86,852

71,516

32,466

29,126

39,088

46,518

24,807

37,539

33,839

26,944

46,187

48,900

51,879

19,141

45,540

47,004

47,762

50,199

52,778

43,226

46,237

48,776

47,416

46,870

44,752

47,693

53,406

48,161

45,524

40,206

42,725

48,802

43,775

43,659

43,194

44,976

38,405

38,355

43,900

43,400

42,000

51,800

41,300

40,300

31,700

39,200

29,600

18,800

24,400

26,200

24,600

22,700

29,500

26,100

26,700

25,000

23,600

25,200

1,300

1,700

1,800

29,400

1,700

2,100

22,300

1,800

2,400

3,000

20,000

1,600

1,500

1,700

> Long-term Liabilities

0
0
0
0
14,300
18,400
25,100
16,700
18,600
11,700
12,800
15,100
14,800
15,500
13,800
21,300
21,200
24,200
25,800
38,200
43,400
37,700
25,400
24,400
21,800
21,200
22,200
24,600
50,100
66,700
66,400
63,600
65,400
65,300
66,100
65,400
65,200
66,700
59,300
54,192
57,502
59,655
69,146
50,351
50,307
50,439
44,135
43,999
42,104
41,798
35,078
35,596
35,602
35,599
29,982
31,802
31,523
31,240
25,890
24,700
24,150
24,074
18,093
16,777
16,817
16,327
10,575
11,070
15,434
11,029
11,450
17,085
17,019
16,709
21,026
16,946
24,038
22,039
21,987
31,039
26,520
29,594
29,335
38,457
37,932
34,639
33,172
47,760
48,750
526,395
517,605
512,891
517,457
489,585
475,855
463,418
495,791
488,771
475,897
467,905
465,999
453,959
441,536
412,415
402,858
387,048
319,303
287,920
273,089
214,911
164,729
100,207
373,114
375,206
373,226
371,140
374,979
366,721
406,477
395,703
416,777
411,683
404,532
834,758
888,768
814,478
745,190
668,044
869,616
873,928
875,198
865,012
860,703
853,400
995,354

995,354

853,400

860,703

865,012

875,198

873,928

869,616

668,044

745,190

814,478

888,768

834,758

404,532

411,683

416,777

395,703

406,477

366,721

374,979

371,140

373,226

375,206

373,114

100,207

164,729

214,911

273,089

287,920

319,303

387,048

402,858

412,415

441,536

453,959

465,999

467,905

475,897

488,771

495,791

463,418

475,855

489,585

517,457

512,891

517,605

526,395

48,750

47,760

33,172

34,639

37,932

38,457

29,335

29,594

26,520

31,039

21,987

22,039

24,038

16,946

21,026

16,709

17,019

17,085

11,450

11,029

15,434

11,070

10,575

16,327

16,817

16,777

18,093

24,074

24,150

24,700

25,890

31,240

31,523

31,802

29,982

35,599

35,602

35,596

35,078

41,798

42,104

43,999

44,135

50,439

50,307

50,351

69,146

59,655

57,502

54,192

59,300

66,700

65,200

65,400

66,100

65,300

65,400

63,600

66,400

66,700

50,100

24,600

22,200

21,200

21,800

24,400

25,400

37,700

43,400

38,200

25,800

24,200

21,200

21,300

13,800

15,500

14,800

15,100

12,800

11,700

18,600

16,700

25,100

18,400

14,300

Long term Debt Total

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,384
4,423
4,194
3,966
3,606
3,332
3,107
2,877
0
477,402
468,250
456,944
448,119
420,711
406,418
392,057
429,010
428,253
421,006
406,369
399,453
387,715
380,814
364,529
352,908
336,505
269,997
253,625
237,167
178,015
118,702
59,423
330,838
330,988
326,618
322,454
318,144
313,984
309,738
305,513
296,893
297,016
292,721
690,592
767,345
698,043
633,118
559,441
763,141
759,552
756,826
754,102
751,381
748,662
0

748,662

751,381

754,102

756,826

759,552

763,141

559,441

633,118

698,043

767,345

690,592

292,721

297,016

296,893

305,513

309,738

313,984

318,144

322,454

326,618

330,988

330,838

59,423

118,702

178,015

237,167

253,625

269,997

336,505

352,908

364,529

380,814

387,715

399,453

406,369

421,006

428,253

429,010

392,057

406,418

420,711

448,119

456,944

468,250

477,402

2,877

3,107

3,332

3,606

3,966

4,194

4,423

4,384

Deferred Long Term Asset Charges

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,433
1,372
937
1,291
1,357
1,353
757
23
0
1,974
733
1,751
1,751
1,751
1,751
1,184
1,119
1,071
1,031
3,023
3,080
3,053
5,290
7,055
7,572
7,942
7,575
3,988
4,399
4,478
4,510
3,961
3,774
3,765
3,702
4,359
4,622
4,328
4,428
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

4,428

4,328

4,622

4,359

3,702

3,765

3,774

3,961

4,510

4,478

4,399

3,988

7,575

7,942

7,572

7,055

5,290

3,053

3,080

3,023

1,031

1,071

1,119

1,184

1,751

733

1,974

757

1,353

1,357

1,291

937

1,372

5,433

Other Liabilities

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,164
2,153
2,102
2,136
3,070
3,004
3,136
2,998
3,212
3,674
3,508
3,357
3,984
4,100
4,210
4,422
4,678
4,609
4,665
5,143
5,469
5,049
5,107
4,976
3,800
3,982
3,637
3,747
4,395
8,912
4,668
5,248
7,795
7,884
7,759
7,849
8,474
13,007
13,363
13,551
12,915
12,730
12,490
13,268
15,822
15,939
13,302
13,290
21,551
21,752
22,480
23,858
26,095
39,377
39,609
37,583
37,641
38,415
33,607
29,020
31,737
32,192
31,463
27,212
26,106
28,534
28,355
24,843
22,181
23,104
23,516
39,599
40,784
42,276
44,218
46,608
48,686
41,542
38,686
42,293
38,177
110,641
107,146
111,811
76,905
118,392
114,674
112,072
108,603
106,475
114,376
117,264
0
109,322
104,738
0

104,738

109,322

117,264

114,376

106,475

108,603

112,072

114,674

118,392

76,905

111,811

107,146

110,641

38,177

42,293

38,686

41,542

48,686

46,608

44,218

42,276

40,784

39,599

23,516

23,104

22,181

24,843

28,355

28,534

26,106

27,212

31,463

32,192

31,737

29,020

33,607

38,415

37,641

37,583

39,609

39,377

26,095

23,858

22,480

21,752

21,551

13,290

13,302

15,939

15,822

13,268

12,490

12,730

12,915

13,551

13,363

13,007

8,474

7,849

7,759

7,884

7,795

5,248

4,668

8,912

4,395

3,747

3,637

3,982

3,800

4,976

5,107

5,049

5,469

5,143

4,665

4,609

4,678

4,422

4,210

4,100

3,984

3,357

3,508

3,674

3,212

2,998

3,136

3,004

3,070

2,136

2,102

2,153

2,164

Deferred Long Term Liability

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,512
12,681
11,872
18,669
18,386
18,005
16,775
23,332
0
26,513
25,497
29,552
29,961
29,265
29,664
29,664
28,366
26,911
25,871
32,097
34,354
34,781
33,510
21,377
21,416
22,188
24,463
12,114
12,818
13,380
6,428
6,526
10,606
13,235
18,441
19,906
14,006
11,687
14,576
10,562
13,116
10,480
9,803
43,825
24,278
24,574
26,132
28,727
32,622
35,974
40,152
36,195
37,342
0
0

37,342

36,195

40,152

35,974

32,622

28,727

26,132

24,574

24,278

43,825

9,803

10,480

13,116

10,562

14,576

11,687

14,006

19,906

18,441

13,235

10,606

6,526

6,428

13,380

12,818

12,114

24,463

22,188

21,416

21,377

33,510

34,781

34,354

32,097

25,871

26,911

28,366

29,664

29,265

29,961

29,552

25,497

26,513

23,332

16,775

18,005

18,386

18,669

11,872

12,681

13,512

> Total Stockholder Equity

0
0
0
0
73,400
76,400
82,400
90,600
100,100
110,400
115,800
126,700
133,400
143,000
149,700
160,800
171,300
180,100
186,600
193,200
197,500
206,200
214,900
217,000
225,900
235,100
233,500
225,300
228,200
231,400
219,100
194,700
199,200
210,500
221,700
221,900
216,100
213,800
212,100
206,443
208,858
189,667
201,205
215,516
235,240
247,337
255,866
236,824
218,766
213,396
221,264
223,237
232,437
239,848
264,228
279,749
294,632
309,666
335,939
355,135
372,569
387,250
418,973
441,650
461,835
456,990
453,344
479,648
476,555
447,726
473,700
494,188
493,930
496,815
515,788
539,884
563,853
579,432
573,080
593,124
564,956
594,392
648,524
686,136
712,456
678,277
705,233
732,631
757,467
771,966
779,158
769,182
774,378
796,473
825,220
839,614
815,072
820,718
833,908
826,122
791,647
776,880
719,552
719,978
715,560
749,114
770,897
739,610
772,770
801,253
822,807
752,429
674,059
701,338
643,129
667,868
590,966
583,754
574,580
587,109
608,569
667,923
719,152
731,670
677,080
698,549
730,775
749,424
770,423
729,009
775,979
817,997
864,616
893,660
943,319

943,319

893,660

864,616

817,997

775,979

729,009

770,423

749,424

730,775

698,549

677,080

731,670

719,152

667,923

608,569

587,109

574,580

583,754

590,966

667,868

643,129

701,338

674,059

752,429

822,807

801,253

772,770

739,610

770,897

749,114

715,560

719,978

719,552

776,880

791,647

826,122

833,908

820,718

815,072

839,614

825,220

796,473

774,378

769,182

779,158

771,966

757,467

732,631

705,233

678,277

712,456

686,136

648,524

594,392

564,956

593,124

573,080

579,432

563,853

539,884

515,788

496,815

493,930

494,188

473,700

447,726

476,555

479,648

453,344

456,990

461,835

441,650

418,973

387,250

372,569

355,135

335,939

309,666

294,632

279,749

264,228

239,848

232,437

223,237

221,264

213,396

218,766

236,824

255,866

247,337

235,240

215,516

201,205

189,667

208,858

206,443

212,100

213,800

216,100

221,900

221,700

210,500

199,200

194,700

219,100

231,400

228,200

225,300

233,500

235,100

225,900

217,000

214,900

206,200

197,500

193,200

186,600

180,100

171,300

160,800

149,700

143,000

133,400

126,700

115,800

110,400

100,100

90,600

82,400

76,400

73,400

Common Stock

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
301
303
307
311
313
314
315
315
316
316
317
317
318
325
326
328
330
334
262
263
265
266
268
270
269
264
265
262
254
256
256
254
252
254
256
257
256
252
255
247
248
255
256
257
249
251
253
256
257
516
510
514
515
519
520
514
513
515
517
509
506
508
509
511
515
518
523
525
527
534
523
516
516
510
510
508
506
504
503
507
507
508
509
510
511
511
511
513
506
504
504
507
507
508

508

507

504

506

513

511

510

509

508

507

503

504

506

508

510

516

523

534

527

525

523

518

515

511

509

508

506

509

517

515

513

514

520

519

515

514

510

516

257

256

253

251

249

257

256

255

248

247

255

252

256

257

256

254

252

254

256

254

262

265

264

269

270

268

266

265

263

262

334

330

328

326

325

318

317

316

315

314

313

311

307

303

301

300

Retained Earnings Total Equity

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
311,568
332,907
352,642
373,630
390,577
364,726
382,977
400,783
0
412,764
409,553
398,199
390,324
406,873
423,163
433,347
409,307
411,199
423,563
420,365
387,344
384,359
324,916
316,184
305,838
325,663
341,056
289,916
310,053
330,155
323,608
266,942
189,859
194,375
140,584
161,418
99,418
85,634
69,868
78,512
89,039
137,140
169,022
157,981
154,562
169,418
192,650
202,391
222,268
204,364
223,785
253,168
284,017
0
0

284,017

253,168

223,785

204,364

222,268

202,391

192,650

169,418

154,562

157,981

169,022

137,140

89,039

78,512

69,868

85,634

99,418

161,418

140,584

194,375

189,859

266,942

323,608

330,155

310,053

289,916

341,056

325,663

305,838

316,184

324,916

384,359

387,344

420,365

423,563

411,199

409,307

433,347

423,163

406,873

390,324

398,199

409,553

412,764

400,783

382,977

364,726

390,577

373,630

352,642

332,907

311,568

Accumulated Other Comprehensive Income

0
0
0
0
-19,900
-22,000
-24,300
-25,300
-27,800
-30,200
-32,300
-34,200
-36,600
-40,000
-42,700
-45,100
-49,000
-52,800
-56,500
-60,900
-65,300
-69,200
-73,800
-74,400
9,400
12,000
4,200
-12,400
-10,000
-14,200
-15,600
-19,200
-20,000
-10,400
-7,400
-19,600
-24,600
-9,500
-11,000
-13,078
-13,701
-15,692
-15,448
-17,618
-13,893
-16,501
-15,271
-16,395
-17,473
-16,203
-15,450
-13,486
-9,961
-10,472
-8,302
-6,535
-4,716
-2,924
-987
-699
-1,151
-1,336
-1,761
-2,834
-2,533
-2,076
-602
-199
1,015
2,089
3,389
4,803
8,801
7,776
2,922
3,283
3,786
4,061
5,595
5,905
2,028
5,166
5,721
9,541
11,539
8,785
9,118
9,110
5,241
4,556
6,890
5,433
5,174
3,932
4,931
1,410
565
66
-7,575
-21,724
-24,084
-38,473
-41,349
-35,040
-35,927
-36,715
-39,025
-32,873
-29,244
-27,409
-27,212
-18,991
-23,710
-24,033
-29,096
-30,380
-33,998
-36,106
-33,705
-45,135
-43,706
-38,472
-29,858
-29,547
-29,100
-29,536
-29,349
-25,954
-32,717
-40,255
-35,799
-30,381
-29,518
-32,705
-24,382

-24,382

-32,705

-29,518

-30,381

-35,799

-40,255

-32,717

-25,954

-29,349

-29,536

-29,100

-29,547

-29,858

-38,472

-43,706

-45,135

-33,705

-36,106

-33,998

-30,380

-29,096

-24,033

-23,710

-18,991

-27,212

-27,409

-29,244

-32,873

-39,025

-36,715

-35,927

-35,040

-41,349

-38,473

-24,084

-21,724

-7,575

565

1,410

4,931

3,932

5,174

5,433

6,890

4,556

5,241

9,110

9,118

8,785

11,539

9,541

5,721

5,166

2,028

5,905

5,595

4,061

3,786

3,283

2,922

7,776

8,801

4,803

3,389

2,089

1,015

-199

-602

-2,076

-2,533

-2,834

-1,761

-1,336

-1,151

-699

-987

-2,924

-4,716

-6,535

-8,302

-10,472

-9,961

-13,486

-15,450

-16,203

-17,473

-16,395

-15,271

-16,501

-13,893

-17,618

-15,448

-15,692

-13,701

-13,078

-11,000

-9,500

-24,600

-19,600

-7,400

-10,400

-20,000

-19,200

-15,600

-14,200

-10,000

-12,400

4,200

12,000

9,400

-74,400

-73,800

-69,200

-65,300

-60,900

-56,500

-52,800

-49,000

-45,100

-42,700

-40,000

-36,600

-34,200

-32,300

-30,200

-27,800

-25,300

-24,300

-22,000

-19,900

Capital Surplus

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
251,113
256,071
289,906
302,709
310,083
304,517
312,887
322,485
0
354,389
362,199
365,040
378,366
385,153
396,607
402,611
404,686
408,940
417,405
426,964
427,878
430,488
435,477
439,912
445,138
459,651
468,348
482,044
491,436
497,980
525,877
503,955
507,394
530,480
531,131
536,320
525,038
533,720
537,913
553,229
562,729
568,748
579,480
602,727
551,108
558,156
566,963
572,476
580,359
564,394
587,489
594,706
609,610
616,960
0

616,960

609,610

594,706

587,489

564,394

580,359

572,476

566,963

558,156

551,108

602,727

579,480

568,748

562,729

553,229

537,913

533,720

525,038

536,320

531,131

530,480

507,394

503,955

525,877

497,980

491,436

482,044

468,348

459,651

445,138

439,912

435,477

430,488

427,878

426,964

417,405

408,940

404,686

402,611

396,607

385,153

378,366

365,040

362,199

354,389

322,485

312,887

304,517

310,083

302,709

289,906

256,071

251,113

Treasury Stock

-163,158

-163,640

-164,077

-164,679

-165,335

-160,149

-156,726

-141,725

-115,949

-89,035

-89,234

-89,456

-89,664

-85,173

Other Stockholders Equity

0
0
0
0
50,800
51,600
55,300
58,900
65,700
72,400
73,300
79,200
81,500
86,500
87,600
92,700
99,000
103,100
104,800
107,300
107,200
110,700
115,100
108,700
24,100
22,000
21,200
21,700
15,800
19,100
19,900
22,800
23,200
19,600
23,100
29,400
22,600
-500
-7,200
-11,511
-15,107
-13,122
-10,808
-1,498
4,525
9,280
14,042
-11,688
-35,443
-48,864
-52,096
-56,565
-55,873
-53,447
-40,558
-36,333
-33,091
-28,725
-15,400
121,803
126,804
130,723
134,781
141,371
149,945
157,175
157,700
163,815
172,763
170,941
181,256
186,933
193,413
209,427
217,036
226,829
232,221
235,792
236,553
252,323
251,113
256,071
289,906
302,709
310,083
304,517
312,887
322,485
341,401
354,389
362,199
365,040
378,366
385,153
396,607
404,337
404,686
408,940
417,405
426,964
427,878
430,488
435,477
438,325
445,138
459,651
468,348
482,044
491,436
497,980
525,877
503,955
507,394
530,480
531,131
536,320
525,038
533,720
537,913
553,229
562,729
568,748
579,480
602,727
551,108
558,156
566,963
572,476
580,359
564,394
587,489
594,706
609,610
616,960
627,094

627,094

616,960

609,610

594,706

587,489

564,394

580,359

572,476

566,963

558,156

551,108

602,727

579,480

568,748

562,729

553,229

537,913

533,720

525,038

536,320

531,131

530,480

507,394

503,955

525,877

497,980

491,436

482,044

468,348

459,651

445,138

438,325

435,477

430,488

427,878

426,964

417,405

408,940

404,686

404,337

396,607

385,153

378,366

365,040

362,199

354,389

341,401

322,485

312,887

304,517

310,083

302,709

289,906

256,071

251,113

252,323

236,553

235,792

232,221

226,829

217,036

209,427

193,413

186,933

181,256

170,941

172,763

163,815

157,700

157,175

149,945

141,371

134,781

130,723

126,804

121,803

-15,400

-28,725

-33,091

-36,333

-40,558

-53,447

-55,873

-56,565

-52,096

-48,864

-35,443

-11,688

14,042

9,280

4,525

-1,498

-10,808

-13,122

-15,107

-11,511

-7,200

-500

22,600

29,400

23,100

19,600

23,200

22,800

19,900

19,100

15,800

21,700

21,200

22,000

24,100

108,700

115,100

110,700

107,200

107,300

104,800

103,100

99,000

92,700

87,600

86,500

81,500

79,200

73,300

72,400

65,700

58,900

55,300

51,600

50,800

Balance Sheet

Currency in USD. All numbers in thousands.

	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31	2006-03-31	2005-03-31	2004-03-31	2003-03-31	2002-03-31	2001-03-31	2000-03-31	1999-03-31	1998-03-31	1997-03-31	1996-03-31	1995-03-31	1994-03-31	1993-03-31	1992-03-31	1991-03-31
Accounts Payable	63,929	58,371	50,293	50,730	63,361	55,265	42,973	39,674	48,425	53,562	49,893	35,425	28,323	25,590	20,652	19,724	17,187	14,217	11,111	14,249	13,677	12,536	13,350	17,224	10,700	21,700	27,900	16,900	15,600	14,700	13,200	9,100	-
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	-375,767	-348,877	-320,156	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Accumulated Other Comprehensive Income	-30,381	-25,954	-29,547	-45,135	-30,380	-18,991	-32,873	-35,040	-21,724	1,410	5,433	9,110	9,541	5,905	3,283	4,803	-199	-2,834	-699	-6,535	-13,486	-16,395	-17,618	-13,078	-19,600	-19,200	-12,400	-74,400	-60,900	-45,100	-34,200	-25,300	-
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Capital Lease Obligations	0	7,196	70,668	59,320	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Capital Stock	504	511	509	503	510	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Capital Surpluse	594,706	572,476	602,727	553,229	536,320	503,955	482,044	439,912	426,964	402,611	365,040	322,485	302,709	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Cash	284,466	259,496	192,305	137,311	169,351	180,169	139,564	115,123	160,662	192,469	179,120	228,861	196,707	141,562	156,721	133,553	229,227	250,667	185,815	118,117	49,885	34,913	41,441	61,328	56,300	21,800	8,300	13,400	4,200	16,200	10,300	2,900	-
Cash And Equivalents	284,466	259,496	192,305	137,311	169,351	180,169	139,564	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Cash And Short Term Investments	284,466	259,496	192,305	137,311	169,351	180,169	139,564	115,123	160,662	192,469	179,120	228,861	196,707	141,562	156,721	133,553	229,227	250,667	185,815	118,117	49,885	67,549	74,483	61,328	56,300	21,800	8,300	13,400	4,200	16,200	10,300	2,900	-
Common Stock	504	511	509	503	510	523	523	509	517	520	510	253	256	255	256	256	265	268	262	326	317	315	307	300	300	300	300	0	0	0	0	0	-
Common Stock Shares Outstanding	51,420	51,353	51,292	51,815	52,942	53,501	51,524	50,910	52,089	52,377	52,259	51,590	51,192	52,126	52,346	53,492	55,298	54,948	52,852	49,277	50,096	54,310	52,010	53,002	53,768	53,333	54,833	55,231	56,949	57,798	57,011	57,143	55,600
Common Stock Total Equity	504	511	509	503	510	523	523	509	517	500	500	253	300	300	300	300	265	300	300	300	300	300	307	300	300	300	300	0	0	0	0	0	-
Current Deferred Revenue	30,209	31,826	26,272	28,843	27,279	25,814	26,485	27,053	22,362	24,777	23,737	-35,425	33,179	-25,590	0	25,109	15,685	28,582	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Deferred Long Term Asset Charges	0	0	0	0	4,359	3,961	3,988	7,055	3,023	1,184	1,751	23	1,291	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Deferred Long Term Liab	36,195	28,727	43,825	10,562	19,906	6,526	12,114	21,377	32,097	29,664	29,552	23,332	18,669	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Good Will	466,231	467,287	466,444	210,652	210,819	211,395	210,841	267,840	334,310	336,768	330,474	115,058	115,367	120,543	56,426	54,222	34,958	18,483	18,200	17,200	16,000	14,168	14,426	1,800	0	0	0	0	0	0	0	0	-
Intangible Assets	275,771	310,261	365,483	133,106	127,693	156,589	177,540	204,458	244,588	271,159	264,388	96,549	101,789	86,102	65,261	64,333	33,857	22,945	44,020	42,026	42,349	24,204	15,842	1,832	10,500	10,700	10,300	0	0	9,300	7,600	6,900	-
Inventory	259,379	293,027	322,614	270,276	194,337	160,799	176,929	186,144	211,077	197,661	183,784	117,163	84,387	79,953	76,522	65,388	61,797	54,571	53,088	52,235	65,805	67,244	54,007	59,817	59,800	61,700	55,100	56,700	60,000	41,300	30,300	30,600	-
Liabilities And Stockholders Equity	1,934,825	1,859,734	1,819,923	1,267,110	1,274,767	1,237,339	1,238,709	1,317,105	1,483,119	1,520,847	1,461,871	910,632	833,264	754,143	649,693	608,950	572,735	546,543	467,757	407,394	359,208	364,921	345,314	349,110	356,400	336,700	323,500	287,800	280,500	230,700	180,300	144,800	-
Long Term Debt	754,102	559,441	690,592	305,513	322,454	59,423	253,625	364,529	406,369	392,057	456,944	2,877	3,966	4,589	5,343	6,037	6,675	12,977	19,231	25,442	31,612	40,787	47,281	41,306	0	0	0	0	0	0	0	0	-
Long Term Debt Total	754,102	559,441	690,592	305,513	322,454	59,423	253,625	364,529	406,369	392,057	456,944	2,877	3,966	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Long Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Net Debt	481,420	514,093	515,303	245,182	180,769	73,513	175,083	292,877	267,229	245,218	300,974	-225,090	-191,828	-119,911	-150,683	-121,190	-200,351	-211,514	-139,972	-59,857	20,732	37,230	28,278	12,874	2,800	49,300	21,200	5,200	29,200	-1,900	3,300	21,200	-
Net Invested Capital	765,886	773,589	707,608	969,602	1,017,988	1,006,111	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Net Receivables	179,142	159,376	127,555	165,207	185,027	151,226	152,683	157,093	145,827	164,961	170,111	135,464	127,166	118,684	113,598	120,252	91,832	86,901	80,719	82,640	77,913	63,743	59,842	59,140	63,000	58,900	72,200	60,300	63,300	47,500	38,800	33,400	-
Net Tangible Assets	75,995	-28,124	-100,257	243,351	329,356	384,445	351,229	249,267	247,224	229,961	174,320	521,024	468,980	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Net Working Capital	517,906	313,765	440,051	328,817	340,362	136,474	298,850	302,490	378,887	411,830	417,167	395,882	340,160	242,585	289,530	261,757	321,654	330,288	255,689	185,606	122,880	148,737	139,717	121,443	162,200	112,800	94,100	112,500	108,500	81,500	57,000	41,000	-
Non Current Assets Total	1,165,103	1,103,703	1,126,377	663,471	698,646	716,162	728,680	829,903	915,140	891,202	864,906	384,006	384,433	380,453	267,300	249,516	169,064	128,139	124,146	125,945	135,953	132,086	126,150	139,192	125,100	145,500	155,800	128,900	122,900	100,600	84,800	66,300	-
Non Current Liabilities Other	110,910	108,603	144,166	89,104	5,814	9,526	6,494	26,106	31,737	37,641	26,095	21,551	15,822	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Non Current Liabilities Total	865,012	668,044	834,758	395,703	371,140	100,207	287,920	412,415	467,905	463,418	512,891	44,813	38,457	29,914	16,946	17,085	11,070	16,777	24,700	31,802	35,596	43,999	50,351	54,192	65,400	63,600	24,600	24,400	38,200	21,300	15,100	16,700	-
Non Currrent Assets Other	106,975	63,205	76,891	66,314	16,155	16,022	16,437	19,971	593,192	619,765	607,953	222,349	10,458	227,155	4,799	5,233	4,961	10,208	10,687	5,889	6,663	3,362	10,894	34,252	-4,800	2,100	-1,900	42,500	40,800	23,000	21,200	12,600	-
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Other Assets	58,803	67,673	17,035	14,078	16,155	16,022	16,437	21,110	14,294	11,838	13,092	10,742	11,749	14,574	7,806	14,477	9,474	6,445	5,789	3,852	6,649	5,603	37,508	33,621	0	0	0	0	0	0	0	0	-
Other Current Assets	46,735	44,132	51,072	30,845	27,406	28,983	40,853	28,842	50,413	74,554	63,950	45,138	40,571	33,491	35,552	40,241	20,815	26,265	23,989	1,859	2,681	2,783	5,680	29,633	52,200	48,800	32,100	28,500	30,100	25,100	16,100	11,600	-
Other Current Liab	145,894	137,921	159,914	127,745	117,453	109,365	80,699	74,514	96,783	93,846	83,018	129,850	46,256	114,043	71,516	46,518	26,944	19,141	50,199	48,776	47,693	40,206	43,659	38,355	51,800	39,200	26,200	26,100	25,200	29,400	22,300	20,000	-
Other Liab	0	108,603	76,905	38,177	48,686	40,784	34,295	47,483	31,737	37,641	26,095	21,551	15,822	12,915	8,474	7,795	4,395	3,800	5,469	4,678	3,984	3,212	3,070	2,164	0	0	0	0	0	0	0	0	-
Other Stockholder Equity	594,706	572,476	602,727	553,229	536,320	503,955	482,044	438,325	426,964	404,337	365,040	324,929	302,709	252,323	226,829	186,933	163,815	141,371	121,803	-36,333	-56,565	-11,688	-1,498	-11,511	29,400	22,800	21,700	108,700	107,300	92,700	79,200	58,900	-
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Property Plant And Equipment Gross	944,215	869,147	217,559	305,635	343,979	332,156	323,862	337,634	321,948	271,400	257,000	161,657	155,500	153,300	137,800	116,500	90,775	75,300	69,300	78,000	84,000	84,900	83,251	81,600	83,000	84,200	103,600	86,400	82,100	68,300	56,000	46,800	-
Property Plant And Equipment Net	310,885	258,482	217,559	253,399	343,979	332,156	323,862	337,634	321,948	271,437	256,953	161,657	155,528	153,298	137,807	116,484	90,775	75,266	69,337	78,030	83,987	84,877	83,251	81,608	83,000	84,200	103,600	86,400	82,100	68,300	56,000	46,800	-
Property Plant Equipment	310,885	258,482	277,415	253,399	343,979	332,156	323,862	337,634	321,948	271,437	256,953	161,657	155,528	153,298	137,807	116,484	90,775	75,266	69,337	78,030	83,987	84,877	83,251	81,608	0	0	0	0	0	0	0	0	-
Retained Earnings	253,168	202,391	157,981	78,512	161,418	266,942	289,916	316,184	420,365	433,347	398,199	400,783	373,630	334,641	309,516	302,196	315,767	302,845	233,769	322,291	292,971	264,592	234,325	230,732	211,800	190,800	215,700	182,700	146,800	113,200	81,700	57,000	-
Retained Earnings Total Equity	253,168	202,391	157,981	78,512	161,418	266,942	289,916	316,184	420,365	433,347	398,199	400,783	373,630	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Short Long Term Debt	11,784	214,148	17,016	76,980	27,666	194,259	61,022	43,625	21,681	437,687	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Short Long Term Debt Total	765,886	773,589	707,608	382,493	350,120	253,682	314,647	408,000	427,891	437,687	480,094	3,771	4,879	21,651	6,038	12,363	28,876	39,153	45,843	58,260	70,617	72,143	69,719	74,202	59,100	71,100	29,500	18,600	33,400	14,300	13,600	24,100	-
Short Term Debt	11,784	214,148	17,016	76,980	27,666	194,259	61,022	43,471	21,522	45,630	23,150	894	913	17,062	695	6,326	22,201	26,176	26,612	32,818	39,005	31,356	22,438	32,896	6,600	17,500	19,500	3,400	8,300	4,500	3,000	8,400	-
Short Term Investments	1,110	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,900	2,700	32,636	33,042	8,000	12,300	11,900	13,600	0	0	0	0	0	-
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Total Assets	1,934,825	1,859,734	1,819,923	1,267,110	1,274,767	1,237,339	1,238,709	1,317,105	1,483,119	1,520,847	1,461,871	910,632	833,264	754,143	649,693	608,950	572,735	546,543	467,757	407,394	359,208	364,921	345,314	349,110	356,400	336,700	323,500	287,800	280,500	230,700	180,300	144,800	-
Total Current Assets	769,722	756,031	693,546	603,639	576,121	521,177	510,029	487,202	567,979	629,645	596,965	526,626	448,831	373,690	382,393	359,434	403,671	418,404	343,611	281,449	223,255	232,835	219,164	209,918	231,300	191,200	167,700	158,900	157,600	130,100	95,500	78,500	-
Total Current Liabilities	251,816	442,266	253,495	284,298	235,759	384,703	211,179	184,712	189,092	217,815	179,798	130,744	108,671	131,105	92,863	97,677	82,017	88,116	87,922	95,843	100,375	84,098	79,447	88,475	69,100	78,400	73,600	46,400	49,100	48,600	38,500	37,500	-
Total Liab	1,116,828	1,110,310	1,088,253	680,001	606,899	484,910	499,099	597,127	656,997	681,233	692,689	175,557	147,128	161,019	109,809	114,762	93,087	104,893	112,622	127,645	135,971	128,097	129,798	142,667	134,500	142,000	98,200	70,800	87,300	69,900	53,600	54,200	-
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Total Stockholder Equity	817,997	749,424	731,670	587,109	667,868	752,429	739,610	719,978	826,122	839,614	769,182	735,075	686,136	593,124	539,884	494,188	479,648	441,650	355,135	279,749	223,237	236,824	215,516	206,443	221,900	194,700	225,300	217,000	193,200	160,800	126,700	90,600	-
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-164,077	-165,335	-115,949	-89,456	-85,173	0	0	0	0	0	0	0	0	-
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31	1999-09-30	1999-06-30	1999-03-31	1998-12-31	1998-09-30	1998-06-30	1998-03-31	1997-12-31	1997-09-30	1997-06-30	1997-03-31	1996-12-31	1996-09-30	1996-06-30	1996-03-31	1995-12-31	1995-09-30	1995-06-30	1995-03-31	1994-12-31	1994-09-30	1994-06-30	1994-03-31	1993-12-31	1993-09-30	1993-06-30	1993-03-31	1992-12-31	1992-09-30	1992-06-30	1992-03-31	1991-12-31	1991-09-30	1991-06-30	1991-03-31	1990-12-31	1990-09-30	1990-06-30
Accounts Payable	56,845	80,160	78,134	63,929	63,769	61,484	57,907	58,371	51,175	44,969	49,131	50,293	42,979	49,071	48,459	50,730	52,298	57,449	60,792	63,361	62,579	57,857	65,393	55,265	41,496	41,764	39,389	42,973	48,848	42,013	36,799	39,674	39,636	42,088	42,155	48,425	46,830	44,173	55,213	53,562	43,106	45,380	47,915	49,893	53,077	42,987	33,978	35,425	28,891	29,759	28,155	28,323	19,608	21,628	23,418	25,590	23,740	24,804	23,448	20,652	17,201	20,292	21,300	19,724	15,790	17,665	17,740	17,187	16,514	17,293	15,477	14,217	14,734	13,252	15,123	11,111	12,305	15,105	13,344	14,249	13,922	13,682	14,759	13,677	11,296	11,927	12,309	12,536	12,054	12,254	11,923	13,350	9,726	11,078	8,323	17,224	14,200	13,400	9,500	10,700	11,500	13,900	15,100	21,700	21,700	26,400	22,600	27,900	19,200	19,000	12,100	16,900	16,700	17,300	15,200	15,600	39,400	39,100	36,900	14,700	37,500	33,500	31,100	13,200	28,600	28,200	24,300	9,100	30,600	29,500	25,300	-	-	-	-
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-416,283	-404,468	-386,500	-375,767	-356,373	-351,786	0	-348,877	-338,805	-333,203	-328,140	-320,156	-318,064	-312,202	-294,027	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Accumulated Other Comprehensive Income	-24,382	-32,705	-29,518	-30,381	-35,799	-40,255	-32,717	-25,954	-29,349	-29,536	-29,100	-29,547	-29,858	-38,472	-43,706	-45,135	-33,705	-36,106	-33,998	-30,380	-29,096	-24,033	-23,710	-18,991	-27,212	-27,409	-29,244	-32,873	-39,025	-36,715	-35,927	-35,040	-41,349	-38,473	-24,084	-21,724	-7,575	66	565	1,410	4,931	3,932	5,174	5,433	6,890	4,556	5,241	9,110	9,118	8,785	11,539	9,541	5,721	5,166	2,028	5,905	5,595	4,061	3,786	3,283	2,922	7,776	8,801	4,803	3,389	2,089	1,015	-199	-602	-2,076	-2,533	-2,834	-1,761	-1,336	-1,151	-699	-987	-2,924	-4,716	-6,535	-8,302	-10,472	-9,961	-13,486	-15,450	-16,203	-17,473	-16,395	-15,271	-16,501	-13,893	-17,618	-15,448	-15,692	-13,701	-13,078	-11,000	-9,500	-24,600	-19,600	-7,400	-10,400	-20,000	-19,200	-15,600	-14,200	-10,000	-12,400	4,200	12,000	9,400	-74,400	-73,800	-69,200	-65,300	-60,900	-56,500	-52,800	-49,000	-45,100	-42,700	-40,000	-36,600	-34,200	-32,300	-30,200	-27,800	-25,300	-24,300	-22,000	-19,900	-	-	-	-
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Capital Lease Obligations	0	0	0	0	0	0	0	7,196	0	0	0	70,668	0	0	0	59,320	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Capital Stock	508	507	507	504	504	506	513	511	511	511	510	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Capital Surpluse	0	616,960	609,610	594,706	587,489	564,394	580,359	572,476	566,963	558,156	551,108	602,727	579,480	568,748	562,729	553,229	537,913	533,720	525,038	536,320	531,131	530,480	507,394	503,955	525,877	497,980	491,436	482,044	468,348	459,651	445,138	439,912	435,477	430,488	427,878	426,964	417,405	408,940	404,686	402,611	396,607	385,153	378,366	365,040	362,199	354,389	0	322,485	312,887	304,517	310,083	302,709	289,906	256,071	251,113	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Cash	193,978	351,005	285,719	284,466	224,002	241,200	214,948	259,496	236,877	192,420	173,462	192,305	189,002	279,169	275,725	137,311	126,417	112,030	190,234	169,351	154,871	199,763	192,106	180,169	251,591	203,622	171,739	139,564	129,639	138,870	118,248	115,123	105,167	100,247	112,204	160,662	125,200	129,971	139,943	192,469	177,846	159,148	166,328	179,120	193,181	187,051	236,047	228,861	205,372	183,421	216,891	196,707	169,538	115,049	83,467	141,562	168,993	178,322	173,822	156,721	125,325	111,331	120,287	133,553	116,857	154,983	216,056	229,227	227,707	242,200	260,031	250,667	229,351	209,981	198,067	185,815	160,276	143,829	130,356	118,117	97,182	66,771	50,190	49,885	49,666	43,615	42,006	34,913	52,900	57,847	40,959	41,441	59,212	38,617	52,195	61,328	46,500	56,200	53,300	56,300	42,300	37,200	24,300	21,800	7,300	6,600	5,600	8,300	16,600	13,200	10,900	13,400	13,900	8,400	3,700	4,200	3,700	8,400	6,300	16,200	13,800	10,300	4,400	10,300	7,500	2,200	900	2,900	300	700	1,200	-	-	-	-
Cash And Equivalents	0	351,005	285,719	284,466	224,002	241,200	214,948	259,496	236,877	192,420	173,462	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Cash And Short Term Investments	193,978	351,005	285,719	284,466	224,002	241,200	214,948	259,496	236,877	192,420	173,462	192,305	189,002	279,169	275,725	137,311	126,417	112,030	190,234	169,351	154,871	199,763	192,106	180,169	251,591	203,622	171,739	139,564	129,639	138,870	118,248	115,123	105,167	100,247	112,204	160,662	125,200	129,971	139,943	192,469	177,846	159,148	166,328	179,120	193,181	187,051	236,047	228,861	205,372	183,421	216,891	196,707	169,538	115,049	83,467	141,562	168,993	178,322	173,822	156,721	125,325	111,331	120,287	133,553	116,857	154,983	216,056	229,227	227,707	242,200	260,031	250,667	229,351	209,981	198,067	185,815	160,276	143,829	130,356	118,117	97,182	66,771	50,190	49,885	49,666	43,615	42,006	67,549	99,438	103,651	86,413	74,483	59,212	38,617	52,195	61,328	46,500	56,200	53,300	56,300	42,300	37,200	24,300	21,800	7,300	6,600	5,600	8,300	16,600	13,200	10,900	13,400	13,900	8,400	3,700	4,200	3,700	8,400	6,300	16,200	13,800	10,300	4,400	10,300	7,500	2,200	900	2,900	300	700	1,200	-	-	-	-
Common Stock	508	507	507	504	504	506	513	511	511	511	510	509	508	507	507	503	504	506	508	510	510	516	516	523	534	527	525	523	518	515	511	509	508	506	509	517	515	513	514	520	519	515	514	510	516	257	256	253	251	249	257	256	255	248	247	255	252	256	257	256	254	252	254	256	256	254	262	265	264	269	270	268	266	265	263	262	334	330	328	326	325	318	317	317	316	316	315	315	314	313	311	307	303	301	300	300	300	300	300	300	300	300	300	300	300	300	300	300	300	300	300	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Common Stock Shares Outstanding	51,445	51,396	51,340	51,221	51,219	51,558	51,683	51,354	51,344	51,458	50,939	50,848	51,363	51,093	51,247	51,275	51,638	52,046	51,010	52,216	52,822	53,138	52,119	54,151	53,090	52,981	52,811	51,990	52,103	51,701	51,021	50,863	50,741	51,187	51,360	51,565	51,962	51,925	51,741	52,609	52,511	52,361	51,231	52,199	52,606	52,314	51,864	50,966	50,876	51,686	52,432	51,900	51,034	50,456	51,406	51,600	51,814	52,642	52,402	52,400	52,112	51,834	53,034	53,200	52,874	52,922	54,806	53,068	54,734	55,938	55,858	55,500	55,292	54,708	54,418	53,800	52,628	51,568	51,158	50,900	49,560	48,654	48,446	48,700	49,146	50,326	52,220	53,800	55,050	54,478	53,894	51,958	51,982	50,266	51,462	53,000	52,194	51,818	54,545	53,800	53,333	53,000	51,579	52,100	53,182	54,167	54,167	54,100	53,846	55,484	55,294	55,625	55,625	55,758	54,375	56,667	56,667	56,667	57,857	57,241	57,241	57,143	56,667	57,391	57,391	57,143	54,737	57,500	57,500	57,333	53,846	55,600	55,600	55,600	55,600
Common Stock Total Equity	0	0	507	504	504	506	513	511	511	511	510	509	508	507	507	503	504	506	508	510	510	500	516	523	500	527	500	500	518	500	500	500	500	500	500	500	500	500	500	500	500	500	500	500	500	300	256	253	251	200	300	300	300	200	200	300	300	300	300	300	300	300	300	300	300	300	262	265	300	269	300	300	266	300	300	300	300	300	300	300	300	300	300	300	300	300	300	300	300	300	311	307	300	301	300	300	300	300	300	300	300	300	300	300	300	300	300	300	300	300	300	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Current Deferred Revenue	58,762	-80,160	32,970	30,209	0	0	31,826	31,826	39,046	41,067	34,372	26,272	-42,979	29,226	36,409	28,843	-52,298	-57,449	31,352	27,279	51,811	49,132	45,828	25,814	63,066	37,364	31,934	26,485	41,556	40,808	44,330	27,053	-39,636	45,061	-42,155	22,362	-46,830	-44,173	-55,213	24,777	-43,106	-45,380	-47,915	23,737	-53,077	-42,987	-33,978	37,590	-28,891	-29,759	-28,155	33,179	-19,608	-21,628	-23,418	0	-23,740	-24,804	-23,448	0	31,433	29,713	27,864	25,109	33,579	16,814	15,935	15,685	0	0	0	28,582	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Deferred Long Term Asset Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4,428	4,328	4,622	4,359	3,702	3,765	3,774	3,961	4,510	4,478	4,399	3,988	7,575	7,942	7,572	7,055	5,290	3,053	3,080	3,023	1,031	1,071	1,119	1,184	1,751	1,751	1,751	1,751	733	1,974	0	23	757	1,353	1,357	1,291	937	1,372	5,433	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Deferred Long Term Liab	0	0	37,342	36,195	40,152	35,974	32,622	28,727	26,132	24,574	24,278	43,825	9,803	10,480	13,116	10,562	14,576	11,687	14,006	19,906	18,441	13,235	10,606	6,526	6,428	13,380	12,818	12,114	24,463	22,188	21,416	21,377	33,510	34,781	34,354	32,097	25,871	26,911	28,366	29,664	29,664	29,265	29,961	29,552	25,497	26,513	0	23,332	16,775	18,005	18,386	18,669	11,872	12,681	13,512	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Good Will	554,999	465,405	465,910	466,231	466,112	464,987	466,115	467,287	468,199	468,590	466,314	466,444	215,508	214,594	217,298	210,652	211,062	211,041	211,140	210,819	210,723	210,844	210,903	211,395	211,086	211,125	210,930	210,841	267,314	268,546	268,589	267,840	266,945	333,575	334,187	334,310	334,990	336,301	337,237	336,768	337,029	341,673	341,509	330,474	321,284	322,114	115,048	115,058	115,320	115,582	115,707	115,367	111,268	112,383	117,739	120,543	71,255	72,157	64,730	56,426	55,434	54,556	54,786	54,222	55,828	35,242	34,703	34,958	33,548	33,494	18,625	18,483	18,437	18,730	17,936	18,200	18,500	17,800	16,900	17,200	17,000	16,600	16,200	16,000	14,900	14,700	15,000	14,168	12,100	12,771	12,388	14,426	4,700	0	1,800	13,200	0	0	2,000	2,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Intangible Assets	429,270	250,504	268,146	275,771	284,383	292,595	302,710	310,261	323,951	337,249	353,688	365,483	119,716	127,210	137,520	133,106	107,307	113,540	120,340	127,693	134,724	141,483	148,730	156,589	163,946	169,379	173,420	177,540	185,427	192,451	198,121	204,458	214,809	237,685	241,873	244,588	251,221	257,544	264,560	271,159	275,287	277,065	279,098	264,388	273,695	297,972	94,913	96,549	97,060	98,847	100,892	101,789	99,649	94,544	84,214	86,102	74,496	74,872	72,008	65,261	63,936	65,095	65,520	64,333	60,153	37,580	35,059	33,857	25,927	25,915	23,321	22,945	41,069	43,594	43,227	44,020	44,862	45,722	41,161	42,026	42,196	42,258	42,316	42,349	37,843	38,083	38,874	24,204	30,440	18,696	19,063	15,842	4,739	4,836	1,788	1,832	11,800	11,300	10,400	11,000	11,100	9,900	10,000	10,700	10,900	11,900	11,400	10,300	11,200	11,700	11,900	0	0	0	0	0	14,000	10,100	9,500	9,300	9,400	9,400	9,300	7,600	0	0	0	6,900	0	0	0	-	-	-	-
Inventory	304,024	285,830	289,207	259,379	255,756	254,680	277,887	293,027	305,741	322,661	326,500	322,614	299,710	305,224	294,510	270,276	254,167	244,504	221,953	194,337	168,936	163,584	175,329	160,799	158,840	168,592	173,894	176,929	188,489	194,511	189,431	186,144	203,863	207,645	211,131	211,077	212,493	209,418	207,487	197,661	209,331	205,251	196,673	183,784	180,037	173,506	126,843	117,163	107,913	101,444	94,960	84,387	81,915	86,009	84,571	79,953	78,806	77,136	76,097	76,522	73,557	73,181	71,196	65,388	63,847	66,069	68,209	61,797	59,680	58,925	55,561	54,571	56,313	57,581	55,998	53,088	52,485	50,712	52,589	52,235	56,081	58,726	64,178	65,805	70,138	71,755	74,444	67,244	63,289	61,986	56,671	54,007	52,768	52,969	57,615	59,817	59,200	59,500	57,800	59,800	64,000	67,700	64,500	61,700	60,800	65,100	59,000	55,100	46,800	52,500	58,300	56,700	57,200	58,400	59,800	60,000	56,000	51,300	46,700	41,300	40,500	35,400	31,200	30,300	29,400	30,000	30,100	30,600	32,700	27,700	26,500	-	-	-	-
Liabilities And Stockholders Equity	2,200,428	2,011,275	1,962,258	1,934,825	1,878,066	1,865,112	1,820,526	1,859,734	1,831,376	1,801,497	1,794,187	1,819,923	1,318,068	1,418,174	1,433,173	1,267,110	1,237,749	1,190,541	1,259,610	1,274,767	1,227,637	1,265,711	1,241,168	1,237,339	1,311,714	1,271,163	1,251,382	1,238,709	1,306,421	1,334,826	1,317,391	1,317,105	1,336,422	1,418,944	1,427,411	1,483,119	1,471,799	1,474,545	1,476,731	1,520,847	1,490,083	1,483,592	1,479,630	1,461,871	1,474,373	1,454,555	928,123	911,135	847,773	823,722	853,406	833,264	783,389	737,737	694,164	760,660	702,212	714,294	691,943	649,693	622,348	600,710	608,229	608,950	565,532	548,690	578,104	572,735	549,868	561,432	568,234	546,543	523,136	499,223	485,862	467,757	456,774	427,535	416,383	407,394	396,564	374,387	366,183	359,208	365,922	355,880	355,072	364,921	389,000	392,012	369,648	345,314	342,443	323,139	337,911	349,110	361,900	347,400	341,800	356,400	353,200	342,700	331,400	336,700	359,400	366,900	347,600	323,500	311,900	308,800	296,200	287,800	288,400	289,800	283,900	280,500	260,800	252,300	235,700	230,700	207,100	201,100	184,600	180,300	162,200	160,700	152,200	144,800	144,300	130,500	119,700	-	-	-	-
Long Term Debt	856,849	748,662	751,381	754,102	756,826	759,552	763,141	559,441	633,118	698,043	767,345	690,592	292,721	297,016	296,893	305,513	309,738	313,984	318,144	322,454	326,618	330,988	330,838	59,423	118,702	178,015	237,167	253,625	269,997	336,505	352,908	364,529	380,814	387,715	399,453	406,369	421,006	428,253	429,010	392,057	406,418	420,711	448,119	456,944	468,250	477,402	2,642	2,877	3,107	3,332	3,606	3,966	4,194	4,423	4,384	4,589	4,778	4,974	5,160	5,343	5,522	5,697	5,882	6,037	6,202	6,361	6,522	6,675	6,828	12,690	12,835	12,977	13,117	18,967	19,101	19,231	19,359	25,199	25,322	25,442	25,560	31,389	31,502	31,612	31,721	38,290	38,430	40,787	41,137	47,303	47,303	47,281	50,720	41,098	41,184	41,306	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Long Term Debt Total	0	748,662	751,381	754,102	756,826	759,552	763,141	559,441	633,118	698,043	767,345	690,592	292,721	297,016	296,893	305,513	309,738	313,984	318,144	322,454	326,618	330,988	330,838	59,423	118,702	178,015	237,167	253,625	269,997	336,505	352,908	364,529	380,814	387,715	399,453	406,369	421,006	428,253	429,010	392,057	406,418	420,711	448,119	456,944	468,250	477,402	0	2,877	3,107	3,332	3,606	3,966	4,194	4,423	4,384	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Long Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Net Debt	676,607	411,223	479,234	481,420	542,773	576,546	555,046	514,093	540,305	588,356	610,908	515,303	120,774	184,848	252,532	245,182	245,287	258,888	245,458	180,769	188,946	143,889	155,775	73,513	18,576	82,982	131,304	175,083	206,629	249,184	281,464	292,877	321,940	334,061	319,645	267,229	303,554	299,937	290,998	245,218	269,382	305,250	314,225	300,974	289,266	294,600	-230,988	-225,090	-199,720	-177,009	-212,379	-191,828	-157,100	-98,924	-72,665	-120,911	-149,083	-158,167	-151,462	-150,683	-115,369	-97,579	-105,377	-121,190	-104,449	-130,705	-190,933	-200,351	-197,631	-207,588	-224,970	-211,514	-190,438	-163,371	-152,708	-139,972	-111,055	-90,332	-74,387	-59,857	-30,606	3,006	19,945	20,732	26,933	35,273	32,793	37,230	22,457	22,636	34,747	28,278	10,680	20,244	13,812	12,874	31,300	6,800	8,100	2,800	21,900	27,000	47,200	49,300	65,400	67,000	50,300	21,200	8,600	9,400	8,300	5,200	3,900	20,400	30,700	29,200	18,200	11,300	7,600	-1,900	0	7,400	8,700	3,300	7,100	16,300	22,800	21,200	28,900	21,800	17,600	-	-	-	-
Net Invested Capital	1,813,904	762,228	1,629,569	765,886	1,542,754	817,746	1,540,417	773,589	1,507,957	1,479,325	1,461,450	707,608	1,028,928	1,131,940	1,136,826	969,602	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Net Receivables	211,611	174,249	177,117	179,142	181,100	171,532	146,463	159,376	154,980	141,305	132,908	127,555	146,939	141,533	141,094	165,207	170,753	176,535	163,339	185,027	167,641	161,590	151,336	151,226	146,718	143,693	151,507	152,683	150,557	151,600	149,668	157,093	148,774	145,411	139,103	145,827	143,635	151,055	156,733	164,961	149,585	162,084	155,958	170,111	167,347	158,175	126,130	135,464	127,443	129,242	120,759	127,166	120,373	121,767	114,834	118,684	114,732	118,668	114,161	113,598	124,575	122,500	127,931	120,252	108,811	100,896	91,917	91,832	85,988	84,001	89,281	86,901	86,262	83,409	83,625	80,719	87,578	83,347	84,046	82,640	84,399	84,162	84,326	77,913	79,198	77,842	69,417	63,743	64,115	66,800	61,800	59,842	60,253	59,849	58,814	59,140	72,000	59,600	58,600	63,000	65,300	60,500	57,100	58,900	78,400	78,400	77,900	72,200	67,400	67,800	65,000	60,300	63,200	67,500	65,500	63,300	58,200	55,800	51,400	47,500	43,600	45,200	42,200	38,800	34,700	39,400	36,900	33,400	33,500	27,300	27,100	-	-	-	-
Net Tangible Assets	0	177,751	130,560	75,995	25,484	-28,573	1,598	-28,124	-61,375	-107,290	-142,922	-100,257	383,928	326,119	253,751	243,351	256,211	259,173	259,486	329,356	297,682	349,011	314,426	384,445	447,775	420,749	388,420	351,229	318,156	288,117	248,850	249,267	237,798	205,620	215,587	247,224	247,697	226,873	213,275	229,961	212,904	177,735	153,771	174,320	184,179	151,880	0	521,024	492,853	463,848	495,857	468,980	437,607	387,465	363,003	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Net Working Capital	503,227	601,529	564,668	517,906	479,420	453,614	507,296	313,765	374,044	410,776	456,029	440,051	473,964	421,711	351,583	328,817	325,883	327,723	321,613	340,362	304,615	363,638	357,022	136,474	265,535	298,390	322,566	298,850	280,341	313,723	290,622	302,490	326,029	312,619	338,596	378,887	385,491	391,903	403,437	411,830	416,514	393,893	403,577	417,167	421,272	420,606	418,281	396,385	357,805	330,294	365,251	340,160	300,487	248,472	220,858	249,646	286,962	293,302	292,102	289,530	268,358	254,282	256,530	261,757	246,874	271,066	316,951	321,654	312,564	325,690	343,695	330,288	316,028	291,161	275,722	255,689	233,511	217,626	205,439	185,606	163,638	142,629	133,081	122,880	128,346	125,610	127,753	148,737	172,633	170,270	158,026	139,717	130,906	107,741	128,930	121,443	134,700	155,900	157,500	162,200	152,000	140,400	121,300	112,800	113,900	116,100	107,700	94,100	107,100	114,300	115,800	112,500	115,100	117,900	116,500	108,500	96,400	94,900	87,600	81,500	69,600	64,400	56,900	57,000	52,100	47,400	47,800	41,000	40,900	30,200	34,200	-	-	-	-
Non Current Assets Total	1,435,446	1,145,531	1,160,651	1,165,103	1,171,757	1,149,323	1,132,743	1,103,703	1,101,921	1,102,251	1,109,819	1,126,377	649,720	657,895	673,763	663,471	655,174	622,752	644,332	698,646	711,740	712,906	690,151	716,162	722,001	717,774	723,293	728,680	809,859	822,439	827,796	829,903	835,059	918,220	919,050	915,140	924,314	917,586	907,426	891,202	884,561	892,165	888,258	864,906	875,491	877,755	387,936	384,006	380,600	382,622	385,137	384,433	377,372	375,514	370,618	374,517	308,105	308,169	295,789	267,300	268,456	259,242	254,419	249,516	238,276	187,689	175,038	169,064	151,355	147,627	134,957	128,139	121,038	120,163	120,997	124,146	128,318	123,280	120,716	125,945	130,572	132,818	134,958	135,953	127,996	129,584	133,117	132,086	127,368	127,506	127,521	126,150	139,445	141,581	137,430	139,192	136,700	124,600	123,800	125,100	135,800	135,400	143,300	145,500	171,600	182,000	170,600	155,800	148,600	142,000	131,900	128,900	125,200	126,000	124,400	122,900	116,000	109,400	104,900	100,600	93,900	94,100	91,300	84,800	76,500	74,700	70,900	66,300	66,600	64,600	53,500	-	-	-	-
Non Current Liabilities Other	76,259	104,738	71,980	110,910	78,220	114,376	73,853	108,603	85,940	91,861	97,145	144,166	102,008	104,187	106,768	89,104	82,163	41,050	42,829	28,780	28,167	30,983	31,670	34,258	39,599	23,516	23,104	22,181	24,843	28,355	28,534	26,106	27,212	31,463	32,192	31,737	29,020	33,607	38,415	37,641	37,583	39,609	39,377	26,095	23,858	22,480	0	21,551	13,290	13,302	15,939	15,822	13,268	12,490	12,730	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Non Current Liabilities Total	995,354	853,400	860,703	865,012	875,198	873,928	869,616	668,044	745,190	814,478	888,768	834,758	404,532	411,683	416,777	395,703	406,477	366,721	374,979	371,140	373,226	375,206	373,114	100,207	164,729	214,911	273,089	287,920	319,303	387,048	402,858	412,415	441,536	453,959	465,999	467,905	475,897	488,771	495,791	463,418	475,855	489,585	517,457	512,891	517,605	526,395	48,750	47,760	33,172	34,639	37,932	38,457	29,335	29,594	26,520	31,039	21,987	22,039	24,038	16,946	21,026	16,709	17,019	17,085	11,450	11,029	15,434	11,070	10,575	16,327	16,817	16,777	18,093	24,074	24,150	24,700	25,890	31,240	31,523	31,802	29,982	35,599	35,602	35,596	35,078	41,798	42,104	43,999	44,135	50,439	50,307	50,351	69,146	59,655	57,502	54,192	59,300	66,700	65,200	65,400	66,100	65,300	65,400	63,600	66,400	66,700	50,100	24,600	22,200	21,200	21,800	24,400	25,400	37,700	43,400	38,200	25,800	24,200	21,200	21,300	13,800	15,500	14,800	15,100	12,800	11,700	18,600	16,700	25,100	18,400	14,300	-	-	-	-
Non Currrent Assets Other	127,442	121,856	117,152	106,975	103,282	79,615	71,045	63,205	64,880	66,601	68,838	76,891	74,487	71,380	71,888	66,314	68,701	33,933	31,482	11,796	11,483	12,254	10,871	16,022	12,433	12,571	12,591	16,437	13,586	13,657	13,848	19,971	20,533	15,674	590,168	593,192	600,823	605,587	613,326	619,765	624,456	633,898	633,282	607,953	612,363	638,595	221,696	10,719	222,897	225,756	228,159	10,458	221,256	218,217	213,253	9,664	154,099	155,215	145,402	4,799	4,832	4,792	5,081	5,233	5,128	5,277	4,746	4,961	4,071	4,280	10,938	10,208	9,451	9,287	9,641	10,687	10,772	5,334	5,745	5,889	6,059	6,193	6,697	6,663	6,761	3,378	3,555	3,362	1,939	2,091	5,788	10,894	30,250	54,624	32,637	55,752	9,700	-4,800	-4,700	-7,300	-1,700	-1,600	2,400	2,100	2,300	4,800	-200	-1,900	-1,300	-1,200	-1,100	42,500	40,700	41,100	42,100	40,800	23,700	22,900	23,500	23,000	19,900	21,400	20,800	21,200	24,500	25,000	22,300	12,600	20,600	18,600	9,200	-	-	-	-
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Other Assets	0	121,856	122,128	112,216	108,124	83,897	75,597	67,673	70,930	72,665	75,035	17,035	74,487	75,686	75,976	14,078	14,543	14,577	14,887	16,155	15,185	16,019	14,645	16,022	391,975	397,553	401,340	404,818	473,902	482,596	488,130	493,408	502,287	589,987	590,168	593,192	600,823	605,587	613,326	619,765	624,456	633,898	633,282	607,954	612,363	638,595	221,696	222,349	222,897	225,756	228,159	228,905	221,255	218,218	216,714	221,219	154,099	155,215	145,402	129,493	138,986	134,337	135,341	133,032	127,837	83,897	79,708	78,289	67,305	66,870	55,037	52,873	50,744	53,088	53,087	54,809	55,634	51,056	46,906	47,915	51,252	51,473	52,035	51,966	46,240	46,658	47,271	47,209	43,668	45,096	45,412	42,899	57,189	59,460	57,125	57,584	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Other Current Assets	55,369	54,660	49,564	46,735	45,451	48,377	48,485	44,132	31,857	42,860	51,498	51,072	32,697	34,353	48,081	30,845	31,238	34,720	39,752	27,406	24,449	27,868	32,246	28,983	32,564	37,482	30,949	40,853	27,877	27,406	32,248	28,842	43,559	35,444	45,923	50,413	66,157	66,515	65,142	74,554	68,760	64,944	72,413	63,950	58,317	58,068	51,167	45,641	26,445	26,993	35,659	40,571	34,191	39,398	40,674	45,944	31,576	31,999	32,074	35,552	30,435	34,456	34,396	40,241	37,741	39,053	26,884	20,815	25,138	28,679	28,404	26,265	30,172	28,089	27,175	23,989	28,117	26,367	28,676	1,859	2,102	31,910	2,488	2,681	2,661	2,478	2,700	2,783	16,975	12,052	5,616	5,680	30,765	30,123	31,857	29,633	47,500	47,500	48,300	52,200	45,800	41,900	42,200	48,800	41,300	34,800	34,500	32,100	32,500	33,300	30,100	28,500	28,900	29,500	30,500	30,100	26,900	27,400	26,400	25,100	15,300	16,100	15,500	16,100	14,100	14,400	13,400	11,600	11,200	10,200	11,400	-	-	-	-
Other Current Liab	132,412	250,649	112,263	145,894	153,171	142,497	115,727	137,921	121,126	119,701	127,811	159,914	177,329	93,270	91,595	127,745	194,726	183,132	83,973	117,453	79,693	69,514	65,731	109,365	68,151	67,282	68,324	80,699	59,546	64,294	71,040	74,514	129,041	54,363	137,369	96,783	154,246	163,401	163,937	93,846	148,198	153,847	155,361	83,018	163,413	151,945	119,489	56,835	106,823	107,726	102,112	46,256	97,286	102,049	96,270	94,845	92,013	97,642	86,852	71,516	32,466	29,126	39,088	46,518	24,807	37,539	33,839	26,944	46,187	48,900	51,879	19,141	45,540	47,004	47,762	50,199	52,778	43,226	46,237	48,776	47,416	46,870	44,752	47,693	53,406	48,161	45,524	40,206	42,725	48,802	43,775	43,659	43,194	44,976	38,405	38,355	43,900	43,400	42,000	51,800	41,300	40,300	31,700	39,200	29,600	18,800	24,400	26,200	24,600	22,700	29,500	26,100	26,700	25,000	23,600	25,200	1,300	1,700	1,800	29,400	1,700	2,100	2,100	22,300	1,800	2,400	3,000	20,000	1,600	1,500	1,700	-	-	-	-
Other Liab	0	104,738	109,322	0	117,264	114,376	106,475	108,603	112,072	114,674	118,392	76,905	111,811	107,146	110,641	38,177	42,293	38,686	41,542	48,686	46,608	44,218	42,276	40,784	39,599	23,516	23,104	22,181	24,843	28,355	28,534	26,106	27,212	31,463	32,192	31,737	29,020	33,607	38,415	37,641	37,583	39,609	39,377	26,095	23,858	22,480	21,752	21,551	13,290	13,302	15,939	15,822	13,268	12,490	12,730	12,915	13,551	13,363	13,007	8,474	7,849	7,759	7,884	7,795	5,248	4,668	8,912	4,395	3,747	3,637	3,982	3,800	4,976	5,107	5,049	5,469	5,143	4,665	4,609	4,678	4,422	4,210	4,100	3,984	3,357	3,508	3,674	3,212	2,998	3,136	3,004	3,070	2,136	2,102	2,153	2,164	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Other Stockholder Equity	627,094	616,960	609,610	594,706	587,489	564,394	580,359	572,476	566,963	558,156	551,108	602,727	579,480	568,748	562,729	553,229	537,913	533,720	525,038	536,320	531,131	530,480	507,394	503,955	525,877	497,980	491,436	482,044	468,348	459,651	445,138	438,325	435,477	430,488	427,878	426,964	417,405	408,940	404,686	404,337	396,607	385,153	378,366	365,040	362,199	354,389	341,401	322,485	312,887	304,517	310,083	302,709	289,906	256,071	251,113	252,323	236,553	235,792	232,221	226,829	217,036	209,427	193,413	186,933	181,256	170,941	172,763	163,815	157,700	157,175	149,945	141,371	134,781	130,723	126,804	121,803	-15,400	-28,725	-33,091	-36,333	-40,558	-53,447	-55,873	-56,565	-52,096	-48,864	-35,443	-11,688	14,042	9,280	4,525	-1,498	-10,808	-13,122	-15,107	-11,511	-7,200	-500	22,600	29,400	23,100	19,600	23,200	22,800	19,900	19,100	15,800	21,700	21,200	22,000	24,100	108,700	115,100	110,700	107,200	107,300	104,800	103,100	99,000	92,700	87,600	86,500	81,500	79,200	73,300	72,400	65,700	58,900	55,300	51,600	50,800	-	-	-	-
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Property Plant And Equipment Gross	979,291	949,995	942,658	944,215	0	0	0	0	0	0	214,782	217,559	240,009	240,405	242,969	305,635	322,262	264,238	276,748	343,979	351,108	344,600	315,873	332,156	330,000	320,221	322,000	323,900	335,957	339,800	339,700	337,600	332,800	328,200	328,900	321,900	323,500	312,000	294,100	271,400	260,100	258,300	255,000	257,000	263,100	239,200	166,240	161,657	157,703	156,900	157,000	155,500	156,100	157,300	157,400	154,300	154,000	153,000	150,400	137,800	129,500	124,900	119,100	116,500	110,400	103,800	95,330	90,775	84,100	80,757	79,900	75,300	70,294	67,100	67,900	69,300	72,700	72,200	73,800	78,000	79,300	81,300	82,900	84,000	81,800	82,900	85,800	84,900	83,700	82,400	82,109	83,251	82,300	82,121	80,300	81,600	83,100	84,200	82,200	83,000	83,500	81,100	82,800	84,200	107,700	112,000	106,700	97,400	102,200	95,900	87,800	86,400	84,500	84,900	82,300	82,100	78,300	76,400	71,900	68,300	64,600	63,300	61,200	56,000	52,000	49,700	48,600	46,800	46,000	46,000	44,300	-	-	-	-
Property Plant And Equipment Net	318,665	307,766	304,467	310,885	313,138	307,844	288,321	258,482	238,841	223,747	214,782	217,559	240,009	240,405	242,969	253,399	268,104	264,238	276,748	343,979	351,108	344,560	315,873	332,156	330,026	320,221	321,953	323,862	335,957	339,843	339,666	337,634	332,772	328,233	328,882	321,948	323,491	311,999	294,100	271,437	260,105	258,267	254,976	256,953	263,128	239,160	166,240	161,657	157,703	156,866	156,978	155,528	156,116	157,297	157,365	153,298	154,006	152,954	150,387	137,807	129,470	124,905	119,078	116,484	110,439	103,792	95,330	90,775	84,050	80,757	79,920	75,266	70,294	67,075	67,910	69,337	72,684	72,224	73,810	78,030	79,320	81,345	82,923	83,987	81,756	82,926	85,846	84,877	83,700	82,410	82,109	83,251	82,256	82,121	80,305	81,608	83,100	84,200	82,200	83,000	83,500	81,100	82,800	84,200	107,700	112,000	106,700	103,600	102,200	95,900	87,800	86,400	84,500	84,900	82,300	82,100	78,300	76,400	71,900	68,300	64,600	63,300	61,200	56,000	52,000	49,700	48,600	46,800	46,000	46,000	44,300	-	-	-	-
Property Plant Equipment	0	307,766	304,467	310,885	313,138	307,844	288,321	258,482	238,841	223,747	214,782	277,415	240,009	240,405	242,969	253,399	268,104	283,594	276,748	343,979	351,108	344,560	315,873	332,156	330,026	320,221	321,953	323,862	335,957	339,843	339,666	337,634	332,772	328,233	328,882	321,948	323,491	311,999	294,100	271,437	260,105	258,267	254,976	256,953	263,128	239,160	166,240	161,657	157,703	156,866	156,978	155,528	156,116	157,297	157,365	153,298	154,006	152,954	150,387	137,807	129,470	124,905	119,078	116,484	110,439	103,792	95,330	90,775	84,050	80,757	79,920	75,266	70,294	67,075	67,910	69,337	72,684	72,224	73,810	78,030	79,320	81,345	82,923	83,987	81,756	82,926	85,846	84,877	83,700	82,410	82,109	83,251	82,256	82,121	80,305	81,608	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Retained Earnings	340,099	308,898	284,017	253,168	223,785	204,364	222,268	202,391	192,650	169,418	154,562	157,981	169,022	137,140	89,039	78,512	69,868	85,634	99,418	161,418	140,584	194,375	189,859	266,942	323,608	330,155	310,053	289,916	341,056	325,663	305,838	316,184	324,916	384,359	387,344	420,365	423,563	411,199	409,307	433,347	423,163	406,873	390,324	398,199	409,553	412,764	410,569	400,783	382,977	364,726	390,577	373,630	352,642	332,907	311,568	334,641	330,680	339,323	327,589	309,516	295,576	279,360	291,462	302,196	288,799	274,442	302,515	315,767	295,982	301,622	314,153	302,845	285,687	257,598	246,653	233,769	351,992	340,985	332,111	322,291	312,763	303,449	297,954	292,971	288,494	278,147	271,367	264,592	256,781	254,245	244,297	234,325	227,158	218,180	237,366	230,732	230,000	223,500	217,800	211,800	205,700	201,000	195,700	190,800	214,500	226,200	222,100	215,700	207,800	200,800	192,100	182,700	173,600	164,700	155,600	146,800	138,300	129,800	121,300	113,200	104,800	96,500	88,500	81,700	74,800	68,200	62,200	57,000	51,400	46,800	42,500	-	-	-	-
Retained Earnings Total Equity	0	0	284,017	253,168	223,785	204,364	222,268	202,391	192,650	169,418	154,562	157,981	169,022	137,140	89,039	78,512	69,868	85,634	99,418	161,418	140,584	194,375	189,859	266,942	323,608	330,155	310,053	289,916	341,056	325,663	305,838	316,184	324,916	384,359	387,344	420,365	423,563	411,199	409,307	433,347	423,163	406,873	390,324	398,199	409,553	412,764	0	400,783	382,977	364,726	390,577	373,630	352,642	332,907	311,568	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Short Long Term Debt	13,736	13,566	13,572	11,784	9,949	58,194	6,853	214,148	144,064	82,733	17,025	17,016	17,055	167,001	231,364	76,980	61,966	56,934	117,548	27,666	20,040	12,664	17,043	194,259	151,465	108,589	303,043	61,022	66,271	51,549	46,804	43,625	0	0	0	21,681	0	0	0	437,687	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Short Long Term Debt Total	870,585	762,228	764,953	765,886	766,775	817,746	769,994	773,589	777,182	780,776	784,370	707,608	309,776	464,017	528,257	382,493	371,704	370,918	435,692	350,120	343,817	343,652	347,881	253,682	270,167	286,604	303,043	314,647	336,268	388,054	399,712	408,000	427,107	434,308	431,849	427,891	428,754	429,908	430,941	437,687	447,228	464,398	480,553	480,094	482,447	481,651	5,059	3,771	5,652	6,412	4,512	4,879	12,438	16,125	10,802	20,651	19,910	20,155	22,360	6,038	9,956	13,752	14,910	12,363	12,408	24,278	25,123	28,876	30,076	34,612	35,061	39,153	38,913	46,610	45,359	45,843	49,221	53,497	55,969	58,260	66,576	69,777	70,135	70,617	76,599	78,888	74,799	72,143	75,357	80,483	75,706	69,719	69,892	58,861	66,007	74,202	77,800	63,000	61,400	59,100	64,200	64,200	71,500	71,100	72,700	73,600	55,900	29,500	25,200	22,600	19,200	18,600	17,800	28,800	34,400	33,400	21,900	19,700	13,900	14,300	13,800	17,700	13,100	13,600	14,600	18,500	23,700	24,100	29,200	22,500	18,800	-	-	-	-
Short Term Debt	13,736	13,566	13,572	11,784	9,949	58,194	6,853	214,148	144,064	82,733	17,025	17,016	17,055	167,001	231,364	76,980	61,966	56,934	117,548	27,666	17,199	12,664	17,043	194,259	151,465	108,589	65,876	61,022	66,271	51,549	46,804	43,471	46,293	46,593	32,396	21,522	7,748	1,655	1,931	45,630	40,810	43,687	32,434	23,150	14,197	4,249	2,417	894	2,545	3,080	906	913	8,244	11,702	6,418	16,062	15,132	15,181	17,200	695	4,434	8,055	9,028	6,326	6,206	17,917	18,601	22,201	23,248	21,922	22,226	26,176	25,796	27,643	26,258	26,612	29,862	28,298	30,647	32,818	41,016	38,388	38,633	39,005	44,878	40,598	36,369	31,356	34,220	33,180	28,403	22,438	19,172	17,763	24,823	32,896	32,400	10,100	9,000	6,600	12,600	12,700	20,000	17,500	22,600	23,600	22,300	19,500	12,400	10,800	6,900	3,400	4,700	3,600	4,200	8,300	7,700	7,200	4,500	4,500	4,400	7,000	3,200	3,000	3,200	8,000	6,200	8,400	4,600	4,700	5,000	-	-	-	-
Short Term Investments	0	2,576	2,442	1,110	1,687	1,114	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,900	2,100	2,200	2,500	2,700	2,700	2,500	2,700	32,636	46,538	45,804	45,454	33,042	6,400	0	7,500	43,500	9,700	10,600	11,200	12,300	12,400	11,800	11,800	11,900	14,300	14,400	14,600	13,600	13,200	12,900	12,100	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Total Assets	2,200,428	2,011,275	1,962,258	1,934,825	1,878,066	1,865,112	1,820,526	1,859,734	1,831,376	1,801,497	1,794,187	1,819,923	1,318,068	1,418,174	1,433,173	1,267,110	1,237,749	1,190,541	1,259,610	1,274,767	1,227,637	1,265,711	1,241,168	1,237,339	1,311,714	1,271,163	1,251,382	1,238,709	1,306,421	1,334,826	1,317,391	1,317,105	1,336,422	1,418,944	1,427,411	1,483,119	1,471,799	1,474,545	1,476,731	1,520,847	1,490,083	1,483,592	1,479,630	1,461,871	1,474,373	1,454,555	928,123	911,135	847,773	823,722	853,406	833,264	783,389	737,737	694,164	760,660	702,212	714,294	691,943	649,693	622,348	600,710	608,229	608,950	565,532	548,690	578,104	572,735	549,868	561,432	568,234	546,543	523,136	499,223	485,862	467,757	456,774	427,535	416,383	407,394	396,564	374,387	366,183	359,208	365,922	355,880	355,072	364,921	389,000	392,012	369,648	345,314	342,443	323,139	337,911	349,110	361,900	347,400	341,800	356,400	353,200	342,700	331,400	336,700	359,400	366,900	347,600	323,500	311,900	308,800	296,200	287,800	288,400	289,800	283,900	280,500	260,800	252,300	235,700	230,700	207,100	201,100	184,600	180,300	162,200	160,700	152,200	144,800	144,300	130,500	119,700	-	-	-	-
Total Current Assets	764,982	865,744	801,607	769,722	706,309	715,789	687,783	756,031	729,455	699,246	684,368	693,546	668,348	760,279	759,410	603,639	582,575	567,789	615,278	576,121	515,897	552,805	551,017	521,177	589,713	553,389	528,089	510,029	496,562	512,387	489,595	487,202	501,363	500,724	508,361	567,979	547,485	556,959	569,305	629,645	605,522	591,427	591,372	596,965	598,882	576,800	540,187	527,129	467,173	441,100	468,269	448,831	406,017	362,223	323,546	386,143	394,107	406,125	396,154	382,393	353,892	341,468	353,810	359,434	327,256	361,001	403,066	403,671	398,513	413,805	433,277	418,404	402,098	379,060	364,865	343,611	328,456	304,255	295,667	281,449	265,992	241,569	231,225	223,255	237,926	226,296	221,955	232,835	261,632	264,506	242,127	219,164	202,998	181,558	200,481	209,918	225,200	222,800	218,000	231,300	217,400	207,300	188,100	191,200	187,800	184,900	177,000	167,700	163,300	166,800	164,300	158,900	163,200	163,800	159,500	157,600	144,800	142,900	130,800	130,100	113,200	107,000	93,300	95,500	85,700	86,000	81,300	78,500	77,700	65,900	66,200	-	-	-	-
Total Current Liabilities	261,755	264,215	236,939	251,816	226,889	262,175	180,487	442,266	355,411	288,470	228,339	253,495	194,384	338,568	407,827	284,298	256,692	240,066	293,665	235,759	211,282	189,167	193,995	384,703	324,178	254,999	205,523	211,179	216,221	198,664	198,973	184,712	175,334	188,105	169,765	189,092	161,994	165,056	165,868	217,815	189,008	197,534	187,795	179,798	177,610	156,194	121,906	130,744	109,368	110,806	103,018	108,671	105,530	113,751	102,688	136,497	107,145	112,823	104,052	92,863	85,534	87,186	97,280	97,677	80,382	89,935	86,115	82,017	85,949	88,115	89,582	88,116	86,070	87,899	89,143	87,922	94,945	86,629	90,228	95,843	102,354	98,940	98,144	100,375	109,580	100,686	94,202	84,098	88,999	94,236	84,101	79,447	72,092	73,817	71,551	88,475	90,500	66,900	60,500	69,100	65,400	66,900	66,800	78,400	73,900	68,800	69,300	73,600	56,200	52,500	48,500	46,400	48,100	45,900	43,000	49,100	48,400	48,000	43,200	48,600	43,600	42,600	36,400	38,500	33,600	38,600	33,500	37,500	36,800	35,700	32,000	-	-	-	-
Total Liab	1,257,109	1,117,615	1,097,642	1,116,828	1,102,087	1,136,103	1,050,103	1,110,310	1,100,601	1,102,948	1,117,107	1,088,253	598,916	750,251	824,604	680,001	663,169	606,787	668,644	606,899	584,508	564,373	567,109	484,910	488,907	469,910	478,612	499,099	535,524	585,712	601,831	597,127	616,870	642,064	635,764	656,997	637,891	653,827	661,659	681,233	664,863	687,119	705,252	692,689	695,215	682,589	170,656	178,504	142,540	145,445	140,950	147,128	134,865	143,345	129,208	167,536	129,132	134,862	128,090	109,809	106,560	103,895	114,299	114,762	91,832	100,964	101,549	93,087	96,524	104,442	106,399	104,893	104,163	111,973	113,293	112,622	120,835	117,869	121,751	127,645	132,336	134,539	133,746	135,971	144,658	142,484	136,306	128,097	133,134	144,675	134,408	129,798	141,238	133,472	129,053	142,667	149,800	133,600	125,700	134,500	131,500	132,200	132,200	142,000	140,300	135,500	119,400	98,200	78,400	73,700	70,300	70,800	73,500	83,600	86,400	87,300	74,200	72,200	64,400	69,900	57,400	58,100	51,200	53,600	46,400	50,300	52,100	54,200	61,900	54,100	46,300	-	-	-	-
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Total Stockholder Equity	943,319	893,660	864,616	817,997	775,979	729,009	770,423	749,424	730,775	698,549	677,080	731,670	719,152	667,923	608,569	587,109	574,580	583,754	590,966	667,868	643,129	701,338	674,059	752,429	822,807	801,253	772,770	739,610	770,897	749,114	715,560	719,978	719,552	776,880	791,647	826,122	833,908	820,718	815,072	839,614	825,220	796,473	774,378	769,182	779,158	771,966	757,467	732,631	705,233	678,277	712,456	686,136	648,524	594,392	564,956	593,124	573,080	579,432	563,853	539,884	515,788	496,815	493,930	494,188	473,700	447,726	476,555	479,648	453,344	456,990	461,835	441,650	418,973	387,250	372,569	355,135	335,939	309,666	294,632	279,749	264,228	239,848	232,437	223,237	221,264	213,396	218,766	236,824	255,866	247,337	235,240	215,516	201,205	189,667	208,858	206,443	212,100	213,800	216,100	221,900	221,700	210,500	199,200	194,700	219,100	231,400	228,200	225,300	233,500	235,100	225,900	217,000	214,900	206,200	197,500	193,200	186,600	180,100	171,300	160,800	149,700	143,000	133,400	126,700	115,800	110,400	100,100	90,600	82,400	76,400	73,400	-	-	-	-
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-163,158	-163,640	-163,640	-164,077	-164,077	-164,679	-164,679	-165,335	-160,149	-156,726	-141,725	-115,949	-89,035	-89,234	-89,234	-89,456	-89,456	-89,664	-89,664	-85,173	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-

Cash Flow

Currency in USD. All numbers in thousands.

	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31	2006-03-31	2005-03-31	2004-03-31	2003-03-31	2002-03-31	2001-03-31	2000-03-31	1999-03-31	1998-03-31	1997-03-31	1996-03-31	1995-03-31	1994-03-31	1993-03-31	1992-03-31
Begin Period Cash Flow	259,496	192,305	137,311	169,351	180,169	139,564	115,123	160,662	192,469	179,120	228,861	196,707	141,562	156,721	133,553	229,227	250,667	185,815	79,467	49,885	34,913	45,173	25,911	56,319	21,800	8,300	13,400	4,200	16,200	10,300	2,900	1,700
Capital Expenditures	110,191	96,509	37,040	48,758	118,961	74,799	76,135	102,405	122,220	73,648	62,188	53,198	46,669	56,304	56,379	57,790	41,458	36,774	17,530	13,862	13,535	21,602	30,540	23,315	22,500	20,400	32,000	19,700	24,900	22,900	17,600	11,400
Cash And Cash Equivalents Changes	28,906	70,169	50,815	-30,167	-10,818	40,605	24,441	-45,539	-31,807	13,349	-49,741	32,154	55,145	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	-19,982	-22,616	-33,424	-9,479	-3,100	19,106	-16,858	2,470	2,649	6,045	-6,018	6,018	4,257	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Cash	24,970	67,191	54,994	-32,040	-10,818	40,605	24,441	-45,539	-31,807	13,349	-49,741	32,154	55,145	-15,159	23,168	-95,674	-21,440	64,852	106,348	68,232	14,972	-10,260	15,530	5,009	34,500	13,500	-5,100	9,200	-12,000	5,900	7,300	1,200
Change In Working Capital	25,503	-15,177	-59,682	-84,562	-62,750	76,488	-983	-20,107	-3,455	237	-41,396	-15,482	-19,012	4,077	5,084	-10,705	-8,417	-14,442	-512	14,143	-14,950	-25,732	5,922	4,066	10,100	-15,400	-22,100	8,900	-32,700	-13,600	-800	-6,400
Change Receivables	-24,421	-34,974	44,121	18,863	-38,064	5,087	3,155	-10,328	8,835	6,154	-38,080	-10,539	-3,920	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Account Receivables	-24,421	-34,974	44,121	18,863	-38,064	5,087	3,155	-10,328	8,835	6,154	-38,080	-10,539	-3,920	4,364	2	-18,229	77	-10,305	1,900	-4,700	-14,200	-3,900	805	3,900	-4,100	13,300	-11,900	0	0	0	0	0
Change To Inventory	30,754	24,307	-38,909	-84,721	-39,322	14,385	-1,552	12,780	-16,932	-12,684	-18,685	-32,528	-2,560	-1,665	-11,236	-2,874	-8,520	-5,501	-4,730	9,267	-5,486	-18,344	6,417	-1,843	2,500	-14,700	-900	-200	-13,500	-10,600	1,100	-6,700
Change To Liabilities	39,816	7,642	-56,422	-17,308	17,736	41,401	21,072	-30,239	1,993	2,416	25,581	19,413	-18,683	5,263	20,104	10,455	0	2,550	3,346	344	1,229	0	0	0	0	0	0	0	0	0	0	0
Change To Netincome	36,213	46,318	4,731	64,047	57,594	5,552	90,456	113,734	26,670	19,200	16,856	16,102	16,652	0	0	0	0	0	0	0	555	0	0	0	0	0	0	0	0	0	0	0
Change To Operating Activities	0	-4,510	-4,650	-2,876	494	17,670	-18,253	3,121	-4,227	4,825	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	93,307	97,747	84,287	110,289	109,418	89,247	89,733	90,033	86,053	81,740	65,481	49,966	48,145	43,236	36,462	31,197	27,504	25,150	27,576	30,149	28,431	25,616	24,499	24,906	24,600	22,900	12,300	13,100	13,700	10,700	8,500	7,000
Dividends Paid	7,016	0	0	12,016	13,445	0	0	0	0	0	0	15,187	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4,300
End Period Cash Flow	284,466	259,496	192,305	137,311	169,351	180,169	139,564	115,123	160,662	192,469	179,120	228,861	196,707	141,562	156,721	133,553	229,227	250,667	185,815	118,117	49,885	34,913	41,441	61,328	56,300	21,800	8,300	13,400	4,200	16,200	10,200	2,900
Exchange Rate Changes	0	0	0	0	-3,323	3,939	-1,571	-12	-4,057	355	-273	-498	1,332	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	162,867	75,754	71,765	109,459	40,320	145,551	83,603	19,460	4,958	65,876	22,886	62,120	76,786	74,364	59,985	19,879	42,105	48,842	53,677	60,748	30,132	10,636	30,470	30,150	11,200	-1,700	-5,300	35,100	-9,300	4,100	18,300	7,400
Investments	-143,788	-86,345	-425,442	-57,176	-116,148	-63,041	-73,313	-3,000	0	-9,546	-1,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	269,257	-17,500	370,725	31,875	95,927	-60,983	-93,410	-20,013	-9,749	-43,548	476,093	-1,103	-15,153	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	115,401	43,375	79,469	76,526	55,019	45,572	-26,268	-55,620	16,897	35,148	38,800	772	674	58,370	59,304	51,980	49,109	69,076	39,639	29,320	28,379	30,027	7,236	18,998	21,100	-24,800	33,000	35,900	33,600	31,500	24,800	18,000
Other Cashflows From Financing Activities	-15,739	-4,796	452,554	56,917	376,225	40,340	32,997	18,373	15,452	17,327	512,739	16,620	31,916	26,784	35,535	-15,477	-10,430	-3,020	-11,651	-17,332	-3,587	4,035	-4,997	13,374	-11,900	42,600	13,900	-13,000	16,100	-500	-12,000	-500
Other Cashflows From Investing Activities	-392	10,164	-388,402	-8,418	2,813	11,758	2,822	637	452	-22,636	-533,207	1,002	-4,889	0	0	0	0	0	0	0	0	0	0	3,562	0	0	0	0	0	0	0	0
Other Non Cash Items	8,481	16,946	-919	42,468	27,055	1,846	94,906	101,648	9,358	9,520	10,631	65,670	77,730	12,126	3,688	6,079	15,367	6,122	539	-340	-2,223	3,074	21,241	7,192	-14,800	38,000	-100	100	100	-1,600	0	-200
Sale Purchase Of Stock	-75,000	-75,000	10,230	-175,000	-160,000	-100,000	32,997	-60,983	-39,033	20,500	-50,000	-49,998	-50,000	-40,000	-59,998	-74,996	-40,000	16,600	26,200	18,100	-50,166	-26,914	-4,729	-39,703	6,400	-5,600	-15,800	-8,900	-15,700	-100	0	-2,000
Stock Based Compensation	25,583	24,359	25,516	20,454	17,188	13,025	9,150	6,949	14,095	13,081	10,969	9,286	10,810	10,267	10,181	222	10,251	0	0	0	0	0	0	0	-14,700	0	0	0	0	0	0	0
Total Cash From Financing Activities	-100,364	-15,749	367,452	-131,208	-50,628	-120,643	-60,413	-62,623	-33,160	-20,700	461,853	-30,470	-18,084	-13,970	-30,737	-73,228	-35,554	12,094	14,531	718	-49,001	-9,336	5,008	-17,789	-5,500	40,100	2,800	-19,000	2,200	1,800	-10,800	800
Total Cash From Operating Activities	273,058	172,263	108,805	158,217	159,281	220,350	159,738	121,865	127,178	139,524	85,074	115,318	123,455	130,668	116,364	77,669	83,563	85,616	71,207	74,610	43,667	32,238	61,010	53,465	33,700	20,400	26,700	54,800	15,600	27,000	35,900	18,800
Total Cashflows From Investing Activities	-143,788	-86,345	-425,442	-57,176	-116,148	-63,041	-73,313	-104,768	-121,768	-105,830	-596,395	-52,196	-51,558	0	0	0	0	0	19,428	0	19,485	0	0	0	0	0	0	0	0	0	0	0

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31	1999-09-30	1999-06-30	1999-03-31	1998-12-31	1998-09-30	1998-06-30	1998-03-31	1997-12-31	1997-09-30	1997-06-30	1997-03-31	1996-12-31	1996-09-30	1996-06-30	1996-03-31	1995-12-31	1995-09-30	1995-06-30	1995-03-31	1994-12-31	1994-09-30	1994-06-30	1994-03-31	1993-12-31	1993-09-30	1993-06-30	1993-03-31	1992-12-31	1992-09-30	1992-06-30	1992-03-31	1991-12-31	1991-09-30	1991-06-30
Begin Period Cash Flow	351,005	285,719	284,466	224,002	241,200	214,948	259,496	236,877	192,420	173,462	192,305	189,002	279,169	275,725	137,311	126,417	112,030	190,234	169,351	154,871	199,763	192,106	180,169	251,591	203,622	171,739	139,564	129,639	138,870	118,248	115,123	105,167	100,247	112,204	160,662	125,200	129,971	139,943	192,469	177,846	159,148	166,328	179,120	193,181	187,051	236,047	228,861	205,372	183,421	216,891	196,707	169,538	115,049	83,467	141,562	168,993	178,322	173,822	156,721	125,325	111,331	120,287	133,553	116,857	154,983	216,056	229,227	227,707	242,200	260,031	250,667	229,351	209,981	198,067	185,815	160,276	143,829	130,356	118,117	97,182	66,771	50,190	49,885	49,666	43,615	42,006	34,913	52,900	57,847	40,959	41,441	59,212	38,617	52,195	61,328	46,500	56,200	53,700	56,300	42,300	37,200	24,300	21,800	7,300	6,600	5,600	8,300	16,600	13,200	10,900	13,400	5,600	4,700	3,700	4,200	0	2,000	6,400	16,200	3,600	5,900	4,400	10,300	5,600	1,400	800	2,900	0	0	1,200	1,700
Capital Expenditures	22,294	24,654	9,663	11,919	16,848	35,957	45,467	35,115	26,663	20,812	13,919	11,632	9,373	8,339	7,696	10,646	20,390	9,473	8,249	13,716	29,243	48,488	27,514	19,103	26,571	15,404	13,721	15,618	18,893	19,145	22,479	28,534	23,741	25,884	24,246	21,690	29,658	33,787	37,085	29,927	15,519	15,110	13,092	12,503	15,253	25,991	8,441	16,239	13,116	12,042	11,801	11,683	10,898	8,864	15,224	11,428	11,996	11,676	21,204	10,709	16,895	16,380	12,395	15,293	15,242	15,807	11,448	14,473	9,695	6,983	10,307	15,412	10,831	4,055	6,476	4,550	5,803	3,419	3,758	6,327	2,301	3,107	2,127	4,407	5,956	410	2,762	6,087	4,640	7,949	2,926	20,920	3,457	1,527	4,636	2,115	4,300	10,000	6,900	5,200	9,600	3,900	3,800	16,500	10,800	7,200	7,500	5,300	10,800	11,700	4,200	600	10,200	4,500	4,400	4,700	6,000	7,800	6,400	5,700	4,300	4,900	8,000	5,700	5,200	3,000	3,700	2,500	1,500	3,300	4,100
Cash And Cash Equivalents Changes	0	0	3,227	60,002	-21,765	30,285	-39,616	24,773	44,936	19,625	-19,165	5,206	-93,230	1,972	136,867	12,767	14,387	-78,204	20,883	14,480	-44,892	7,657	11,937	-71,422	47,969	31,883	32,175	9,925	-9,231	20,622	3,125	9,956	4,920	-11,957	-48,458	35,462	-4,771	-9,972	-52,526	14,623	18,698	-7,180	-12,792	-14,061	6,130	-41,810	0	23,489	21,951	-33,470	20,184	27,169	54,489	31,582	-58,095	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	0	0	-10,176	-11,771	-1,103	-1,072	-6,036	-26,301	6,358	-1,742	-931	-4,679	-30,012	3,946	-2,679	-377	3,102	-768	-11,436	-15,199	8,353	4,888	-1,142	554	13,856	-5,119	9,815	-16,730	-2,640	2,318	194	-5,149	9,513	-5,224	3,330	21,702	-8,865	-9,286	-902	-1,138	1,927	2,912	2,344	-3,761	1,789	-4,046	0	-7,313	3,517	4,435	5,379	-13,278	15,361	-390	2,564	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Cash	-157,027	65,286	1,253	60,464	-17,198	26,252	-44,548	22,619	44,457	18,958	-18,843	3,303	-90,167	3,444	138,414	10,894	14,387	-78,204	20,883	14,480	-44,892	7,657	11,937	-71,422	47,969	31,883	32,175	9,925	-9,231	20,622	3,125	9,956	4,920	-11,957	-48,458	35,462	-4,771	-9,972	-52,526	14,623	18,698	-7,180	-12,792	-14,061	6,130	-48,996	7,186	23,489	21,951	-33,470	20,184	27,169	54,489	31,582	-58,095	-27,431	-9,329	4,500	17,101	31,396	13,994	-8,956	-13,266	16,696	-38,126	-61,073	-13,171	1,520	-14,493	-17,831	9,364	21,316	19,370	11,914	12,252	25,539	16,447	13,473	12,239	20,935	30,411	16,581	305	219	6,051	1,609	7,093	-17,987	-4,947	16,888	-482	-17,771	20,595	-13,578	-9,133	14,828	-9,700	2,500	-2,900	14,000	5,000	12,500	2,500	14,700	400	1,300	-2,800	-8,200	3,200	2,400	-2,500	-500	5,600	4,700	-500	400	-4,600	2,000	-9,800	2,300	3,600	5,900	-5,900	2,600	5,600	1,400	-2,100	2,600	-400	-500	-500
Change In Working Capital	-67,063	31,472	-51,704	7,887	-4,619	27,779	-5,544	22,978	5,708	-4,046	-39,817	-26,892	6,511	-11,909	-27,392	-3,426	11,172	-29,164	-63,144	-49,401	4,728	6,613	-24,690	17,705	46,370	14,334	1,570	-4,306	7,296	-10,143	12,970	9,585	-3,478	-10,218	-15,996	24,408	-17,164	-2,451	-8,248	17,265	3,794	-16,083	-4,739	-13,023	-11,137	6,273	-23,509	-4,271	-4,398	-1,854	-4,959	-6,795	10,595	-2,786	-20,026	3,210	-388	5,239	-3,984	17,414	2,474	-615	-14,189	8,939	2,483	-15,244	-6,883	-4,970	856	-2,724	-1,579	2,518	-2,212	-8,700	-6,048	3,640	1,443	-852	-4,743	8,731	8,891	5,483	-8,962	-43	190	-3,839	-11,258	-6,471	-7,886	-5,035	-6,340	10,908	-5,418	8,028	-7,596	12,266	-13,000	7,100	-2,300	17,800	-8,500	5,800	-5,000	7,300	3,700	-8,300	-18,100	-12,200	5,900	-2,300	-13,500	2,700	7,200	4,700	-5,700	-4,700	-8,700	-6,200	-13,100	-1,300	500	-4,900	-7,900	-3,000	4,700	2,400	-4,900	8,000	-10,500	-4,600	700
Change Receivables	0	0	1,010	-51	-7,327	-27,401	10,358	-6,238	-14,162	-9,232	-5,342	25,533	-3,803	-2,676	25,067	5,056	6,001	-14,712	22,518	-18,312	-6,426	-11,749	-1,577	-3,117	-2,535	8,536	2,203	-723	-2,929	-1,432	8,239	-6,720	-3,851	-6,331	6,574	-5,587	4,277	2,227	7,918	-14,278	11,743	-5,411	14,100	-5,915	-9,479	-22,686	0	-9,078	-129	-9,271	7,939	-3,680	597	-1,492	655	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Account Receivables	-30,600	1,847	1,010	-51	-7,327	-27,401	10,358	-6,238	-14,162	-9,232	-5,342	25,533	-3,803	-2,676	25,067	5,056	6,001	-14,712	22,518	-18,312	-6,426	-11,749	-1,577	-3,117	-2,535	8,536	2,203	-723	-2,929	-1,432	8,239	-6,720	-3,851	-6,331	6,574	-5,587	4,277	2,227	7,918	-14,278	11,743	-5,411	14,100	-5,915	-9,479	-30,706	8,020	-9,078	-129	-9,271	7,939	-3,680	597	-1,492	655	181	2,397	564	1,222	7,938	-586	3,098	-10,448	-4,852	-6,651	-6,086	-640	77	-965	5,126	-574	-91	0	-444	-5,618	6,900	-4,300	700	-1,400	1,800	-200	100	-5,700	600	-1,400	-8,400	-5,700	400	2,700	-5,000	0	805	-500	0	300	12,900	-12,400	-1,000	4,400	2,300	-4,800	-3,400	1,800	19,500	0	-500	-7,000	-3,500	400	-2,800	-4,700	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Inventory	-10,067	-1,258	-29,396	-3,752	-1,484	20,750	15,240	12,718	17,064	3,078	-8,553	-5,181	4,461	-13,632	-24,557	-16,470	-8,812	-22,025	-37,414	-27,698	-7,712	11,146	-15,058	-3,075	10,176	5,867	1,417	12,408	-1,299	-8,940	-3,721	6,512	3,758	3,228	-718	974	-4,721	-3,616	-9,569	11,943	-5,289	-6,493	-12,845	-5,953	-9,284	13,592	-17,040	-9,481	-7,657	-5,102	-10,288	-2,433	3,773	267	-4,167	-1,962	-1,774	1,446	625	-2,316	-1,073	-2,982	-4,865	-315	2,491	2,999	-8,049	-2,028	-1,051	-3,752	-1,689	1,751	435	-3,247	-4,440	-2,399	437	-528	-2,240	2,793	2,850	3,486	138	1,721	1,681	-1,494	-7,394	-4,996	-2,690	-6,102	-4,556	4,755	-2,010	1,556	2,116	-1,743	-400	-900	1,200	3,300	4,500	-2,400	-2,900	-8,800	3,600	-6,500	-3,000	-10,100	5,400	5,900	-2,100	-1,000	1,000	-500	300	0	-5,200	-4,200	-4,100	0	-5,800	-3,700	-1,100	-400	-200	400	1,300	900	-3,800	-800	-3,000
Change To Liabilities	0	33,689	-14,927	23,642	7,307	27,181	-27,181	19,398	6,051	3,850	-29,299	-34,904	3,252	453	-25,223	282	10,881	8,341	-36,812	11,808	10,513	2,328	-6,913	23,343	24,873	5,050	-11,865	739	14,164	-2,089	8,258	9,732	-12,898	-1,891	-25,182	7,319	-7,855	8,224	-5,695	18,344	-2,147	-6,404	-7,377	2,895	9,742	12,944	0	21,601	-129	5,841	-7,900	12,596	-9,136	-3,065	-19,078	5,263	0	0	0	20,104	6,917	9,634	6,817	10,455	4,806	6,590	3,883	0	0	0	5,346	2,550	1,143	0	3,075	3,346	229	1,514	1,729	344	0	1,459	0	1,229	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Netincome	0	18,810	7,671	17,434	9,723	2,761	4,416	13,126	-1,272	7,303	20,182	14,238	8,239	3,582	7,953	11,526	11,160	-5,453	46,814	19,393	7,244	6,741	24,216	5,062	3,291	2,270	-5,071	67,821	10,234	6,874	5,527	36,955	71,833	1,910	3,036	11,449	5,578	4,866	4,777	3,404	1,605	7,921	6,270	7,836	3,162	5,858	0	7,730	2,313	2,993	3,066	6,826	4,288	2,479	3,059	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	555	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Operating Activities	0	-305	-9,986	-9,986	-2,940	9,367	-31,142	1,500	-5,168	-2,098	1,256	-7,337	-19,552	1,037	865	6,226	3,102	-3,996	-8,208	-11,606	8,005	5,309	-1,214	-77	13,827	-5,078	8,998	-18,253	-2,640	2,318	194	3,121	0	0	0	-4,227	0	0	0	4,825	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	23,531	23,013	23,032	23,854	23,570	23,436	22,447	24,813	24,367	23,534	25,033	21,910	20,774	20,879	20,724	28,765	27,055	27,032	27,437	29,781	27,945	25,277	26,415	22,980	22,281	22,197	21,789	22,202	22,278	22,709	22,544	22,312	22,723	22,743	22,255	22,162	22,266	21,114	20,511	22,677	20,807	19,899	18,357	18,740	18,131	17,430	11,180	12,710	12,637	12,631	11,988	11,120	12,335	12,280	12,410	11,455	11,082	10,641	10,058	6,621	11,758	10,097	7,986	8,799	7,713	7,505	7,180	6,478	6,906	7,378	6,742	6,665	6,200	6,954	5,331	6,853	6,395	7,167	7,161	6,958	7,588	8,018	7,585	6,263	7,915	7,189	7,064	6,390	3,739	9,650	5,837	6,493	6,034	5,945	6,027	3,306	5,400	8,800	7,400	3,200	7,100	7,500	6,800	18,200	-6,300	5,700	5,300	2,000	4,100	3,700	2,500	500	4,200	4,200	4,200	2,900	3,700	3,500	3,600	2,200	2,700	3,100	2,700	1,700	2,400	2,200	2,200	1,400	1,900	1,900	1,800
Dividends Paid	0	3,667	2,015	0	0	72,808	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4,300
End Period Cash Flow	193,978	351,005	285,719	284,466	224,002	241,200	214,948	259,496	236,877	192,420	173,462	192,305	189,002	279,169	275,725	137,311	126,417	112,030	190,234	169,351	154,871	199,763	192,106	180,169	251,591	203,622	171,739	139,564	129,639	138,870	118,248	115,123	105,167	100,247	112,204	160,662	125,200	129,971	139,943	192,469	177,846	159,148	166,328	179,120	193,181	187,051	236,047	228,861	205,372	183,421	216,891	196,707	169,538	115,049	83,467	141,562	168,993	178,322	173,822	156,721	125,325	111,331	120,287	133,553	116,857	154,983	216,056	229,227	227,707	242,200	260,031	250,667	229,351	209,981	198,067	185,815	160,276	143,829	130,356	118,117	97,182	66,771	50,190	49,885	49,666	43,615	42,006	34,913	52,900	57,847	40,959	41,441	59,212	38,617	52,195	61,328	46,500	56,200	53,400	14,000	5,000	12,500	24,300	14,700	400	1,300	5,500	-8,200	3,200	2,400	10,900	-500	5,600	4,700	3,700	400	-4,600	2,000	6,400	2,300	3,600	5,900	4,400	2,600	5,600	1,400	800	2,600	-400	-500	1,200
Exchange Rate Changes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,124	-1,552	304	64	736	-1,539	-2,584	1,576	558	766	1,039	366	-1,726	-19	-192	650	-304	448	-806	-736	-1,794	-1,095	-432	-8	-162	576	-51	-562	257	32	0	24	-163	-727	368	1,493	-489	1,899	-1,571	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	-22,834	74,470	9,423	67,692	47,567	51,082	-3,474	32,935	35,770	22,648	-15,599	-10,085	56,918	20,816	4,116	35,760	58,892	20,428	-5,621	6,922	28,921	8,869	-4,392	38,524	38,824	43,499	24,704	18,959	36,308	20,120	8,216	24,719	8,110	1,627	-14,996	33,615	-2,765	-2,545	-23,347	21,544	29,772	14,250	310	15,039	8,712	7,023	-7,888	17,736	15,688	13,366	15,330	20,456	36,132	21,896	-1,698	25,259	20,506	24,097	4,502	32,997	13,986	11,555	1,447	16,622	9,634	-9,110	2,733	9,623	16,273	9,007	7,202	10,711	26,034	6,814	5,283	18,194	15,276	14,506	5,701	20,530	22,694	16,753	771	9,935	11,312	10,379	-1,494	11,029	-5,525	6,545	-1,413	5,921	6,038	17,256	1,255	22,650	-3,700	11,000	200	14,200	-12,500	2,400	7,100	23,300	-3,600	-5,800	-13,900	-4,300	6,100	-1,500	-5,600	8,700	10,100	13,500	2,800	3,100	-2,700	-1,900	-7,800	2,000	7,200	1,300	-6,400	3,100	8,700	7,800	-1,300	12,600	-5,500	-1,700	2,000
Investments	-268,937	-1,000	-6,000	-18,006	-19,810	-31,068	-10,395	-34,512	-15,462	-20,520	-15,851	-429,100	-9,581	37,135	-23,896	-45,135	-19,866	5,964	1,861	-13,217	0	0	0	0	0	0	0	0	0	0	0	-3,000	0	0	0	0	0	0	0	-9,546	0	0	0	-1,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	0	-3,500	-1,750	278,250	-51,750	48,250	-4,375	-4,375	-4,375	-4,375	-4,375	443,850	-154,375	-64,375	145,625	10,625	625	-65,000	85,625	6,250	6,250	-4,375	94,052	-16,508	-16,437	-16,437	-11,601	-21,608	-51,716	-11,711	-8,375	-19,070	-7,182	2,262	4,104	-83	-1,408	-1,160	-7,098	-9,876	-17,440	-16,261	29	2,655	1,117	472,321	0	-1,750	-711	1,728	-370	-6,364	-3,540	4,687	-9,936	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	31,241	24,908	41,042	29,383	32,944	33,197	19,877	9,741	23,232	14,856	-4,454	-11,041	31,882	48,101	10,527	17,624	29,895	37,486	-8,479	20,835	18,277	18,726	-2,819	11,880	-6,547	20,102	20,137	-51,140	15,393	19,825	-10,346	-8,776	-59,440	12,863	-267	-2,930	15,988	7,488	-3,649	10,184	16,290	16,548	-7,874	12,561	9,904	6,547	9,787	17,806	18,252	13,880	16,947	20,988	19,735	21,339	17,918	3,961	18,286	18,050	18,073	13,939	16,217	14,807	14,341	13,781	14,355	11,167	12,677	19,785	16,902	1,114	11,308	17,158	28,089	10,945	12,884	9,938	11,007	8,874	9,820	9,528	9,314	5,495	4,983	4,477	10,347	6,780	6,775	10,007	128	9,948	9,944	7,167	8,963	-15,558	6,664	798	6,500	5,700	6,000	6,100	4,800	5,300	4,900	-23,600	-11,700	4,000	6,500	7,900	7,000	8,700	9,400	9,100	8,900	9,200	8,700	8,500	8,500	8,500	8,100	8,400	8,300	8,000	6,800	7,000	6,600	6,000	5,200	5,600	4,600	4,300	3,500
Other Cashflows From Financing Activities	110,011	3,662	1,152	326,488	-9	401,680	-19,147	-4,390	2,340	1,060	2,741	495,292	-145,565	-59,943	153,326	15,747	8,222	-62,517	95,465	15,745	3,793	4,296	352,391	-96,053	24,905	3,852	8,307	1,407	-33,532	12,267	2,128	3,544	4,411	8,025	9,536	3,120	4,974	918	6,440	2,749	-2,026	6,867	9,737	3,001	9,150	478,802	16,444	5,311	6,287	4,051	2,979	4,086	28,894	12,362	-44,796	5,022	-30,514	-6,751	19,027	3,143	-4,019	2,874	4,305	51	-11,549	-1,530	-2,449	-1,513	-4,337	-10,888	-4,321	1,708	-6,828	1,694	406	-2,273	-6,179	-2,110	-1,089	-10,269	-4,207	-1,812	-1,044	-6,017	-2,009	5,030	-591	-29,856	-3,954	5,084	5,847	-250	11,056	-7,541	-8,262	-3,426	14,500	300	2,600	-5,500	5,100	2,000	-7,100	-1,500	500	18,700	24,900	5,400	2,700	3,500	1,300	1,200	-10,800	-2,500	1,500	9,200	2,400	5,900	-500	100	-3,900	4,200	-1,000	-900	-3,100	-6,900	-1,100	-3,400	5,100	1,200	-5,400
Other Cashflows From Investing Activities	0	-6,079	402	-6,087	158	7,889	-2,352	603	9,561	292	-1,932	-388,402	-208	45,474	-16,200	-34,489	524	15,437	10,110	499	1,658	406	250	1,131	281	365	9,981	1,049	1,576	110	87	3,240	104	177	-2,884	65	10	313	64	8,665	-112	-8,634	-22,555	1,647	935	-535,789	0	485	387	111	19	1,134	-6,285	151	111	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3,562	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non Cash Items	189	-1,738	1,512	6,646	5,029	-3,108	-86	2,407	1,570	1,581	15,733	26,373	1,759	-31,338	2,287	255	3,292	-8,472	47,393	-1,454	-239	1,258	19	1,294	86	-346	658	72,079	452	176	257	23,332	-4,685	301	94	-3,408	472	460	571	-802	1,227	4,146	548	6,226	14,054	6,146	10,355	16,607	18,537	12,109	17,645	77,804	506	-2,296	1,042	12,777	790	-418	-1,319	5,732	432	3,646	4,352	396	325	3,269	1,400	2,803	1,304	10,222	3,027	98	4,783	1,670	-429	225	2,277	257	-2,220	159	-741	855	-613	-1,236	-663	1,123	-1,447	3,434	1,218	1,842	-3,420	0	-37	20,454	787	10,192	1,700	-600	-4,000	-200	-100	-12,300	4,500	38,100	-100	-8,800	-600	-200	0	200	-100	0	100	-100	100	1,100	-200	100	0	-1,600	0	0	0	0	0	200	-100	100	0	0	100
Sale Purchase Of Stock	0	-4,359	-1,483	159	2,079	-75,000	2,586	414	6,133	1,069	2,710	10,230	4,447	66	3,337	936	-50,000	-50,000	-75,000	745	-80,000	4,300	-80,000	-96,145	24,800	3,690	8,100	11,200	6,327	12,100	3,400	1	4,100	-21,952	-39,032	-332	-4,931	-7,304	-26,466	3,600	6,100	2,300	8,500	-31,958	-12,700	5,000	0	6,400	6,244	-49,998	4,500	8,800	28,300	2,800	-45,300	12,200	-30,500	-3,900	2,400	5,100	4,000	-35,053	-24,945	2,400	7,800	-50,243	-24,753	0	-29,371	0	4,500	5,500	0	3,300	4,500	7,400	11,600	4,100	3,100	3,800	11,500	2,100	700	-5,186	-3,947	-15,001	-26,032	-29,100	4,900	4,700	0	0	2,300	0	-4,729	-10,303	-8,800	-11,100	-9,500	100	5,000	1,300	1,100	1,100	0	1,200	-5,600	-9,500	-5,300	-800	2,200	-4,000	0	-100	-4,800	-12,500	-100	-1,500	-1,600	0	0	0	0	0	0	0	0	0	0	0	0
Stock Based Compensation	7,217	6,706	6,989	7,058	7,491	5,735	5,299	5,097	6,455	5,979	6,828	7,110	6,287	5,952	6,167	5,399	5,325	5,000	4,730	4,445	4,782	4,582	3,379	5,665	3,161	2,856	1,343	2,542	2,373	2,395	1,840	750	2,316	719	3,164	3,876	3,281	3,449	3,489	3,417	3,248	3,403	3,013	3,038	2,917	2,597	2,417	2,559	2,026	2,300	2,401	2,665	4,056	1,892	2,197	2,692	2,583	2,213	2,779	0	0	0	2,367	0	0	0	2,271	0	0	0	3,027	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	200	-6,900	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Cash From Financing Activities	109,429	-7,172	-598	-1,603	-49,680	-25,686	-23,395	-8,765	-2,035	-3,315	-1,634	432,759	-149,940	-64,318	148,951	11,372	-46,153	-112,517	16,090	6,995	-76,207	-79	18,663	-112,653	8,306	-12,747	-3,549	-10,449	-45,389	411	-4,986	-15,652	-2,990	-14,209	-29,772	2,518	-222	-6,645	-28,811	-6,032	-10,800	-13,372	9,504	-29,185	-3,774	478,585	16,227	5,244	6,039	-46,220	4,467	4,086	25,131	7,636	-54,937	4,833	-30,710	-6,937	18,844	3,143	-55	-19,360	-14,465	191	-4,832	-50,112	-18,475	775	-32,165	-4,640	476	5,716	-3,503	4,954	4,927	5,106	5,433	1,971	2,021	-5,644	6,844	-127	-355	-10,412	-5,383	-8,504	-24,702	-31,992	913	9,841	11,902	9,064	13,388	-5,556	-11,888	-7,389	7,300	-10,800	-6,900	-5,500	5,100	2,000	-7,100	-500	500	20,000	20,100	-2,500	-1,900	3,700	3,500	-2,400	-10,700	-2,600	-3,300	-2,700	2,600	4,400	-2,100	1,600	-3,400	3,900	-300	-500	-3,100	-6,400	-800	-3,000	5,100	1,200	-2,500
Total Cash From Operating Activities	-540	99,124	19,086	79,611	64,415	87,039	41,993	68,050	62,433	43,460	-1,680	1,547	66,291	29,155	11,812	46,406	79,282	29,901	2,628	20,638	58,164	57,357	23,122	57,627	65,395	58,903	38,425	34,577	55,201	39,265	30,695	53,253	31,851	27,511	9,250	55,305	26,893	31,242	13,738	51,471	45,291	29,360	13,402	27,542	23,965	33,014	553	33,975	28,804	25,408	27,131	32,139	47,030	30,760	13,526	36,687	32,502	35,773	25,706	43,706	30,881	27,935	13,842	31,915	24,876	6,697	14,181	24,096	25,968	15,990	17,509	26,123	36,865	10,869	11,759	22,744	21,079	17,925	9,459	26,857	24,995	19,860	2,898	14,342	17,268	10,789	1,268	17,116	-885	14,494	1,513	26,841	9,495	18,783	5,891	24,765	600	21,000	7,100	19,400	-2,900	6,300	10,900	39,800	-14,400	1,400	-6,400	1,000	16,900	10,200	-1,400	9,300	20,300	18,000	7,200	7,800	3,300	5,900	-1,400	7,700	11,500	6,200	1,600	8,800	13,900	10,800	2,400	15,100	-4,000	1,600	6,100
Total Cashflows From Investing Activities	0	-25,135	-15,261	-18,006	-36,500	-31,068	-58,214	-34,512	-51,833	-20,520	-15,851	-429,100	-9,581	37,135	-23,896	-45,135	-19,866	5,964	1,861	-13,217	-27,585	-48,082	-27,264	-17,972	-26,290	-15,039	-3,740	-14,569	-17,317	-19,035	-22,392	-28,294	-23,637	-25,707	-27,130	-21,625	-29,648	-33,474	-37,021	-30,808	-15,631	-23,744	-35,647	-11,856	-14,318	-570,221	0	-15,754	-12,729	-11,931	-11,782	-10,549	-17,183	-8,713	-15,113	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19,428	0	0	781	0	0	0	0	19,485	23,311	29,486	30,144	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Income Statement

Currency in USD. All numbers in thousands.

	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31	2006-03-31	2005-03-31	2004-03-31	2003-03-31	2002-03-31	2001-03-31	2000-03-31	1999-03-31	1998-03-31	1997-03-31	1996-03-31	1995-03-31	1994-03-31	1993-03-31	1992-03-31	1991-03-31
Cost Of Revenue	553,563	487,694	472,625	503,966	550,043	492,015	507,622	503,802	475,955	470,144	463,859	358,604	321,485	307,949	289,709	258,715	222,307	199,198	185,722	192,109	182,260	165,135	126,948	121,700	124,000	127,100	137,800	110,500	103,900	94,200	88,800	78,500	-
Depreciation And Amortization	93,307	88,721	84,287	110,289	109,418	89,247	89,733	90,033	86,053	81,740	65,481	49,966	48,145	43,236	36,462	31,197	27,504	25,150	27,576	30,149	28,431	25,616	24,499	24,906	24,600	22,900	12,300	13,100	13,700	10,700	8,500	7,000	-
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Ebit	156,033	80,750	57,963	153,950	83,545	56,157	39,212	36,338	40,540	47,327	-4,797	34,892	110,932	53,785	87,535	68,313	72,433	69,850	59,817	44,887	35,070	54,388	76,713	40,569	26,600	54,000	44,400	51,100	50,400	49,100	41,600	29,300	157,300
Ebitda	249,340	169,471	142,250	264,239	192,963	145,404	128,945	126,371	126,593	129,067	60,684	84,858	159,077	97,021	123,997	99,510	99,937	95,000	87,393	75,036	63,501	80,004	101,212	65,475	51,200	76,900	56,700	64,200	64,100	59,800	50,100	36,300	157,300
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Extraordinary Items	0	0	0	0	0	-27,800	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2,304	0	0	0	0	0	0	0	0	0	0	-
Gross Profit	615,097	505,502	397,838	484,513	417,536	411,908	378,494	405,873	434,418	468,365	428,131	369,240	355,209	337,481	308,170	257,725	227,300	220,535	197,876	172,120	154,696	154,834	166,912	156,224	158,100	158,700	172,000	167,700	158,500	154,200	127,500	97,900	157,300
Income Before Tax	141,403	63,629	72,913	87,152	73,633	59,632	-27,476	-53,457	31,165	36,401	49,897	89,498	110,081	81,270	85,002	77,302	72,336	106,882	59,841	45,812	38,607	38,505	17,326	27,325	32,600	4,500	50,700	55,200	52,500	50,800	40,000	27,700	-
Income Tax Expense	26,002	20,254	-6,556	10,626	18,614	14,060	-1,208	2,163	14,268	1,253	11,097	22,612	30,101	22,895	25,698	25,322	23,227	37,806	20,202	16,492	10,228	10,782	10,090	8,471	11,400	3,900	17,700	19,300	18,900	19,300	15,200	9,700	-
Interest Expense	14,630	17,121	16,834	16,199	9,912	4,525	8,095	9,474	9,375	10,926	54,694	54,606	6	742	64	8,989	97	37,032	24	925	3,537	13,579	59,387	13,100	5,900	74,900	6,300	4,100	2,100	1,700	1,600	1,600	0
Interest Income	14,630	17,121	16,834	16,199	9,912	4,525	8,095	9,474	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Net Income	115,401	43,375	79,469	76,526	55,019	45,572	-26,268	-55,620	16,897	35,148	38,800	66,886	79,980	58,375	59,304	51,980	49,109	69,076	39,639	29,320	28,379	30,027	7,236	18,998	21,100	-24,800	33,000	35,900	33,600	31,500	24,800	18,000	-
Net Income Applicable To Common Shares	115,401	43,375	79,469	76,526	55,019	45,572	-26,268	-55,579	16,897	35,148	38,800	66,886	79,980	58,370	59,304	51,980	49,109	69,076	39,639	29,320	28,379	27,723	7,236	18,854	0	0	0	0	0	0	0	0	-
Net Income From Continuing Ops	115,401	43,375	79,469	76,526	55,019	45,572	-26,268	-55,579	16,897	35,148	38,800	66,886	79,980	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Net Interest Income	-14,630	-17,121	-16,834	-16,199	-9,912	-4,525	-8,095	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Non Operating Income Net Other	-14,630	-17,121	-16,834	-16,199	-9,912	3,475	-8,095	-9,474	-9,375	-10,926	-6,540	740	-461	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Non Recurring	0	577	1,028	50,599	0	0	58,593	92,395	5,441	1,711	4,247	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Operating Income	156,033	80,750	57,963	153,950	83,545	56,157	-19,381	-43,983	40,540	47,327	56,437	88,758	110,548	83,281	85,567	70,287	62,745	99,018	59,943	45,877	37,479	36,448	13,420	33,633	31,700	31,000	48,400	54,300	52,400	51,800	41,800	29,900	157,300
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Other Operating Expenses	459,064	921,472	812,500	834,529	884,034	847,766	846,904	873,337	869,833	891,182	831,306	640,666	566,146	548,808	512,312	446,153	377,789	320,715	323,655	318,352	299,477	273,521	237,335	244,291	250,400	254,800	261,400	223,900	210,000	196,600	174,500	146,500	-
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Reconciled Depreciation	93,307	97,747	84,287	110,289	109,418	89,247	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Research Development	50,131	46,801	32,857	30,883	35,714	39,228	37,556	45,565	54,187	54,200	48,641	36,801	32,656	26,376	23,859	24,322	23,884	26,516	19,994	17,793	19,512	19,512	19,039	14,927	15,100	17,900	19,000	18,500	16,700	15,800	0	0	-
Selling And Marketing Expenses	7,200	4,400	2,700	4,300	4,500	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Selling General Administrative	369,475	335,163	271,488	295,380	293,777	316,523	301,726	317,223	258,712	365,100	323,100	245,261	205,600	214,500	198,700	163,100	137,073	121,400	118,000	108,500	97,700	88,900	86,734	82,800	86,700	86,900	92,300	0	0	0	0	0	-
Tax Provision	26,002	20,254	-6,556	10,626	18,614	14,060	-1,208	2,163	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Total Operating Expenses	459,064	433,778	339,875	330,563	333,991	355,751	339,282	369,535	393,878	421,038	367,447	282,062	244,661	240,859	222,603	187,438	155,482	121,517	137,933	126,243	117,217	108,386	110,387	122,591	126,400	127,700	123,600	113,400	106,100	102,400	85,700	68,000	-
Total Other Income Expense Net	-14,630	-17,121	14,950	-66,798	-9,912	8,000	-58,593	-80,321	-5,441	-1,711	-6,540	2,320	-845	-15,009	-2,469	1,974	-615	29,168	126	990	2,409	-7,940	-20,188	-6,936	5,100	-23,000	4,000	3,200	2,000	2,700	200	600	-
Total Revenue	1,168,660	993,196	870,463	988,479	967,579	903,923	886,116	909,675	910,373	938,509	891,990	727,844	676,694	645,430	597,879	516,440	449,607	419,733	383,598	364,229	336,956	319,969	293,860	277,924	282,100	285,800	309,800	278,200	262,400	248,400	216,300	176,400	157,300

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31	1999-09-30	1999-06-30	1999-03-31	1998-12-31	1998-09-30	1998-06-30	1998-03-31	1997-12-31	1997-09-30	1997-06-30	1997-03-31	1996-12-31	1996-09-30	1996-06-30	1996-03-31	1995-12-31	1995-09-30	1995-06-30	1995-03-31	1994-12-31	1994-09-30	1994-06-30	1994-03-31	1993-12-31	1993-09-30	1993-06-30	1993-03-31	1992-12-31	1992-09-30	1992-06-30	1992-03-31	1991-12-31	1991-09-30	1991-06-30	1991-03-31	1990-12-31	1990-09-30	1990-06-30
Cost Of Revenue	158,383	147,673	144,067	148,167	146,594	139,607	119,195	128,691	121,204	117,356	120,443	143,222	120,114	103,742	105,547	124,935	130,920	125,566	122,545	138,085	136,181	129,674	146,103	129,166	122,748	120,815	119,286	145,955	126,762	116,005	118,900	154,003	124,529	114,396	110,874	118,113	120,166	119,466	118,210	125,650	120,491	115,871	108,131	126,802	134,280	116,416	86,362	92,059	95,229	89,496	81,821	82,532	83,299	79,078	76,576	80,980	79,722	76,103	71,144	70,249	77,151	71,230	71,079	68,954	68,029	61,290	60,442	58,572	57,108	53,326	53,301	51,818	50,008	48,723	48,649	46,529	46,317	45,374	47,502	49,680	47,624	46,108	48,697	44,663	46,174	48,135	43,288	41,566	43,176	40,903	39,498	34,590	30,869	31,242	30,249	32,800	32,200	27,800	28,900	36,600	29,600	28,500	29,200	4,200	46,600	36,400	39,900	42,000	34,400	30,800	30,700	30,300	26,500	26,400	27,300	29,000	25,900	25,000	23,900	25,100	23,500	22,900	22,700	23,400	23,300	21,900	20,100	20,700	19,300	19,800	18,700	-	-	-	-
Depreciation And Amortization	23,531	7,222	23,032	23,854	23,570	23,054	22,447	12,061	24,367	23,534	25,033	21,910	20,774	20,879	20,724	28,765	27,055	27,032	27,437	29,781	27,945	25,277	26,415	22,980	22,281	22,197	21,789	22,202	22,278	22,709	22,544	22,312	22,723	22,743	22,255	22,162	22,266	21,114	20,511	22,677	20,807	19,899	18,357	18,740	18,131	17,430	11,180	12,710	12,637	12,631	11,988	11,120	12,335	12,280	12,410	11,455	11,082	10,641	10,058	6,621	11,758	10,097	7,986	8,799	7,713	7,505	7,180	6,478	6,906	7,378	6,742	6,665	6,200	6,954	5,331	6,853	6,395	7,167	7,161	6,958	7,588	8,018	7,585	6,263	7,915	7,189	7,064	6,390	3,739	9,650	5,837	6,493	6,034	5,945	6,027	3,306	5,400	8,800	7,400	3,200	7,100	7,500	6,800	18,200	-6,300	5,700	5,300	2,000	4,100	3,700	2,500	500	4,200	4,200	4,200	2,900	3,700	3,500	3,600	2,200	2,700	3,100	2,700	1,700	2,400	2,200	2,200	1,400	1,900	1,900	1,800	-	-	-	-
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Ebit	45,978	45,722	53,659	35,255	43,279	46,732	30,767	19,199	35,651	24,510	-17,816	-21,374	18,536	27,284	12,743	26,009	42,783	22,707	35,419	23,856	28,320	26,076	5,293	-8,705	1,013	24,258	16,611	-22,499	21,661	24,794	-7,881	-5,591	-3,750	19,179	3,606	-10,624	-4,006	-8,707	-22,177	-10,031	-2,947	3,531	-24,965	-1,032	-2,384	-6,218	1,563	21,330	25,183	5,104	12,026	30,674	16,224	15,224	11,881	17,528	14,809	16,485	16,426	17,735	25,942	24,899	18,959	20,228	19,372	13,885	14,822	18,938	16,189	23,022	14,131	49,457	-12,136	14,898	17,631	15,605	15,038	13,980	15,194	14,398	13,761	8,645	8,083	5,367	11,273	9,301	9,129	31,287	2,343	12,199	25,802	28,354	10,008	30,350	7,560	17,569	8,300	6,600	7,200	8,000	6,100	6,700	6,000	8,700	31,600	5,100	8,600	9,400	9,500	12,000	13,400	12,100	13,400	12,600	12,900	12,800	12,400	13,300	11,900	12,100	13,700	12,600	10,700	11,600	11,300	10,100	8,700	8,900	7,700	6,700	5,800	-	-	-	-
Ebitda	69,509	52,944	76,691	59,109	66,849	69,786	53,214	31,260	60,018	48,044	7,217	536	39,310	48,163	33,467	54,774	69,838	49,739	62,856	53,637	56,265	51,353	31,708	14,275	23,294	46,455	38,400	-297	43,939	47,503	14,663	16,721	18,973	41,922	25,861	11,538	18,260	12,407	-1,666	12,646	17,860	23,430	-6,608	17,708	15,747	11,212	12,743	34,040	37,820	17,735	24,014	41,794	28,559	27,504	24,291	28,983	25,891	27,126	26,484	24,356	37,700	34,996	26,945	29,027	27,085	21,390	22,002	25,416	23,095	30,400	20,873	56,122	-5,936	21,852	22,962	22,458	21,433	21,147	22,355	21,356	21,349	16,663	15,668	11,630	19,188	16,490	16,193	37,677	6,082	21,849	31,639	34,847	16,042	36,295	13,587	20,875	13,700	15,400	14,600	11,200	13,200	14,200	12,800	26,900	25,300	10,800	13,900	11,400	13,600	15,700	15,900	12,600	17,600	16,800	17,100	15,700	16,100	16,800	15,500	14,300	16,400	15,700	13,400	13,300	13,700	12,300	10,900	10,300	9,600	8,600	7,600	39,400	39,300	39,300	39,300
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Extraordinary Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2,304	0	-2,304	2,304	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Gross Profit	177,867	170,510	167,265	156,249	158,707	157,878	142,263	136,311	138,565	122,541	108,085	81,807	120,257	105,744	90,030	113,557	128,050	127,000	115,906	111,210	111,175	111,907	83,244	104,386	111,295	104,562	91,665	82,111	101,079	104,248	91,056	89,182	108,855	105,297	102,539	108,365	111,661	108,114	106,278	115,441	121,629	119,884	111,412	123,140	113,115	101,762	90,113	94,611	95,931	89,949	88,748	87,501	93,490	87,755	86,463	88,124	85,447	80,967	82,943	82,148	78,296	74,689	73,037	69,785	66,558	59,889	61,494	58,347	56,419	55,161	57,373	58,577	55,669	51,765	54,524	53,446	51,781	45,549	47,100	48,041	43,113	41,380	39,586	36,218	40,941	38,890	38,647	37,487	41,235	39,801	36,303	43,108	45,030	39,328	39,444	37,024	38,600	40,400	40,200	37,800	38,400	39,300	42,800	46,900	29,200	40,200	42,400	41,300	42,200	43,600	44,800	40,100	43,400	42,700	41,500	39,200	39,700	40,300	39,400	39,000	39,700	39,700	35,800	34,100	33,800	31,200	28,500	27,300	25,700	23,400	21,400	39,400	39,300	39,300	39,300
Income Before Tax	44,029	32,832	51,590	32,626	42,224	41,059	25,494	15,327	31,388	19,922	-3,008	-27,397	37,374	54,956	7,980	21,960	37,829	45,088	-17,725	21,819	25,462	23,037	3,315	13,312	207	22,861	23,252	-59,187	18,937	22,832	-10,058	-8,309	-63,318	16,573	1,597	9,659	15,952	9,762	-4,209	9,755	15,008	20,888	-9,249	14,686	13,205	8,590	13,415	21,330	25,463	19,011	23,693	28,572	27,974	29,159	24,375	3,888	25,377	26,070	25,935	18,365	23,489	22,809	20,339	21,370	20,892	16,608	18,432	28,416	19,404	7,111	17,556	25,842	44,488	16,421	20,131	16,094	15,607	13,708	14,432	14,886	14,554	8,586	7,786	7,049	11,913	9,826	9,819	10,701	3,376	13,817	10,611	9,816	12,066	-13,374	9,255	725	9,600	8,200	8,800	9,400	7,400	8,200	7,700	6,300	-18,000	6,200	10,000	12,100	10,800	13,300	14,500	14,000	13,700	14,200	13,400	12,900	12,800	13,700	13,100	13,500	13,400	12,900	11,000	11,300	10,700	9,800	8,200	8,600	7,100	6,600	5,400	-	-	-	-
Income Tax Expense	12,788	7,924	10,548	3,243	9,280	7,862	5,617	5,586	8,156	5,066	1,446	-16,356	5,492	6,855	-2,547	4,336	7,934	7,602	-9,246	984	7,185	4,311	6,134	1,432	6,754	2,759	3,115	-8,047	3,544	3,007	288	467	-3,878	3,710	1,864	12,589	-36	2,275	-560	-429	-1,282	4,340	-1,375	2,125	3,301	2,043	3,628	3,524	7,211	5,131	6,746	7,584	8,240	7,821	6,457	-73	7,091	8,020	7,862	4,426	7,273	8,002	5,998	7,589	6,538	5,441	5,755	8,632	2,503	5,845	6,248	8,684	16,399	5,476	7,247	6,156	4,600	4,834	4,612	5,358	5,240	3,091	2,803	2,572	1,566	3,046	3,044	2,998	944	3,869	2,971	2,649	3,103	1,745	2,591	-29	3,100	2,600	2,800	3,300	2,600	2,900	2,700	4,500	-6,300	2,200	3,500	4,200	3,800	4,700	5,100	4,900	4,800	5,000	4,700	4,400	4,300	5,200	5,000	5,100	5,100	4,900	4,200	4,300	4,100	3,800	3,000	3,000	2,500	2,300	1,900	-	-	-	-
Interest Expense	1,949	2,471	2,069	2,629	1,055	5,673	5,273	3,872	4,263	4,588	4,398	6,222	3,051	3,826	3,735	4,047	3,078	4,651	4,423	2,037	2,858	3,039	1,978	963	806	1,397	1,359	1,681	2,275	1,962	2,177	2,718	2,141	2,606	2,009	1,879	2,308	2,645	2,543	2,891	2,852	2,542	15,716	15,718	15,589	14,808	11,852	370	280	17	106	93	20	23	153	20	248	255	214	630	2,453	2,090	1,380	1,142	1,520	2,723	3,610	9,479	3,216	15,911	3,425	23,615	56,624	1,523	2,500	489	569	272	762	488	793	59	297	1,682	640	525	690	20,586	1,033	1,618	12,887	18,538	2,058	43,724	1,695	16,800	1,300	1,700	1,600	1,400	1,300	1,500	1,600	27,800	49,600	1,100	1,400	2,700	1,300	1,300	1,100	1,900	300	1,600	500	100	400	400	1,200	1,400	300	300	300	300	600	300	500	300	600	100	400	-	-	-	-
Interest Income	0	2,471	2,069	2,629	1,055	5,673	5,273	3,872	4,263	4,588	4,398	6,222	3,051	3,826	3,735	4,047	3,078	4,651	4,423	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Net Income	31,241	24,908	41,042	29,383	32,944	33,197	19,877	9,741	23,232	14,856	-4,454	-11,041	31,882	48,101	10,527	17,624	29,895	37,486	-8,479	20,835	18,277	18,726	-2,819	11,880	-6,547	20,102	20,137	-51,140	15,393	19,825	-10,346	-8,776	-59,440	12,863	-267	-2,930	15,988	7,487	-3,649	10,184	16,290	16,548	-7,874	12,561	9,904	6,547	9,787	17,806	18,252	13,880	16,947	20,988	19,734	21,338	17,918	3,961	18,286	18,050	18,073	13,939	16,216	14,807	14,341	13,781	14,354	11,167	12,677	19,785	16,902	1,266	11,308	17,158	28,089	10,945	12,884	9,938	11,007	8,874	9,820	9,528	9,314	5,495	4,983	4,477	10,347	6,780	6,775	7,703	2,432	9,948	9,944	7,167	8,963	-15,119	6,664	798	6,500	5,700	6,000	6,100	4,800	5,300	4,900	-23,600	-11,700	4,000	6,500	7,900	7,000	8,600	9,400	9,100	8,900	9,200	8,700	8,500	8,500	8,500	8,100	8,400	8,300	8,000	6,800	7,000	6,600	6,000	5,200	5,600	4,600	4,300	3,500	-	-	-	-
Net Income Applicable To Common Shares	0	24,908	41,042	29,383	32,944	33,197	19,877	9,741	23,232	14,856	-4,454	-11,041	31,882	48,101	10,527	17,624	29,895	37,486	-8,479	20,835	18,277	18,726	-2,819	11,880	-6,547	20,102	20,137	-51,140	15,393	19,825	-10,346	-8,735	-59,440	12,863	-267	-2,929	15,988	7,487	-3,649	10,184	16,290	16,548	-7,874	12,561	9,904	6,547	9,787	17,807	18,252	13,880	16,947	20,990	19,734	21,338	17,918	3,961	18,286	18,050	18,073	13,939	16,217	14,807	14,341	13,793	14,343	11,167	12,677	19,785	16,902	1,266	11,156	17,005	27,924	10,758	12,709	9,938	11,007	8,874	9,820	9,528	9,314	5,495	4,983	4,477	10,347	6,780	6,775	7,703	2,432	9,948	7,640	7,167	8,962	-6,225	6,225	760	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Net Income From Continuing Ops	31,241	24,908	41,042	29,383	32,944	33,197	19,877	9,741	23,232	14,856	-4,454	-11,041	31,882	48,101	10,527	17,624	29,895	37,486	-8,479	20,835	18,277	18,726	-2,819	11,926	-6,593	20,102	20,137	-51,147	15,393	19,832	-10,346	-8,735	-59,440	12,863	-267	-2,929	15,988	7,487	-3,649	10,184	16,290	16,548	-7,874	0	9,904	6,547	0	17,807	18,252	13,880	16,947	20,990	19,734	21,338	17,918	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Net Interest Income	-1,949	-2,471	-2,069	-2,629	-1,055	-5,673	-5,273	-3,872	-4,263	-4,588	-4,398	-6,222	-3,051	-3,826	-3,735	-4,047	-3,078	-4,651	-4,423	-2,037	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Non Operating Income Net Other	0	0	-2,069	-2,629	-1,055	-5,673	-5,273	-3,872	-4,263	-4,588	-4,398	-6,222	-3,051	-3,826	-3,735	-4,047	-3,078	-4,651	-4,423	-2,037	-2,858	-3,039	-1,978	-963	-806	-1,397	6,641	-1,681	-2,275	-1,962	-2,177	-2,718	-2,141	-2,606	-2,009	-1,879	-2,308	-2,645	-2,543	-2,891	-2,852	-2,542	-2,641	0	-2,542	-1,311	0	264	140	445	-109	-603	-474	277	339	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Non Recurring	0	0	0	0	0	0	0	577	0	0	0	0	0	0	1,028	2	1,876	0	48,721	0	0	0	0	0	0	0	0	58,144	449	-5,536	1,384	7,347	85,048	0	0	5,441	0	0	0	1,711	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Operating Income	45,978	35,303	53,659	35,255	43,279	46,732	30,767	19,199	35,651	24,510	1,390	-21,175	40,425	58,782	11,715	26,007	40,907	49,739	-13,302	23,856	28,320	26,076	5,293	14,275	1,013	24,258	16,611	-57,506	21,212	24,794	-7,881	-5,591	-61,177	19,179	3,606	11,538	18,260	12,407	-1,666	12,646	17,860	23,430	-6,608	17,708	15,747	9,901	13,079	20,960	25,323	18,566	23,908	28,895	28,559	28,905	24,189	4,097	25,835	27,023	26,327	18,133	24,491	23,609	19,334	20,297	19,597	14,616	15,779	25,693	17,005	5,156	15,043	50,188	14,956	15,379	18,495	15,770	15,300	13,911	14,962	14,689	14,096	8,906	8,186	6,139	11,822	9,826	9,692	11,156	2,806	12,954	26,771	-14,225	10,967	8,349	8,327	9,033	8,900	7,300	8,500	9,300	7,300	8,000	7,300	8,000	7,400	6,100	9,600	10,900	10,400	12,900	14,100	13,200	13,900	13,700	13,500	13,000	13,000	13,800	12,700	14,000	13,700	13,000	11,100	11,700	11,200	10,300	8,800	9,100	7,700	7,000	6,000	39,400	39,300	39,300	39,300
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Other Operating Expenses	290,272	272,461	257,673	120,994	262,022	251,135	230,691	245,226	224,118	215,387	236,741	246,403	201,061	182,202	182,834	212,483	216,187	202,827	203,032	225,439	219,036	215,505	224,054	219,277	233,030	201,119	194,340	228,363	206,180	195,459	217,837	248,776	214,411	200,514	209,807	214,940	213,567	215,173	226,154	228,445	224,260	212,325	226,151	232,234	231,648	208,277	163,396	165,710	165,837	162,459	146,661	139,244	148,230	139,822	138,850	151,666	139,335	53,944	127,760	134,264	130,956	122,310	124,782	118,442	114,990	106,563	106,157	91,451	96,522	94,186	95,631	60,207	90,721	85,109	84,678	84,205	82,798	77,012	79,640	83,032	76,641	78,582	80,097	74,742	75,293	77,199	72,243	57,897	81,605	67,750	49,030	48,818	64,932	62,221	61,366	60,791	61,900	60,900	60,600	65,100	60,700	59,800	64,700	43,100	68,400	70,500	72,700	72,400	66,200	61,500	61,400	57,200	56,000	55,400	55,300	55,200	52,600	51,500	50,600	50,100	49,500	49,600	47,400	45,800	45,900	42,800	39,800	38,900	37,300	36,200	34,100	-	-	-	-
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Reconciled Depreciation	23,531	7,222	23,032	23,854	23,570	23,436	22,447	24,813	24,367	23,534	25,033	21,910	20,774	20,879	20,724	28,765	27,055	27,032	27,437	29,781	27,945	25,277	26,415	22,980	22,281	22,197	21,789	22,202	22,278	22,709	22,544	22,190	22,723	22,743	22,255	22,162	22,266	21,114	20,511	22,677	20,807	19,899	18,357	18,740	18,131	17,430	11,180	12,710	12,637	12,631	11,988	11,120	12,335	12,280	12,410	11,455	11,082	10,641	10,058	6,621	11,758	10,097	7,986	8,799	7,713	7,505	7,180	6,478	6,906	7,378	6,742	6,665	6,200	6,954	5,331	6,853	6,395	7,167	7,161	6,958	7,588	8,018	7,585	6,263	7,915	7,189	7,064	6,390	3,739	9,650	5,837	6,493	6,034	5,945	6,027	3,306	5,400	8,800	7,400	3,200	7,100	7,500	6,800	18,200	-6,300	5,700	5,300	2,000	4,100	3,700	2,500	500	4,200	4,200	4,200	2,900	3,700	3,500	3,600	2,200	2,700	3,100	2,700	1,700	2,400	2,200	2,200	1,400	1,900	1,900	1,800	-	-	-	-
Research Development	13,265	12,665	12,648	15,644	12,689	10,896	10,902	13,210	10,037	10,853	12,701	10,843	7,501	6,763	7,750	8,974	7,000	7,422	7,487	8,747	8,978	8,583	9,406	11,087	12,427	7,521	8,193	9,321	8,462	8,336	11,437	11,749	10,942	11,553	11,321	17,225	10,643	10,938	15,382	13,836	14,209	14,946	11,209	17,818	10,588	10,827	9,409	8,611	9,232	10,350	8,609	8,786	7,996	7,954	7,920	6,662	6,461	6,475	6,777	6,958	5,840	5,217	5,844	5,790	5,529	6,727	6,276	6,539	5,804	6,119	5,422	5,229	9,463	6,283	5,541	5,103	6,584	4,253	4,054	4,102	4,072	4,622	4,997	4,830	4,633	5,110	4,939	5,436	15,146	4,988	4,765	5,499	5,204	4,202	4,134	3,727	3,800	3,800	3,600	4,100	3,900	3,300	3,800	3,800	4,300	4,700	5,000	4,700	4,600	4,700	5,000	4,800	4,900	4,500	4,300	4,100	4,100	4,200	4,300	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Selling And Marketing Expenses	0	0	0	7,200	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Selling General Administrative	111,713	104,901	93,485	90,176	94,661	92,411	92,227	91,841	77,861	75,778	91,218	83,712	73	2,160	64,472	79,402	69,852	64,739	70,004	72,205	72,123	75,100	68,545	79,024	66,200	72,783	64,400	73,100	70,956	71,100	87,500	76,300	78,900	74,600	87,600	59,000	65,700	66,000	68,000	88,100	77,000	70,700	76,500	76,700	86,800	68,700	67,625	65,040	61,376	54,400	55,900	48,100	53,200	51,700	52,600	64,000	53,200	47,500	49,800	57,100	48,000	45,900	47,900	44,000	41,100	38,500	39,439	31,815	33,600	34,741	36,900	29,500	31,250	30,100	30,500	32,700	29,900	27,400	28,100	29,300	24,900	27,900	26,400	25,200	24,500	24,000	24,000	21,800	23,300	21,900	22,006	22,121	22,800	20,832	21,000	21,100	20,500	20,500	20,700	21,200	20,100	20,500	24,900	23,900	20,900	21,400	20,700	23,800	23,100	22,300	23,100	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Tax Provision	12,788	7,924	10,548	3,243	9,280	7,862	5,617	5,586	8,156	5,066	1,446	-16,356	5,492	6,855	-2,547	4,336	7,934	7,602	-9,246	984	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Total Operating Expenses	131,889	124,788	113,606	120,994	115,428	111,528	111,496	116,535	102,914	98,031	116,298	103,181	80,947	78,460	77,287	87,548	85,267	77,261	80,487	87,354	82,855	85,831	77,951	90,111	110,282	80,304	75,054	82,408	79,418	79,454	98,937	94,773	89,882	86,118	98,933	96,827	93,401	95,707	107,944	102,795	103,769	96,454	118,020	105,432	97,368	91,861	77,034	73,651	70,608	72,963	64,840	56,712	64,931	60,744	62,274	70,686	59,613	53,944	56,616	64,015	53,805	51,080	53,703	49,488	46,961	45,273	45,715	32,879	39,414	40,860	42,330	8,389	40,713	36,386	36,029	37,676	36,481	31,638	32,138	33,352	29,017	32,474	31,400	30,079	29,119	29,064	28,955	16,331	38,429	26,847	9,532	14,228	34,063	30,979	31,117	27,991	29,700	33,100	31,700	28,500	31,100	31,300	35,500	38,900	21,800	34,100	32,800	30,400	31,800	30,700	30,700	26,900	29,500	29,000	28,000	26,200	26,700	26,500	26,700	25,000	26,000	26,700	24,700	22,400	22,600	20,900	19,700	18,200	18,000	16,400	15,400	-	-	-	-
Total Other Income Expense Net	-1,949	-10,419	-2,069	-2,629	-1,055	-5,673	-5,273	-3,872	-4,263	-4,588	9,603	199	1,115	31,498	-1,028	-2	-1,876	22,381	-48,721	-2,037	-2,858	-3,039	-1,978	22,017	-806	-1,397	8,000	-57,209	-449	-1,962	-2,177	-7,347	-80,150	-2,606	-2,009	20,283	19,958	18,469	-2,543	19,786	17,955	-2,542	-2,641	-3,022	-2,542	-1,311	336	370	140	1,293	-215	-2,195	-565	1,678	237	-13,620	-266	-801	-335	-103	-1,451	-1,290	375	69	225	731	957	6,530	816	-8,721	912	731	27,092	481	864	165	262	-69	-232	291	335	261	103	772	549	525	563	-10,131	463	755	969	526	959	-22,001	767	-8,536	600	700	1,300	1,300	1,200	1,300	1,300	-700	-24,200	1,000	1,000	1,500	900	900	700	1,100	500	1,100	600	200	600	600	800	1,900	100	400	400	100	-100	200	100	200	-600	300	200	-	-	-	-
Total Revenue	336,250	318,183	311,332	304,416	305,301	297,485	261,458	265,002	259,769	239,897	228,528	225,029	240,371	209,486	195,577	238,492	258,970	252,566	238,451	249,295	247,356	241,581	229,347	233,552	234,043	225,377	210,951	228,066	227,841	220,253	209,956	243,185	233,384	219,693	213,413	226,478	231,827	227,580	224,488	241,091	242,120	235,755	219,543	249,942	247,395	218,178	176,475	186,670	191,160	179,445	170,569	170,033	176,789	166,833	163,039	169,104	165,169	157,070	154,087	152,397	155,447	145,919	144,116	138,739	134,587	121,179	121,936	116,919	113,527	108,487	110,674	110,395	105,677	100,488	103,173	99,975	98,098	90,923	94,602	97,721	90,737	87,488	88,283	80,881	87,115	87,025	81,935	79,053	84,411	80,704	75,801	77,698	75,899	70,570	69,693	69,824	70,800	68,200	69,100	74,400	68,000	67,800	72,000	51,100	75,800	76,600	82,300	83,300	76,600	74,400	75,500	70,400	69,900	69,100	68,800	68,200	65,600	65,300	63,300	64,100	63,200	62,600	58,500	57,500	57,100	53,100	48,600	48,000	45,000	43,200	40,100	39,400	39,300	39,300	39,300

Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue	1,168,660
Cost of Revenue	-553,563
Gross Profit	615,097	615,097

Operating Income (+$)
Gross Profit	615,097
Operating Expense	-459,064
Operating Income	156,033	156,033

Operating Expense (+$)
Research Development	50,131
Selling General Administrative	369,475
Selling And Marketing Expenses	7,200
Operating Expense	459,064	426,806

Net Interest Income (+$)
Interest Income	14,630
Interest Expense	-14,630
Other Finance Cost	-14,630
Net Interest Income	-14,630

Pretax Income (+$)
Operating Income	156,033
Net Interest Income	-14,630
Other Non-Operating Income Expenses	-14,630
Income Before Tax (EBT)	141,403	170,663 EBIT - interestExpense = 141,403 141,403 130,031
Interest Expense	14,630
Earnings Before Interest and Taxes (EBIT)	156,033	156,033
Earnings Before Interest and Taxes (EBITDA)	249,340

After tax Income (+$)
Income Before Tax	141,403
Tax Provision	-26,002
Net Income From Continuing Ops	115,401	115,401
Net Income	115,401
Net Income Applicable To Common Shares	115,401

Non-recurring Events
Discontinued Operations	0
Extraordinary Items	0
Effect of Accounting Charges	0
Other Items	0
Non Recurring	0
Other Operating Expenses	459,064
Total Other Income/Expenses Net	-14,630	29,260

Technical Analysis of Haemonetics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Haemonetics. The general trend of Haemonetics is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Haemonetics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitions	Bullish trend (42.9%)		Bearish trend (-42.9%)
Overbought to neutral	Bullish pullback	=	Bearish reversal
Upper to lower neutral	Bullish correction	=	Bearish continuation
Nuetral to oversold	Oversold	=	Oversold
Oversold to neutral	Bullish reversal	=	Bearish correction
Lower to upper neutral	Bullish continuation	=	Bearish pullback
Nuetral to overbought	Overbought	=	Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.

Score

Let's take a look at the Support & Resistance of Haemonetics Corporation.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 87.34 < 90.12 < 90.53.

The bearish price targets are: 81.50 > 80.23 > 72.86.

Tweet this

Haemonetics Corporation Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

Moving averages are lagging trend indicators.
There are many types of moving averages.
Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Haemonetics Corporation. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

MA 20 trending up: The MA 20 is trending up. +1
Close > MA 20: The price is above the MA 20. +1
MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
MA 50 trending up: The MA 50 is trending up. +1
Close > MA 50: The price is above the MA 50. +1
MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
MA 100 trending up: The MA 100 is trending up. +1
Close > MA 100: The price is above the MA 100. +1
MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
MA 200 trending up: The MA 200 is trending up. +1
Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving Average	Amount of candles	vs. MA 50	vs. MA 100	vs. MA 200
MA 20	20
MA 50	50	-
MA 100	100	-	-
MA 200	200	-	-	-

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shows the moving average of the selected period.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

There are various kinds of moving averages:

Simple moving average (SMA);
Exponential moving average (EMA);
Smoothed moving average (SMMA);
Linear weighted moving average (LWMA).

The moving average looks at a certain period of time and it calculates the price average. The various types of averages are using various formulas. Don’t worry, you don’t have to memorize any formula. All moving averages are calculated automatically by basically every charting software you use. But it’s good to know how moving averages are actually calculated.

Simple moving average

SMA is calculated by summing up the price closures of the selected period. The price is then divided by the selected period. For example, when using the 21 day moving average you sum up all the closing prices for each day and divide that by 21. The result is a line on the chart representing the average. Because it’s an average in the selected timeframe, the trend is always lagging. An moving average looks like this on the chart:

Source: Tradingview.com

In this case, the blue line represents a 21 day moving average. Because the average is based on results from the past, the indicator will always lag behind. For example, when price would suddenly go up, the moving average won't immediately follow.

All other moving averages discussed below look the same on the chart. The only difference is that the line will move in different directions based on the maths behind the used indicators and the amount of days used to determine the average.

Exponential moving average

The EMA gives more weight to the latest closing prices by giving them more value in the equation. EMA is calculated by adding a certain percentage to the latest closing prices:

EMA = (CLOSE (i) * P) + (EMA (i - 1) * (1 - P))

Where:

CLOSE (i) = current period close price.
EMA (i - 1) = value of the Moving Average of a preceding period.
P = the percentage of using the price value.

Smoothed moving average

A smoothed moving average is an exponential moving average with a long lookback period. Older prices are reduced in weight but are never left out in the calculation. Unlike SMA and EMA where prices are removed when they are beyond the selected period. SMMA is a combination of the SMA and EMA. The main advantage is that it smooths out fluctuations in price.

Linear weighted moving average

The LWMA gives the latest price the highest weight and then lineary scales down with each price before that. The result is that the LWMA reacts quicker to changes in price than the SMA or EMA. The formula:

LWMA = ((Pn∗W1)+(Pn−1∗W2)+(Pn−2∗W3)...) / ∑W

Where:

P = Price for the period.
n = The most recent period, n-1 is the prior period, and n-2 is two periods prior.
W = The assigned weight to each period, with the highest weight going first and then descending linearly based on the number of periods being used.

Moving averages are widely used by many traders. Which moving average you need depends on your trading strategy. Common practise is using a combination of multiple periods. For example, the EMA21, EMA50, EMA100 and EMA200. How does that look on a chart:

Source: Tradingview.com

The lowest (purple) line on the chart represents the EMA200 then following up the EMA100, EMA50 and EMA21.

You can use moving averages to determine a trend. The 200 moving average is mostly used as a baseline for determining the current trend:

When the 200 moving average is moving up it is considered a bullish trend.
When the 200 moving average is down it is considered a bearish trend.
When moving averages are flatlined, there is no clear trend so you should look for market structure, consolidation or trend reversals. Depending on how you want to trade.

This is not set in stone. Most trading strategies use multiple moving averages each with different settings. While one strategy might use the EMA20, the other uses the SMA21. There can be hundreds of different variations. Moving averages can also be used as support and resistance. More often than not, prices will bounce on moving averages.

Haemonetics Corporation Daily Moving Averages Chart

2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

MACD is a lagging momentum indicator.
Uses two moving averages.
Can show buy or sell signals based on momentum.
Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Haemonetics Corporation. The current macd is 1.11623297.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Haemonetics price going down in the near term. -2
MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Haemonetics. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Haemonetics price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1

Haemonetics Corporation Daily Moving Average Convergence/Divergence (MACD) Chart

2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.

Score

Let's take a look at the Directional Movement Index (DMI) of Haemonetics Corporation. The current adx is 26.66.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Haemonetics shares, leading to potential upward momentum in its price. +1
PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2

Haemonetics Corporation Daily Directional Movement Index (DMI) Chart

2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

Parabolic SAR (stop and reverse) is a lagging trend indicator.
Shows the current trend.
Shows potential entry signals.
Shows potential exit signals.
Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Haemonetics Corporation. The current sar is 80.15.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1

Haemonetics Corporation Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

Leading momentum indicator, meaning the signals are instant.
Ranges between 0 and 100.
Above 70 is considered overbought.
Below 30 is considered oversold.
Above or below 50 can also be used to determine price trend or support and resistance.
RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Haemonetics Corporation. The current rsi is 57.35. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
Trending up: The RSI is trending up. +1

Measures the speed and change of price movements.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

The RSI measures the magnitude of recent price changes to determine if the asset is overbought or oversold.

Overbought (RSI above 70) means that the trading price is above its intrinsic value. This might indicate a sell or short signal.
Oversold (RSI below 30) means that the trading price is below its intrinsic value. This might indicate a buy or long signal.
RSI levels above or below 50 can also be used to determine a trend.
RSI divergence looks at a deviation between RSI and price movement.
Can be used in many different ways.

Original usage

Keep in mind that almost every indicator can be used in different ways. Even beyond the orginal settings. The relative strength index was developed by J. Welles Wilder. Wilder recommended a smoothing period of 14 days. That means a 14 day moving average (read more about this setting below). Another quote from the wikipedia page:

Wilders also considers the RSI 50 line as both support and resistance. I recommend to always read the original settings first before using an indicator. Many traders and websites are using their own version of the indicator which might be confusing.

How you can use RSI (Divergence)

First and foremost, there is no real right or wrong usage of the RSI indicator. You can use it in any way you want. Wilder recommends using a 14 day average but you can make it 50 or 100 if you like. Just keep in mind that using an indicator is just part of a larger trading plan. In other words, it’s not recommended to do any trading or investing based on a single indicator like the RSI.

The RSI is measured on a scale between 0 and 100. From 30 till 0 is considered oversold. and from 70 -100 is overbought. The RSI is a leading indicator, meaning the signals are instant.

I like to use the RSI as a trend\momentum indicator and not as an overbought or oversold indicator. I use the middle (50) as the baseline. When prices go above RSI 50 the trend is bullish and can indicate long positions. When below 50 it is considered bearish and can indicate short positions. Other traders use the 70 and 30 levels as overbought/oversold depending on the used strategy. The RSI indicator looks like this:

Source: Tradingview.com

The general concensus is that an RSI above 70 indicates that the security is overbought. In other words, the price this security is trading for is to high and should come down. So if RSI hits 70 or above this might indicate a sell signal or taking a short position (expecting the price will go down). Although RSI above 70 indicates the security is trading above it's fair value, that does not mean the price will go down.

Use tradingview to add indicators

I highly recommend using tradingview to add indicators to a chart. It has all the indicators you can think off and can add them for free (up to three indicators) to any chart you want. You can see that the levels 30 and 70 are marked with a dotted line. If you want you can remove these lines or give it another colour using Tradingview. You can also adjust the moving average used. You can also find RSI indicators made by the community that include other settings like RSI divergences.

Tradingview

Use Tradingview to (back)test your strategies and add hundreds of indicators created by the community.

View tool on Tradingview.com

RSI divergence

RSI is not only used to determine momentum but can also spot reversals or continuations of the trend. A reversal means that the trend is going in the opposite direction. From bullish to bearish or from bearish to bullish. These reversals can be spotted by looking at the price and the direction of the RSI. When the price is going up but the RSI is going down that means there is a divergence. This is also the case when RSI goes up but price is going down.

There are four types of divergences:

Regular bullish divergence
Regular bearish divergence
Hidden bullish divergence
Hidden bearish divergence

Regular bullish divergence

With a regular bullish divergence, the price is making lower highs but the oscillator (in this case the RSI) is making higher lows. A regular bullish divergence might indicate the end of the current trend. You’ll see regular bullish divergences mostly at the end of a downtrend. But that does not mean that every regular bullish divergence is a trend reversal.

Price is making lower highs
RSI is making higher lows
Indicating bullish reversal (price might go up)

Source: Tradingview.com

Regular bearish divergence

With a regular bearish divergence the price is making higher highs but the oscillator (in this case the RSI) is making lower highs. This might indicate the end of an uptrend.

Price is making higher highs
RSI is making lower highs
Indicating bearish reversal

Source: Tradingview.com

Hidden bullish divergence

With a hidden bullish divergence, the price is making a higher low while the RSI is making a lower low. This might indicate bullish trend continuation.

Price is making higher lows
RSI is making lower lows
Indicating bullish continuation

Source: Tradingview.com

As you have noticed, you can have multiple divergences in a row.

Hidden bearish divergence

With a hidden bearish divergence, price is making lower highs but RSI is making higher highs. This might indicate bearish trend continuation.

Price is making lower highs
RSI making higher highs
Indicating bearish continuation

Source: Tradingview.com

You can find many cheatsheets of RSI divergences online. Search for "RSI divergence overview" and you'll find a lot of examples. You can print these to learn the various types of divergences.

Haemonetics Corporation Daily Relative Strength Index (RSI) Chart

3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

Leading momentum indicator, meaning the signals are instant.
Used to determine overbought and oversold areas much like the RSI.
Ranges between 0 and 100.
Above 80 is considered overbought.
Below 20 is considered oversold.
Consists of two lines named K and D.
K compares the highest high and lowest low on the selected price range.
The D line is a moving average of the K line.
Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Haemonetics Corporation. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Haemonetics price going up in the near term. +2
Trending up: The STOCH %K is trending up. +1

Haemonetics Corporation Daily Stochastic Oscillator Chart

3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

Lagging or leading Momentum indicator
When the CCI is above zero, the price is above the historical average
When the CCI is below zero, the price is below the historical average
Used for spotting trends
- If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
- If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Haemonetics Corporation. The current cci is 22.45.

Haemonetics Corporation Daily Commodity Channel Index (CCI) Chart

3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

Lagging momentum indicator
Ranges between +100 and -100
Considered overbought above +50
Considered oversold below -50
It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Haemonetics Corporation. The current cmo is 13.25.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1

Haemonetics Corporation Daily Chande Momentum Oscillator (CMO) Chart

3.5 Williams %R

Shows the current price relative to the highest high over the last 14 days.

Lagging momentum indicator
Ranging between 0 and -100
Above -20 is considered overbought
Below -80 is considered oversold
Is prone to give false signals

Score

Let's take a look at the Williams %R of Haemonetics Corporation. The current willr is -31.57162726.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Haemonetics is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.

Haemonetics Corporation Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

Lagging volatility indicator
Uses 3 bands: one upper, one lower and one in the middle
Works best when the middle band reflects an intermediate trend (MA20).
When the price is moving closer to the upper band, the market might be overbought
When the price is moving closer to the lower band, the market might be oversold

Score

Let's take a look at the Bollinger Bands of Haemonetics Corporation.

Haemonetics Corporation Daily Bollinger Bands Chart

4.2 Average True Range (ATR)

Measures market volatility

Leading volatility indicator
Can be used to determine stop-loss positions
Calculated by:
- Current high minus the current low
- Current high minus the previous close
- Current low minus the previous close
The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Haemonetics Corporation. The current atr is 2.01681433.

Haemonetics Corporation Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Measures market volatility

Leading momentum indicator
Calculation:
- If the closing price is above the previous closing price: OBV = previous OBV + current volume
- If the closing price is below the previous closing price: OBV = previous OBV - current volume
- If the closing price is the same as the previous closing price than the OBV is the same.
Can be used to confirm price trends
Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Haemonetics Corporation. The current obv is 11,616,929.

Haemonetics Corporation Daily On-Balance Volume (OBV) Chart

5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

Lagging momentum indicator
Looks like RSI but uses volume as an extra metric (RSI only considers price)
Above 80 is considered overbought
Below 20 is considered oversold
Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Haemonetics Corporation. The current mfi is 40.38.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

MFI < 50: -1

Haemonetics Corporation Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

Type	Notification	Date
Currently no notifications for Haemonetics Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

Date	Indicator	Signal
2023-11-30	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-01	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2023-12-04	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2023-12-05	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-06	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
2023-12-07	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-08	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2023-12-12	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-13	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
2023-12-14	STOCH	LONG EXIT		The %K line crosses below the %D line.
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
2023-12-15	MFI	LONG ENTRY	SHORT CLOSE	80 crossover to upside
2023-12-18	MFI	SHORT ENTRY	LONG CLOSE	80 crossover to downside
2023-12-21	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2023-12-22	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2023-12-26	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-29	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-01-03	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-01-04	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-08	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
	MFI	SHORT ENTRY	LONG CLOSE	20 crossover to downside
2024-01-09	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-01-10	STOCH	LONG EXIT		The %K line crosses below the %D line.
	MFI	LONG ENTRY	SHORT CLOSE	20 crossover to upside
2024-01-18	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-19	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-01-22	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
2024-01-23	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-01-24	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-25	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-01-29	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-30	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-31	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-02-01	RSI	LONG ENTRY	SHORT CLOSE	30 crossover to upside
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-02	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-02-06	RSI	LONG ENTRY	SHORT CLOSE	30 crossover to upside
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-08	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
2024-02-09	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-02-12	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-13	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-02-15	RSI	LONG ENTRY	SHORT CLOSE	30 crossover to upside
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-20	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-21	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-22	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
2024-02-23	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-27	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-28	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-02-29	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-03-01	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-04	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-03-05	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-06	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
2024-03-07	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-08	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
2024-03-11	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-14	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-03-18	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-19	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-03-20	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-03-22	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-25	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
2024-03-26	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-27	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-04-01	RSI	SHORT ENTRY	LONG CLOSE	70 crossover to downside
	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-04	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-09	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
2024-04-10	RSI	SHORT ENTRY	LONG CLOSE	70 crossover to downside
	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-12	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
2024-04-15	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
2024-04-18	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-04-19	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-04-22	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-04-23	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.

6.3. Candlestick Patterns

Haemonetics Corporation Daily Candlestick Chart

Date	Candlestick Pattern

6.4. Technical Score

Let's check the technical score of Haemonetics Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	57.347
Ma 20	Greater than	Ma 50	84.555
Ma 50	Greater than	Ma 100	79.185
Ma 100	Greater than	Ma 200	81.078
Open	Greater than	Close	84.200
Total			2/5 (40.0%)

Create your own Symbol Scanner

Get notifications about Haemonetics Corporation

I send you an email if I find something interesting about Haemonetics Corporation.

Haemonetics Corporation Buy, Hold or Sell?

Let's analyse Haemonetics together

Get notifications about Haemonetics Corporation

Quick analysis of Haemonetics (30 sec.)

What can you expect buying and holding a share of Haemonetics? (30 sec.)

How much money do you get?

What is your share worth?

+ What do you gain per year?

For what price can you sell your share?

1. Valuation of Haemonetics (5 min.)

$85.07

$18.34

$-60.73 - $-0.81

$-42.39 - $17.52

2. Growth of Haemonetics (5 min.)

Is Haemonetics growing?

How much money is Haemonetics making?

How much money comes from the company's main activities?

3. Financial Health of Haemonetics (5 min.)

4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)

Industry Rankings (Medical Instruments & Supplies)

What can you expect buying and holding a share of Haemonetics? (5 min.)

What can you expect buying and holding a share of Haemonetics?

Speculation

Investing

How much money are you going to get?

When do you get the money?

How sure are you?

Linear %

Fundamentals of Haemonetics

About Haemonetics Corporation

Financial Health

Valuation

1.1. Profitability of Haemonetics Corporation.

1.1. Profitability

1.1.1. Net Profit Margin

Trends

Compared to industry (Medical Instruments & Supplies)

1.1.2. Return on Assets

Trends

Compared to industry (Medical Instruments & Supplies)

1.1.3. Return on Equity

Trends

Compared to industry (Medical Instruments & Supplies)

1.2. Operating Efficiency of Haemonetics Corporation.

1.2. Operating Efficiency

1.2.1. Operating Margin

Trends

Compared to industry (Medical Instruments & Supplies)

1.2.2. Operating Ratio

Trends

Compared to industry (Medical Instruments & Supplies)

1.3. Liquidity of Haemonetics Corporation.

1.3. Liquidity

1.3.1. Current Ratio

Trends

Compared to industry (Medical Instruments & Supplies)

1.3.2. Quick Ratio

Trends

Compared to industry (Medical Instruments & Supplies)

1.4. Solvency of Haemonetics Corporation.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Trends

Compared to industry (Medical Instruments & Supplies)

1.4.2. Debt to Equity Ratio

Trends

Compared to industry (Medical Instruments & Supplies)

2. Market Valuation of Haemonetics Corporation

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Trends

Compared to industry (Medical Instruments & Supplies)

Haemonetics Corporation
Buy, Hold or Sell?